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Abstract
I. Enantioselective Nickel-Catalyzed Reductive Couplings of Alkynes and Aldehydes
Allylic alcohol synthesis via a nickel-catalyzed reductive coupling reaction of alkyl-
substituted alkynes and aldehydes was studied for ligand effects with respect to the
regioselectivity and enantioselectivity of the coupling process. A class of P-chiral,
ferrocenyl phosphines was designed, synthesized, and evaluated for efficacy. Ultimately,
these phosphines were found to be the most effective chiral ligands for coupling reactions of
this class of alkynes, providing (E)-allylic alcohols in up to 67% ee and 85:15
regioselectivity.
Ni(cod)2 (10 mol%)
o ligand (20 mol%) OH OH
Cy Me + H Me Et3B (200 mol%) Me Me eC _ e Cy Me
Me Me Me Cy Me
~_ 3a 3b
ligand = Fe V Ph
R
II. Total Syntheses of Amphidinolides T and T4 via Catalytic, Stereoselective
Reductive Macrocyclizations
Total syntheses of amphidinolides T and T4 were achieved using two nickel-
catalyzed reductive coupling reactions of alkynes, with an epoxide in one case
(intermolecular) and with an aldehyde in another (intramolecular). The latter was used to
effect a macrocyclization, form a C-C bond and install a stereogenic center with >10:1
selectivity in both natural product syntheses. Alternative approaches in which
intermolecular alkyne-aldehyde reductive coupling reactions would serve to join key
fragments were investigated and are also discussed; it was found that macrocyclization was
superior in several respects (diastereoselectivity, yield, and length of syntheses). Alkyne-
epoxide couplings were instrumental in the construction of key fragments corresponding to
approximately half of the molecule of both natural products. In one case (T4 series), the
alkyne-epoxide coupling exhibited very high site selectivity in a coupling of a diyne. A
model for the stereoselectivity observed in the macrocyclizations is also proposed.
Me
Me CH2
HO
-1~ Me.,
Me
amphidinolide T1 amphidinolide T4
* site of catalytic, stereoselective macrocyclization
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Abbreviations
Ac acetyl
Bn benzyl
Bu butyl
cod cyclooctadiene
Cp cyclopentadienyl
Cy cyclohexyl
dba dibenzylideneacetone
DCC N,N'-dicyclohexylcarbodiimide
DIOP 2,3-O.-isopropylidene-2,3-dihydroxy- 1,4-bis(diphenylphosphino)butane
DMAP 4-dimethylaminopyridine
DMF N,N'-dimethylformamide
DTBMP 2,6-di-tert-butyl-4-methylpyridine
E:DCI 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
Et ethyl
Fc ferrocenyl
g grams
h hours
Hex hexyl
HKR hydrolytic kinetic resolution
HMDS hexamethyldisilamide
HMPA hexamethylphosphoramide
i-Pr isopropyl
LDA lithium diisopropylamide
Me methyl
mg milligram
MOM methoxymethyl
NBS N-bromosuccinimide
NHK Nozaki-Hiyama-Kishi
NMDPP neomenthyldiphenylphosphine
NMO N-methylmorpholine-N-oxide
nOe nuclear Overhauser effect
Oct octyl
OTf trifluoromethanesulfonate
PAMP phenyl(o-anisyl)(methyl)phosphine
P'h phenyl
Py pyridine
t-Bu tert-butyl
TBS tert-butyldimethylsilyl
TBAF tetrabutylammonium fluoride
TMS trimethylsilyl
THF tetrahydrofuran
TPAP tetrapropyl ammonium perruthenate
Ts p-toluenesulfonyl
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Chapter 1
Enantioselective Nickel-Catalyzed Reductive Coupling Reactions of
Alkynes and Aldehydes
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Introduction
Chiral allylic alcohols] are found in many natural products with potential therapeutic
applications2 and, importantly, provide a means for stereoselective functionalization in organic
synthesis.3 Accordingly, several catalytic enantioselective methods of allylic alcohol preparation
have been described and can be divided into three types - additions of organometallic reagents to
carbonyls, carbonyl reduction,4 and kinetic resolution 5 of racemic allylic alcohols. Significantly,
the first of these forms a carbon-carbon bond in the course of the reaction, rendering the process
amenable to fragment coupling within the context of total synthesis. This potential has attracted
a considerable amount of interest in the chemical community and has resulted in the
development of a number of enantioselective methods that fall within this subgroup of allylic
alcohol assembly strategies.
For reviews of useful reactions of allylic alcohols: (a) Briickner, R., in Comprehensive Organic Synthesis, Trost, B.
M., Ed.; Pergamon, New York, 1991; vol. 6, Ch. 4.6, 873-908. (b) Hill, R. K., ibid., vol. 5, Ch. 7.1, 785-826. (c)
Wipf, P., ibid., vol. 5, Ch. 7.2, 827-873.
2 Terpestacin: (a) Iimura, S.; Oka, M.; Narita, Y.; Konishi, M.; Kakisawa, H.; Gao, Q.; Oki, T. Tetrahedron Lett.
19'93, 34 493-496. (b) Oka, M.; Iimura, S.; Tenmyo, O.; Sawada, Y.; Sugawara, M.; Ohkusa, N.; Yamamoto, H.;
Kawano, K.; Hu, S.-L.; Fukagawa, Y.; Oki, T. J. Antibiotics 1993, 46, 367-373. (c) Oka, M.; Iimura, S.; Narita, Y.;
Furumai, T.; Konishi, M.; Oki, T.; Gao, Q.; Kakisawa, H. J. Org. Chem. 1993, 58, 1875-1881. Acutiphycin: (d)
Moore, R. E.; Patterson, G. M. L. J. Am. Chem. Soc. 1984, 106, 8193-8197. Epothilones: (e) Bollag, D. M.;
McQueney, P. A.; Zhu, J.; Hensens, O.; Koupal, L.; Liesch, J.; Goetz, M.; Lazarides, E.; Woods, C. M. Cancer
Research 1995, 55, 2325-2333. Chondropsins: (f) Cantrell, C. L.; Gustafson, K. R.; Cecere, M. R.; Pannell, L. K.;
Boyd, M. R. J. Am. Chem. Soc. 2000, 122, 8825-8829. (g) Rashid, M. A.; Gustafson, K. R.; Boyd, M. R.
Tetrahedron Lett. 2001, 42, 1623-1626. (h) Rashid, M. A.; Cantrell, C. L.; Gustafson, K. R.; Boyd, M. R. J. Nat.
Prod. 2001, 64, 1341-1344. (i) Bowman, E. J.; Gustafson, K. R.; Bowman, B. J.; Boyd, M. R. J. Biol. Chem. 2003,
278, 44147-44152.
3 Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 1307-1370.
4 Ohkuma, T.; Koizunmi, M.; Doucet, H.; Pham, T.; Kozawa, M.; Murata, K.; Katayama, E.; Yokozawa, T.; Ikariya,
T.; Noyori, R. J. Am. Chem. Soc. 1998, 120, 13529-13530.
5 Martin, V.S.; Woodard, S.S.; Katsuki, T.; Yamada, Y.; Ikeda, M.; Sharpless, K.B. J. Am. Chem. Soc. 1981, 103,
6237-6240.
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The methods of Oppolzer6 and Wipf7 form a carbon-carbon bond using different
transition metals, by first preparing organometallic reagents by way of hydrometalation of a
terminal alkyne (hydroboration and hydrozirconation, respectively). In each case,
transmetalation with a dialkylzinc reagent precedes addition of a chiral ligand (amino alcohol
and amino thiol, respectively) and an aldehyde (Scheme 1). The (E)-disubstituted allylic alcohol
products are obtained in good to high yields and, in many cases, in very high enantiomeric
excess. These procedures are not as effective with internal acetylenes (e.g., Et-C-C-Et) as
interconversion of the (E) and (Z) isomers has been reported to occur upon transmetalation with
the organozinc reagent.8
Scheme 1
Oppolzer Method 6
1. c-hex 2BH
2. Et 2Zn
3. R'CHO,
(+)-DAIB (1 mol%)
Wipf Method 7
1. Cp 2 ZrHCI
2. Me 2Zn
3. R'CHO,
amino thiol (10 mol%)
OH
R R'
79-98% ee,
67-94% yield
OH
R R'
63-99% ee,
63-83% yield
6 (a) Oppolzer, W.; Radinov, R. N. Helv. Chim. Acta, 1992, 75, 170-173. (b) Oppolzer, W.; Radinov, R. N. J. Am.
Chem. Soc. 1993, 115, 1593-1594. (c) Oppolzer, W.; Radinov, R. N.; El-Sayed, E. J. Org. Chem. 2001, 66, 4766-
4770.
7 (a) Wipf, P.; Ribe, S. J. Org. Chem. 1998, 63, 6454-6455. (b) Wipf, P.; Xu, W. Org. Synth. 1997, 74, 205-211.
8 (a) Wipf, P.; Xu, W. Tetrahedron Lett. 1994, 35, 5197-5200. In later work Wipf has reported the reductive
coupling of aldehydes and imines and internal alkynes without EIZ- isomerization. Aldehydes: (b) Wipf, P.;
Kendall, C. Chem. Eur. J. 2002, 8, 1778-1784. Imines: (c) Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am.
Chem. Soc. 2003, 125, 761-768. (b) Wipf, P.; Stephenson, C. R. J.; Okumura, K. J. Am. Chem. Soc. 2003, 125,
14694-14695.
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Me Me
-, MeO H
GoC NMe2
(+)-DAIB
Me NMe 2
SH
amino thiol
K 
r -
Another well-known method for chiral allylic alcohol synthesis, the Nozaki-Hiyama-
Kishi (NHK) reaction, 9 involves a chromium-mediated coupling of an alkenyl halide with an
aldehyde. While several catalytic, enantioselective methods have been developed for related
NHK couplings involving allylic halides (resulting in the asymmetric synthesis of homoallylic
alcohols), l ° there are few reports of the use alkenyl halides in such an enantioselective manner.
The method of Kishi using a chromium/nickel/zirconium/manlganese system generates 1,1-
disubstituted allylic alcohols in up to 86% ee when a chiral sulfonamide ligand is employed
(Scheme 2).11 Contemporaneously with this work, Paterson developed enantioselective
couplings of alkenyl iodides and triflates with aldehydes exploiting the efficacy of chiral salen
ligands in combination with a chromium/nickel/manganese/chlorotrimethylsilane system
(Scheme 3). 12 To date, however, there are no reports of catalytic, enantioselective NHK
reactions that generate a trisubstituted allylic alcohol moeity.
Scheme 2. Kishi's Enantioselective NHK Method. 1lb
CrCI 2 (10 mol%), ligand (11 mol%)
i-Pr2NEt (11 mol%) OH
Pplh_ L'-H NiCI 2(dppp) (2 mol%), Cp2ZrCI (100 mol%)
Mn (200 mol%), LiCI (200 mol%) Ph
+ - MeCNBu
MeCN 86% ee, 92% yield
"<'n-Bu
9 (a) Okude, Y.; Hirano, S.; Hiyama, T.; Nozaki, H. J. Am. Chem. Soc. 1977, 99, 3179-3181. (b) Jin, H.; Uenishi, J.;
Chr-ist, W. J.; Kishi, Y. J. Am. Chem. Soc. 1986, 108, 5644-5646. (c) Takai, K.; Tagashira, M.; Kuroda, T.; Oshima,
K.; Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 1986, 108, 6048-6050. (d) Frstner, A.; Shi, N. J. Am. Chem. Soc.
1996, 118, 2533-2534. (e) Fiirstner, A.; Shi, N. J. Am. Chem. Soc. 1996, 118, 12349-12357.
10 (a) Bandini, M.; Cozzi, P. G.; Melchiorre, P.; Umani-Ronchi, A. Angew. Chem. Int. Ed. 1999, 38, 3357-3359. (b)
Bandini, M.; Cozzi, P. G.; Umani-Ronchi, A. Polyhedron 2000, 19, 537-539. (c) Inoue, M.; Suzuki, T.; Nakada, M.
J. Am. Chem. Soc. 2003, 125, 1140-1141. (d) Kurosu, M.; Lin, M.-H.; Kishi, Y. J. Am. Chem. Soc. 2004, 126,
12248-12249.
' ('a) Choi, H.; Nakajima., K.; Demeke, D.; Kang, F.-A.; Jun, H.-S.; Wan, Z.-K.; Kishi, Y. Org. Lett. 2002, 4, 4435-
4438. (b) Namba, K.; Kishi, Y. Org. Lett. 2004, 6, 5031-5033.
2 ]Berkessel, A.; Menche, D.; Sklorz, C. A.; Schr6der, M.; Paterson, I. Angew. Chem. Int. Ed. 2003, 42, 1032-1035.
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OMe
W .OMe
O OMe
ligand = N NH
t-Bu SO2
K
Scheme 3. Paterson's Enantioselective NHK Method. 2
0
PMBO/- H
I"n-Bu
CrCI 3 (10 mol%), NiCI 2 (2 mol%)
NEt 3 (20 mol%), ligand (10 mol%)
Mn (300 mol%), Me3SiCI (150 mol%)
THF
OH
PMBO-/'n-Bu
75% ee, 59% yield
O
PMBO- H
+
OH
PMBO
n-Bu
61% ee, 54% yield
OTf
'n-Bu
Chiral allylic alcohols can also be obtained by way of in situ reductive coupling of an
alkyne and an aldehyde. Several methods that involve stoichiometric use of early transition
metals have been described. Buchwald,l 3 Livinghouse,' 4 and Negishi' 5 have found that
zirconocene-alkyne complexes may be coupled with aldehydes and ketones to fonn
oxametallacyclopentenes which, upon hydrolysis, produce allylic alcohols (Scheme 4).
Scheme 4. Reductive Coupling of Aldehydes with Metal-Alkyne Complexes.'3 -' 5
R
R'CHO R
MLn
R' 
hydrolysis
im- -
OH
R R'
R
M=Zr, Ta, Ti I
13 Buchwald, S. L.; Watson, B. T.; Huffman, J. C. J. Am. Chem. Soc. 1987, 10, 2544-2546.
4 Van Wagenen, B. C.; Livinghouse, T. Tetrahedron Lett. 1989, 30, 3495-3498.
'5 Takagi, K.; Rousset, C. J.; Negishi, E. J. Am. Chem. Soc. 1991, 113, 1440-1442.
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ligand =
MLn
R R
Comparable reactivity has been found for other early transition metals. Takai and Utimoto' 6
have demonstrated that tantalum-alkyne complexes add to aldehydes to form allylic alcohols.
Sato17 has shown an analogous transformation using titanium-alkyne complexes. A subsequent
report by the same group has shown that optically enriched allylic alcohols can be obtained via
stoichiometric use of'chiral titanium-alkyne complexes derived from menthol. 18
Recent advances in the reductive coupling of alkynes and aldehydes have included
catalytic methods for the reductive coupling of alkynes and aldehydes. The first intramolecular
variant'9 was reported by Crowe using a titanium catalyst. Montgomery20 later developed
reductive cyclizations of alkynals employing diethylzinc as a reducing agent and a nickel catalyst
derived from Ni(cod) 2 and tributylphosphine. Despite the success of this catalyst system in an
intramolecular fashion, Montgomery reported that it is not an effective promoter of
intermolecular reductive coupling although intermolecular three-component coupling can be
achieved in the absence of tributylphosphine (Scheme 5).2° a The first such intermolecular
reductive coupling of alkynes and aldehydes was reported by our group21 using a nickel catalyst
system composed of Ni(cod)2, trialkylphosphine, and triethylborane providing (E)-trisubstituted
allylic alcohols in good yield (Scheme 6).22
16 (a) Takai, K.; Kataoka., Y.; Utimoto, K. J. Org. Chem. 1990, 55, 1707-1708. (b) Kataoka, Y.; Miyai, J.; Oshima,
K.; Takai, K. Utimoto, K. J. Org. Chem. 1992, 57, 1973-1981.
17 Harada, K.; Urabe, H.; Sato, F. Tetrahedron Lett. 1995, 36, 3203-3206.
18 Takayanagi, Y.; Yamashita, K.; Yoshida, Y.; Sato, F. Chem. Commun. 1996, 1725-1726.
19 Crowe, W. E.; Rachita, M. J. J. Am. Chem. Soc. 1995, 117, 6787-6788.
20 (a) Oblinger, E.; Montgomery, J. J. Am. Chem. Soc. 1997, 119, 9065-9066. (b) Tang, X.-Q.; Montgomery, J. J.
Am. Chem. Soc. 1999, 121, 6098-6099. (c) Tang, X.-Q.; Montgomery, J. J. Am. Chem. Soc. 2000, 122, 6950-6954.
(d) Review: Montgomery, J. Acc. Chem. Res. 2000, 33, 467-473.
21 Huang, W.-S.; Chan, J.; Jamison, T. F. Org. Lett. 2000, 2, 4221-4223.
22 After the work discussed in this thesis was published, Montgomery reported the intermolecular reductive coupling
of alkynes and aldehydes catalyzed by Ni(cod) 2 and an imidazolium carbene ligand in the presence of triethylsilane,
affording allylic triethylsilyl ethers. Mahandru, G. M.; Liu, G.; Montgomery, J. J. Am. Chem. Soc. 2004, 126,
3698-3699.
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Scheme 5. Montgomery's Ni-Catalyzed Couplings of Alkynes and Aldehydes.20
H
"-R1
X = CH 2, NR'
n = 1,2
PBu3
Ni(cod) 2 (5-20 mol%)
R2Zn (250-300 mol%)
THF no
additive
H
HO R
X nR
HO R 1
/h
PBu 3
Ni(cod) 2 (5-20 mol%)
R2Zn (250-300 mol%)
THF no
additive
reductive coupling
not observed
R OH
R1 - R2
Scheme 6. Jamison's Intermolecular Reductive Coupling of Alkynes and Aldehydes.21
Ni(cod)2 (10 mol%)
PBu3 (20 mol%)
Et 3B (200 mol%)
OH
R 1 R3
R2
R1 = alkyl, aryl
R2 = alkyl, H, SiMe 3
16
H
H R 2
R2 -- R1
0
H R 3
Allylic Alcohols Produced with High Regioselectivity
OH OH OH
R 1 R2 R1 R2 Ar R2
SiMe 3 H R 1
Several intra- and intermolecular variants of nickel-catalyzed alkyne-carbonyl reductive
and alkylative coupling reactions have been described in the literature.2 3 While mechanistic
proposals are essentially speculative, there are two predominant mechanistic frameworks that
have been suggested to account for the observed reactivity. Generally, the first involves the
oxidative cyclization of a nickel (0) complex, alkyne and carbonyl compound to form an
oxanickelacyclopentene intermediate.242526 Transmetalation of an alkyl-metal containing 3-
hydrogen substituents generates an alkenyl-nickel species. Subsequent P-hydride elimination
produces a nickel hydride complex which may then undergo reductive elimination to afford the
final product. In the context of the reaction that we have developed (mechanism I in Scheme 7),
triethylborane is utilized as the alkyl-metal reagent and, importantly, may play a dual role as
reducing agent and aldehyde activator26 a in the promotion of the oxidative cyclization event.
23 Reviews: (a) Montgomery, J. Angew. Chem. Int. Ed. 2004, 43, 3890-3908. (b) Montgomery, J. Acc. Chem. Res.
2000, 33, 467-473. (c) Ikeda, S. Angew. Chem. Int. Ed. 2003, 42, 5120-5122. (d) Miller, K. M.; Molinaro, C.;
Jamison, T. F. Tetrahedron. Asymmetry 2003, 14, 3619-3625.
24 For mechanistic proposals of nickel-catalyzed alkyne-aldehyde coupling reactions that invoke an
oxametallacyclopentene intermediate, see: (a) Tsuda and Saegusa, reference 36. (b) Montgomery, references 20a,
20b, and 22. (c) Miller, K. M.; Huang, W.-S.; Jamison, T. F. J. Am. Chem. Soc. 2003, 125, 3442-3443. (d) Chan,
J.; Jamison. T. F. J. Am. Chem. Soc. 2004, 126, 10682-10691. (e) Miller, K. M.; Jamison, T. F. J. Am. Chem. Soc.
2004, 126, 15342-15343.
25 For x-ray crystal structures of oxanickelacyclopentene structures, see: (a) Walther, D.; Briunlich, G.; Kempe, R.;
Sieler, J. J. Organomet. Chem. 1992, 436, 109-120. (b) Bennett, M. A.; Hockless, D. C. R.; Wenger, E.
Organometallics 1995, 14, 2091-2101. (c) Cmpura, J.; Maya, C. M.; Palma, P.; Carmona, E.; Graiff, C.;
Tirpicchio, A. Chem. Commun. 2003, 1742-1743.
26 For mechanistic proposals invoking related nickelacycles resulting from the oxidative cyclization of alkynes and
allkenes, see: (a) Kimura, M.; Fujimatsu, H.; Ezoe, A.; Shibata, K.; Shimizu, M.; Matsumoto, S.; Tamaru, Y.
Angew. Chem. Int. Ed. 1999, 38, 397-400. (b) Chowdhury, S. K.; Amarasinghe, K. K. D.; Heeg, M. J.;
Montgomery, J. J. Am. Chem. Soc. 2000, 122, 6775-6776. (c) Including a crystal structure: Amarasinghe, K. K. D.;
Chowdhury, S. K.; Heeg, M. J.; Montgomery, J. Organometallics 2001, 20, 370-372. (d) Sato, Y.; Takanashi, T.;
Mori, M. Organomezallics 1999, 18, 4891-4893. (e) Sato, Y.; Saito, N.; Mori, M. J. Am. Chem. Soc. 2000, 122,
23;71-2372.
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Scheme 7. Proposed Mechanism (I) Proceeding via an Oxanickelacyclopentene Intermediate.
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Another possible mechanism for the nickel-catalyzed reductive coupling of alkynes and
carbonyl compounds involves a hydrometalation event.27'28 For the reaction in Scheme 6, this
type of mechanism can be envisioned to proceed first by oxidative addition of a nickel (0)
complex into a carbon-boron bond of triethylborane (proposed mechanism II, Scheme 8).
Elimination of a P-hydride would fonn a nickel-hydride species that could undergo migratory
insertion into an alkyne. Subsequent association of the aldehyde and migratory insertion would
27 For nickel-catalyzed alkyne-aldehyde reductive coupling reactions that propose a hydrometalation pathway, see:
(a) Montgomery, reference 22. (b) Jamison, reference 24e.
28 For related nickel-catalyzed coupling reactions of alkynes and alkenes that suggest a hydrometalation event as part
of the operating mechanism, see: (a) Sato, Y.; Takimoto, M.; Hayashi, K.; Katsuhara, T.; Takagi, K.; Mori, M. J.
Am. Chem. Soc. 1994, 116, 9771-9772. (b) Sato, Y.; Takimoto, M.; Mori, M. J. Am. Chem. Soc. 2000, 122, 1624-
1634.
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transmetallation
I
generate an alkoxy-nickel complex. Finally, reductive elimination
diethylboryl ether, which would be cleaved to the allylic alcohol upon
Scheme 8. Proposed Hydrometalation Mechanistic Pathway (II).
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At the outset: of this work, examples of asymmetric catalytic reductive or alkylative
coupling of alkynes and aldehydes not involving an initial stoichiometric hydrometalation of the
al:kyne had not been described in the literature.29 As a variety of chiral phosphines have proven
to be effective and highly selective ligands for an array of enantioselective transition metal-
catalyzed reactions,3 0 it was anticipated that the use of a chiral phosphine ligand might induce
enantioselectivity in the transformation depicted in Scheme 6. Since the introduction of DIOP in
29 Krische has since reported Rh-catalyzed catalytic, enantioselective reductive coupling reactions of 1,3-diynes and
glyoxals. Huddleston, R. R.; Jang, H.-Y.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 11488-11489.
30 (a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley & Sons: New York, 1994; Chapter 2. (b)
Ojirna, ., Ed. Catalytic Asymmetric Synthesis; VCH Publishers: Weinheim, 1993; Chapter 1. (c) Pietrusiewicz, K.
M.; Zablocka, M. Chem. Rev. 1994, 94, 1375-1411. (d) Ohff, M.; Holz, J.; Quirmbach, M.; B6mer, A. Synthesis
1998, 1391-1415. (e) Yamanoi, Y.; Imamoto, T. Rev. Heteroatom Chem. 1999, 20, 227-248. (f) Brunel, J. M. and
Buono, G., In "Topics in Current Chemistry", Springer-Verlag: New York, 2002, 220, pp. 79-105.
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the early 1970's by Kagan,3' bidentate phosphines have been the center of considerable attention.
The exceptional enantioselectivities observed with chiral bisphosphines have often
overshadowed the utility of chiral monophosphine ligands. Certain metal-catalyzed reactions,
however, are inhibited or completely suppressed by bisphosphine ligands yet proceed smoothly
and with high enantioselectivity when monophosphines are used.3 2 Examples include rhodium-
catalyzed hydrogenation of olefins and carbonyls, palladium-catalyzed hydrosilylation of olefins,
rhodium-catalyzed hydrosilylation of carbonyls, nickel-catalyzed cross-coupling reactions, and
palladium-catalyzed allylic substitution reactions.3 3 The reaction shown in Scheme 6 appears to
fall into this second category with respect to reactivity as several achiral monophosphine ligands
form competent catalysts with Ni(cod)2 but bisphosphines are ineffective.21 Therefore, we set
our sights on the use of chiral monophosphines. In the event that employment of chiral
phosphines was feasible, the readily accessible functional groups of alkynes and aldehydes could
be joined in a single catalytic operation to provide enantiomerically enriched, chiral allylic
alcohols.
Since allylic alcohols corresponding to catalytic reductive couplings between aldehydes
and "alkyl-alkyl" alkynes (alkyl-C-C-alkyl') are commonly found in natural products and related
molecules,2 such an enantioselective transformation would constitute an efficient and rapid entry
into these important functional group assemblies. A significant consideration in such coupling
reactions is control over the regioselectivity of the process. In a number of transition metal-
catalyzed reductive coupling reactions of internal alkynes, selective functionalization can be
difficult to achieve when the alkyne is substituted with groups of similar electronic and steric
demand as shown in the summary of aldehyde-alkyne coupling reactions in Table 1 (reductive
couplings (entries 1-3) and hydroacylation (entry 4)).34 '35' 36 For these cases in which the
3 1 (a) Dang, T. P.; Kagan, H. B. J. Chem. Soc., Chem. Comm. 1971, 481. (b) Kagan, H. B.; Dang, T. P. J. Am.
Chem. Soc. 1972, 94, 6429-6433.
32 (a) Komarov, I. V.; Brner, A. Angew. Chem. Int. Ed. 2001. 40, 1197-1200. (b) Van Leeuwen, P. W. N. M.;
Kamer, P. C. J.; Reek, J. N. H.; Dierkes, P. Chem. Rev. 2000, 100, 2741-2769.
33 Recent reviews: (a) Lagasse, F.; Kagan, H. B. Chem. Pharm. Bull. 2000, 48, 315-324. (b) Hayashi, T. Acc. Chem.
Res. 2000, 33, 354-362.
34 Maier, M. E.; Oost, T. J. Organomet. Chem. 1995, 505, 95-107.
35 Bahadoor, A. B.; Flyer, A. Micalizio, G. C. J. Am. Chem. Soc. 2005, 127, 3694-3695.
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differentiation is between a primary and secondary alkyl group, product ratios are commonly 2:1
or 3:1, with higher selectivity achieved with functionalized alkynes and aldehydes (entry 3).
Table 1. Transition Metal-Mediated Coupling Reactions of Internal Alkynes and Aldehydes.
R2 conditions
R 1
R2
X R3
R21 +
R 2
A
R 3 X
R2 1
R2
B
R1 = Me or primary alkyl
R2 = alkyl
entry conditions products reference
1 1. TaCI 5 (200 mol%), X = H, R3 = CH(OH)R Takai and Utimoto (ref 16b)
Zn (300 mol%) A:B, 65:35 to 74:36
2. pyridine, RCHO,
3. NaOH, H20
2 1. Cp2ZrH(CI) (100 mol%) X = H, R3 = CH(OH)R Maier (ref 34)
2. MeLi A:B, 65:35 Buchwald (ref 13)
3. RCHO
4. MeOH
3 1. BuLi (R2 contains free OH) X = H, R3 = CH(OH)R Micalizio (ref 35)
2. CITi(Oi-Pr) 3; C5H9MgCI A:B, 75:25 to 95:5
3. BF 3 -OEt 2, RCHO
4 Ni(cod) 2 (10 mol%) X = H, R3 = COR Tsuda and Saegusa (ref 36)
P(n-oct) 3 (20 mol%) A:B, 78:22
RCHO (100 mol%)
In contrast to these examples, there are some hydrometalation reactions of this class of
alkynes in which very high selectivity is realized. Hydroboration 37 and hydrozirconation 3 8
36 Tsuda, T.; Kiyoi, T.; Saegusa, T. J. Org. Chem. 1990, 55, 2554-2558.
Brown, H. C.; Gupta, S. K. J. Am. Chem. Soc. 1972, 94, 4370-4371.
8 :Hart, D. W.; Blackburn, T. F.; Schwartz, J. J. Am. Chem. Soc. 1975, 97, 679-680.
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reactions that are conducted under conditions in which thermodynamic equilibration of the initial
alkenyl-metal species is possible result in selective functionalization adjacent to the less-
hindered alkyl group of an alkyne (Table 2, entries 1 and 2). In the case of hydrozirconation, this
equilibration is only possible when superstoichiometric zirconium reagent is utilized. When the
reaction is performed under kinetically-controlled conditions (100 mol% zirconium), selectivity
is not as high (entry 3). Wipf has recently capitalized on the high selectivity and speed of
hydrozirconation under microwave conditions in a two-step reductive coupling of alkynes and
imines in the selective synthesis of (E)-allylic amines (entry 4).39
Table 2. Highly Selective Hydrometalations of Alkynes.
t'"_ conditions
R 2
conditions
X R3 R3 X
R2 1 R2 R 1
R2 R 2
A B
R1 = Me or primary alkyl
R2 = alkyl
products reference
catecholborane
(100 mol%)
2 1. Cp2 ZrH(CI) (200 mol%)
2. 12
3 1. Cp2ZrH(CI) (100 mol%)
2. 12
4 1. Cp2 ZrH(CI) (200 mol%, pLW)
2. Me2Zn
3. ArCHNP(O)Ph 2
X = H, R3 = BOR 2
A:B, 92:8
X = H, R3 = I
A:B, >98:2
X = H, R3 = I
A:B, 89:16
X = H, R3 = CArH(NH)P(O)Ph 2
A:B, >99:1
Brown (ref 37)
Schwartz (ref 38)
Schwartz (ref 38)
Wipf (ref 39)
39 Wipf, P.; Janjic, J.; Stephenson, C. R. J. Org. Biomol. Chem. 2004, 2, 443-445.
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entry
1
Results and Discussion
At the outset of our studies directed toward the development of nickel-catalyzed
enantioselective reductive couplings of aldehydes and "alkyl-alkyl" alkynes, it was clearly
necessary not only to consider how an appropriate chiral ligand might control the formation of
the stereogenic center, but also how the use of such a ligand might achieve high regioselectivity
in the formation of allylic alcohol products. Accordingly, we launched our investigations by
probing the second of these considerations, regioselectivity, by examining achiral catalyst
systems. We planned to apply our findings regarding ligand structure and regioselectivity to
related chiral catalyst systems in an effort to develop an enantioselective reductive coupling
reaction.
Initial Regioselectivity Investigations
In the original report of intermolecular reductive coupling of alkynes and aldehydes using
achiral phosphine ligands,2 several notable observations with respect to regioselectivity of the
transformation are included. That is, allylic alcohols formed via couplings of terminal alkynes
and alkynes containing one aromatic substituent or a trimethylsilyl group (or both) were obtained
in high regioselectivity (see Scheme 6). We sought to study the effect of ligand structure on the
regiochemical outcome of couplings in which there was a small difference in electronic and
steric demand between the two groups bonded to the alkyne. To this end, 1-cyclohexyl-1-
propyne (1) was chosen as a test alkyne with isobutyraldehyde (2) as the coupling partner (eq 1).
Tributylphosphine was effective in this catalytic reaction although allylic alcohols 3a and 3b
were afforded in low regioselectivity (Table 3, entries 1-2). Similar low levels of selectivity
were also observed with other achiral phosphines (entries 3-6), with
ferrocenyldiphenylphosphine (entry 6) emerging as the most selective ligand. Performing the
reaction in hexane or toluene had a minimal effect on yield and regioselectivity (entries 1-2 and
6-7), wrhile reducing the temperature to 0 °C failed to increase selectivity.
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Table 3. Representative Achiral Ligand Effects on Regioselectivity.
Me
1
0
Me
2
Ni(cod) 2 (10 mol%)
ligand (20 mol%)
Et3 B (200 mol%)
hexane, rt, 14h
OH
Me
Me Me
3a
OH
Me- - Me
bMe
3b
entrya ligand yield 3 b 3a: 3bc
1 PBu3 55% 67:33
2 d PBu3 52% 63:37
3 Ph2P(n-Bu) 56% 65:35
4 d Ph2 P(Cy) 62% 67:33
5 PBn 3 19% 43:57
6 Ph2 PFc 52% 75:25
7 d Ph2 PFc 60% 75:25
8 de Ph2 PFc 55% 70:30
a Reaction conducted in hexane unless noted. b Combined
isolated yield of 3a and 3b. c Determined by integration of
the alkenyl H signals in the 1 H NMR spectrum (doublet and
quartet, 3a and 3b). d Reaction conducted in toluene.
e Reaction conducted at 0 °C.
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(1)
Initial Investigations with Known Chiral Ligands
Upon conclusion of the initial achiral ligand screen, an investigation of chiral ligands was
conducted. Disappointingly, (neomenthyl)diphenylphosphine (NMDPP, 4),40 a ligand that
induces a high degree of enantioselectivity in couplings of aryl alkynes and branched
aldehydes,4 1 provided both low regioselectivity and enantioselectivity in the test coupling
reaction of 1-cyclohexyl-l-propyne (1) and isobutyraldehyde (2) (entry 1). Likewise, Hayashi's
chiral ferrocenyl phosphine ligands4 2 (eg 5, Table 4, entry 2) did not deliver the allylic alcohol
wJith promising levels of regio- or enantioselectivity. Finally, proline-derived
alkyldiphenylphosphine 643 also provided products with disappointing selectivity (entry 3).
Table 4. Effects of Representative Known Chiral Ligands.
Me Me
OMe PPh2
Pph Ph2 N
Fe
Me Me 
4 5 6
entrya ligand yield 3 b 3a: 3bc ee (3a)d
1 e 4 50% 67:33 35%
2 e 5 40% 50:50 20%
3f 6 20% 55:45 35%
a Reaction as performed in Eq 1. bCombined isolated
yield of 3a and 3b. CDetermined by integration of 1H
NMR spectrum. d Measured by chiral GC analysis, B-PH
column. e Conducted in toluene, f Conducted in hexane.
40 Morrison, J. D.; Burnett, R. E.; Aguiar, A. M.; Morrow, C. J.; Philips, C. J. Am. Chem. Soc. 1971, 93, 1301-1303.
41 See reference 24c.
42 Prepared by Dr. Johann Chan as reported by: (a) Hayashi, T.; Konishi, M.; Fukushima, M.; Mise, T.; Kagotani,
M.; Tajika, M.; Kumada, M.; J. Am. Chem. Soc. 1982, 104, 180-186. (b) Hayashi, T.; Hayashizaki, K.; Kiyoi, T.;
Ito, Y. J. Am. Chemn. Soc. 1988, 110, 8153-8156.
43 Prepared by Dr. Sejal Patel as reported by: Hiroi, K.; Hidaka, A.; Sezaki, R.; Imamura, Y. Chem. Pharm. Bull.
1997, 45, 769-777.
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Encouraged both by the precedent that monophosphines containing a ferrocenyl moiety
have been particularly effective ligands for several catalytic, asymmetric metal-catalyzed
reactions4 4 4 5 '46 and by the original screening of achiral ligands for regioselectivity (Table 3),
FcPPh 2 was taken as a lead structure. Because ferrocenyl phosphines containing C-chiral
substituents did not selectively deliver allylic alcohols, we targeted several P-chiral ferrocenyl
phosphines. Compounds 7a-h (Chart 1) are representative members of a class of P-chiral
monodentate phosphines that has not been thoroughly explored to date and were prepared in
order to investigate their steric and electronic effects on these and other catalytic reactions.4 7
Chart 1
Fe "PhMe
7a 7b 7c
Fe Ph OMe Fe Ph Me Fe
Ae ..
7e 7f 7g 7h
44 Reviews: (a) Colacot, T. J. Chem. Rev. 2003, 103, 3101-3118. (b) Togni, A.; Hayashi, T, eds. Ferrocenes.
Homogeneous Catalysis, Organic Synthesis, Materials Science; VCH Publishers: Weinheim, 1995. (c) Richards, C.
J.; Locke, A. J. Tetrahedron. Asymmetry 1998, 9, 2377-2407.
45 Asymmetric, catalytic reactions using planar-chiral phosphaferrocene ligands: (a) Qiao, S.; Fu, G. C. J. Am.
Chem. Soc. 1998, 63, 4168-4169. (b) Tanaka, K.; Qiao, S.; Tobisu, M.; Lo, M. M.-C.; Fu, G. C. J. Am. Chem. Soc.
2000, 122, 9870-9871. (c) Shintani, R.; Lo, M. M-C.; Fu, G. C. Org. Lett. 2000, 2, 3695-3697. (d) Fu, G. C. Acc.
Chem. Res. 2004, 37, 542-547.
46 Both achiral and chiral (racemic) ferrocenyl monophosphines are highly effective for Pd-catalyzed arylation and
cross-coupling reactions, see: (a) Stambuli, J. P.; Stauffer, S. R.; Shaughnessy, K. H.; Hartwig, J. F. J. Am. Chem.
Soc. 2001, 123, 2677-2678. (b) Stauffer, S. R.; Beare, N. A.; Stambuli, J. P.; Hartwig, J. F. J. Am. Chem. Soc.
2001, 123, 4641-4642. (c) Beare, N. A.; Hartwig, J. F. J. Org. Chem. 2002, 67, 541-555. (d) Kataoka, N.; Shelby,
Q.; Stambuli, J. P; Hartwig, J. F. J. Org. Chem. 2002, 67, 5553-5566.
47 The o-anisyl derivative 7e has been previously reported (92% ee): (a) Brown, J. M.; Laing, J. C. P. J. Organomet.
Chem. 1997, 529, 435-444. Racemic 7a and 7b have also been synthesized previously, but not in enantiomerically
enriched form (b) (+/-) 7a: Seyferth, D.; Withers, Jr., H. P. Organometallics 1982, 1, 1275-1282. (c) (+/-) 7b:
Chacon, S. T.; Cullen, W. R.; Bruce, M. I.; Shawkataly, O. B. Can. J. Chem. 1990, 68, 2001-2010.
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Synthesis of P-Chiral Monodentate Ferrocenyl Phosphines
The van Leeuwen 48 and Mezzetti49 laboratories recently described procedures for
preparing related bidentate P-chiral ferrocenyl bisphosphines using Jug6's method5 ° for the
enantioselective synthesis of PAMP5 1 and other P-chiral phosphines using ephedrine-based
oxazaphospholidine borane 8 (prepared in one step from dichlorophenylphosphine, ephedrine,
diethy'lisopropylamine and borane-tetrahydrofuran, see Experimental Section). This method is
based upon a highly diastereoselective addition of an organolithium species to 8 (shown using
ferrocenyllithium in Scheme 9). The addition is believed to proceed through an associative
mechanism, culminating in the cleavage of the O-P bond.52 Specifically, the organolithium
approaches 8 opposite nitrogen to form a pentacoordinate intermediate which undergoes
pseudorotation to relieve eclipsing steric interactions between the phenyl and N-methyl groups.
Cleavage of the O-P bond generates phosphinamide boranes (9) with overall retention of
configuration. Substitution reactions from this point forward in the sequence proceed via SN2-
type displacements with inversion of stereochemistry. Finally, removal of the borane protecting
group proceeds with retention at phosphorus as diethylamine attacks at boron.
Our initial investigations began with one of van Leeuwen's intermediates, (R)-methyl
(ferrocenylphenyl)phosphinite borane (Oi).48 c Using this strategy (Scheme 9), the ferrocenyl
and phenyl groups of all the ligands would be installed first to allow for straightforward variation
of the third group from a common intermediate. Phosphinamide borane 9i ((Rp, 1R, 2S)-N-
methyl-N-(1-hydroxy- 1-phenyl)prop-2-yl-P-(ferrocenyl)-P-(phenyl)-phosphinamide borane) was
prepared by addition of ferrocenyllithium (generated from bromoferrocene, vide infra) to 8.
48 (a) Nettekoven, U.; Widhalm, M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. Tetrahedron. Asymmetry 1997, 8,
3185-3188. (b) Nettekoven, U.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; Widhalm, M.; Spek, A. L.; Lutz, M. J.
Org. Chem. 1999, 64, 3996-4004. (c) Nettekoven, U.; Widhalm, M.; Kalchhauser, H.; Kamer, P. C. J.; van
Leeuwen, P. W. N. M.; Lutz, M.; Spek, A. L. J. Org. Chem. 2001, 66, 759-770.
49 Maienza, F.; W6rle, M.; Steffanut, P.; Mezzetti, A.; Spindler, F. Organometallics 1999, 18, 1041- 1049.
50 Jug6, S.; Stephan, M.; Laffitte, J. A.; Gent, J. P. Tetrahedron Lett. 1990, 31, 6357-6360.
5' PAMP was first synthesized by Knowles using a strategy developed by Mislow, by way of an enantiomerically-
enriched menthyl phosphinate. (a) Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. J. Chem. Soc., Chem. Comm.
19'72, 10-11. (b) Korpiun, O.; Lewis, R. A.; Chickos, J.; Mislow, K. J. Am. Chem. Soc. 1968, 90, 4842-4846.
52 .lug6, S.; Stephan, M.; Merdes, R.; Genet, J. P.; Halut-Desportes, S. J. Chem. Soc., Chem. Comm. 1993, 531-533.
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However, as observed by van Leeuwen, we found that the acid-promoted methanolysis to key
intermediate 10i was sluggish and low yielding (approximately 30% yield of 10i, 35% recovered
9i).
Scheme 9. Strategy for the Synthesis of 7a-h from a Common Intermediate.
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Accordingly, in order to prepare the ligands in a quantity suitable for thorough study, we
investigated an alternative strategy that installs the sterically bulky (and acid-sensitive)
fen-ocenyl group later in the synthesis.53 As shown in Scheme 10, treatment of
oxazaphospholidine borane 8 with the appropriate organolithium reagent (retention of
stereochemistry) was followed by acid-promoted methanolysis of the resulting phosphinamide
borane product 9 (inversion). It should be noted that preparation of cyclohexyllithium and 2-
methyl-2-phenyl-1 -propyllithium (neophyllithium) was accomplished using a naphthalene-
catalyzed oxidative addition of lithium metal54 to chlorocyclohexane and 1-chloro-2-methyl-2-
phenylpropane, respectively. Methanolysis of aryl and primary alkyl substituted phosphinamide
boranes 9a-b and 9d-h proceeded smoothly, but formation of methyl-
cyclohexylphenylphosphinite borane 10c was lower yielding. Secondary and tertiary alkyl
substituted phosphinamide boranes are notoriously difficult to convert to phosphinite boranes,
and usually require heating to obtain the desired product, often in low yield.55
Scheme 10. Higher-Yielding Route to 7a-h.
Ph RLi R Me MeOH, H2S04 OMe
Ph,\ p N retention Ph"/PN OH inversion Ph"" Ph/ N IPh"/PR
H3 B Me H3 B Me Ph H3 BH3B e
8 9a-i 1 Oa-i
R'Li
inversion
a-h: R = methyl (a)
n-butyl (b)
cyclohexyl (c)
neophyl (d) R
p-anisyl (e) I
o-anisyl (f) Ph"'RI
o-tolyl (g) R' Ph retention R
o-biphenyl (h) R3
R' = ferrocenyl 7a-h 11a-h
3i, 4i: R = ferrocenyl
53 Brown used a similar approach to prepare le in 92% ee. See reference 47a.
54 YUS, M.; Ram6n, D. J. J. Chem. Soc., Chem. Comm. 1991, 398-400.
55 Rippert, A. J.; Linden, A.; Hansen, H.-J. Helv. Chim. Acta 2000, 83, 311-321.
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Completion of the phosphine syntheses required installation of the ferrocenyl substituent.
Although methods of direct deprotonation of ferrocene with s-butyllithium or t-butyllithium are
commonly used to generate ferrocenyllithium (FcLi), we found that FcLi prepared via metal-
halogen exchange of commercially-available bromoferrocene and t-butyllithium provided the
desired substitution products (inversion of configuration) in superior yields.56'57 The metal-
halogen exchange can also be performed with n-butyllithium, but in the case of
ferrocenylmethylphenylphosphine (7a), we observed significant amounts (>30%) of an n-pentyl-
containing product, which likely arose from ferrocenyl substitution, deprotonation of one of the
methyl protons, and alkylation of the resulting organolithium compound by n-butyl bromide.58
In all cases, the BH3 group facilitates chromatographic purification, providing the
corresponding complexes of the phosphines as orange, air-stable compounds. Removal of the
BH 3 group by heating in the presence of diethylamine proceeds in good to excellent yield in all
cases, providing the free phosphines. The enantiomeric purities of 7a-h were determined by re-
protection with BH3 (retention) and subsequent measurement via chiral HPLC. As shown in
Scheme 11, comparison of the enantiomeric excesses of 11 a-h before and after the deprotection-
reprotection sequence confirmed the preservation of stereochemical integrity during the
diethylamine-mediated BH 3 removal.
56 For other selective methods of FcLi generation, see: (a) Sanders, R.; Mueller-Westerhoff, U. T. J. Organomet.
Chem. 1996, 512, 219-224. (b) Chieffi, A.; Comasseto, J. V.; Snieckus, V. Synlett 2000, 2, 269-271. (c)
Guillaneux, D.; Kagan, H. B. J. Org. Chem. 1995, 60, 2502-2505.
57 Bromoferrocene was recently discontinued by Aldrich. In subsequent ligand syntheses, Kagan's procedure
(reference 56c) was used to generate FcLi from ferrocene, using 200 mol% t-BuLi in THF/hexane at 0 °C. This
method produced the desired compounds of structure 11 in yields that are typically 10-20% lower than the yields
obtained using FcLi generated fiom bromoferrocene.
58 (a) Imamoto, T.; Kusumoto, T.; Suzuki, N.; Sato, K. J. Am Chem. Soc. 1985, 107, 5301-5303. (b) Imamoto, T.;
Oshiki, T.; Onozawa, T.; Kusumoto, T.; Sato, K. J. Am. Chem. Soc. 1990, 112, 5244-5252.
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Scheme 11. Determination of the Enantiomeric Purity of 7a-h.
Et 2NH dR' P , Ph
deprotect
11c 7c
97% ee
BH 3* THF
protect
identical ee before and after
deprotection/reprotection sequence
Summarized in Table 5 are the results obtained for the synthesis leading to P-chiral
phosphines 7a-h. The average yield for the 4-step sequences range from 75-86% per step in all
but one case (R = c--C6HlI, 7c), and 7b is the only ligand of the eight described that was not
afforded in > 94% ee at the end of the sequence. Several of these ligands are moderately air-
stable, and the corresponding BH3 complexes (la-h) are convenient for long-term storage of
these novel P-chiral phosphines (Scheme 9).59
59 In two cases shown in Table 5, the diastereoselectivity of RLi addition (for 9b and 9g) does not agree with the
enantiomeric excess of the corresponding phosphine-borane complexes (11b and 11g). It is possible that
racemization may occur (luring the methanolysis step (giving 10b and 10g) in these cases. For similar observations,
see: Moulin, D.; Bago, S.; Bauduin, C.; Darcel, C.; Jug6, S. Tetrahedron. Asymmetry 2000, 11, 3939-3956.
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Table 5. Summary of Synthetic Operations in the Preparation of 7a-h.'
Fe 'Ph
R
7a-h
a See Scheme 10. D Determined by 'H NMR. C Determined by HPLC. a Recrystallized from
hexane. e Crystallized from diethylamine upon standing after BH3 removal.
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Overall
RLi addition Methanolysis FcLi addition BH3 removal Yield
(4 steps)
R Cpd Yield d.r.b Cpd Yield Cpd Yield eec Cpd Yield eec
Me 9a 79% 9:1 10a 75% 11a 58% 83% 7a 93% >9 5 %d 32%
n-Bu 9b 80% 16:1 10b 62% 11b 90% 77% 7b 88% 80% 39%
Cy 9c 88% >98:2 10c 29% 11c 66% 97% 7c 83% 98% 14%
Neophyl 9d 72% >98:2 10d 65% 11d 79% 98% 7d >99% 96% 37%
p-anisyl 9e 80% >98:2 10e 77% 11e 85% 95% 7e 95% 94% 50%
o-anisyl 9f 93% >98:2 10f 77% 11f 92% >98% 7f 83% >98% 55%
o-tolyl 9g 80% >98:2 10g 87% 11g 70% 83% 7g >99% >98%e 48%
o-biphenyl 9h 81% >98:2 10h 77% 11h 69% 98% 7h 94% 96% 40%
Enantioselective Reductive Coupling Reactions of Alkynes and Aldehydes
With the target ligands 7a-h in hand, they were tested for efficacy in the nickel-catalyzed
reductive coupling of 1 and 2.60 As shown in Table 6, all of the ligands were found to be
competent promoters of the desired reaction. In these studies of 7a-7h, we found o-tolyl ligand
7g to be superior with respect to regio- and enantioselectivity, giving an 85:15 mixture of 3a
(55% ee) and 3b (entry 7). Phosphines 7a (R = Me, entry 1) and 7f (R = o-anisyl, entry 6)
displayed nearly the same degrees of selectivity, with 7a (entry 1) providing the best
combination of yield and selectivity among these three ligands.
Table 6. Catalytic, Enantioselective Reductive Couplings with P-Chiral Ferrocenyl Ligands.
Ni(cod) 2 (10 mol%)
ligand 7 (10 mol%) OH OH
1 + 2 Et 3B (200 mol%) Cy Me Me - Me (2) 7 Fe \P
EtOAc, rt, 14h Me Me Cy Me R
3a 3b
entry ligand R yield 3 a 3a: 3bb ee (3a)c ee (3b)c
1 7a Me 65% 70:30 46% 45%
2 7b n-Bu 27% 65:35 8% 12%
3 7c Cy 53% 62:38 - 3 4 %d - 2 8 %d
4 7d neophyl 33% 50:50 - 4 4 %d - 10%d
5 7e p-anisyl 71% 71:29 2% 4%
6 7f o-anisyl 60% 79:21 - 2 8 %d - 17%d
7 7g o-tolyl 4 6 %e 85:15 - 5 5 %d - 1 9 %d
8 7h o-biphenyl 33%e 50:50 - 5 2 %d - 37% d
a Combined isolated yield of 3a and 3b. b Determined by integration
of 1H NMR spectrum. C Measured by chiral GC analysis, B-PH
column. Absolute configuration assigned by Mosher ester analysis.
d Opposite enantiomer favored (ent-3a/3b). e Byproducts include
significant quantities of alkylative coupling (Et addition instead of H
addition to the alkyne, 3c and 3d ).
Et OH Et OH
Cy M e Me Me
Me Me Cy Me
3c 3d
60 In the course of screening, it was found that a 1:1 ratio of Ni(cod) 2 and phosphine ligand was instrumental in
reducing the amount of side products resulting from aldol reactions of 2.
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Of significance is that the reaction is quite sensitive to the size of the R group bound to
phosphorus (FcP(Ph)R). When R is an alkyl group (7a-7d, entries 1-4), less sterically
demanding R groups promote higher regioselectivity. This observation is consistent with the
hypothesis that the level of differentiation between the groups bound to phosphorus (Fc vs. Ph vs
R) is greatest when R is small. When R is an aryl group (7e-7h, entries 5-8), the size of the
group at the ortho position of that aryl group appears to influence regioselectivity. As the ortho
substituent is changed from hydrogen to methoxy to methyl (7e-7g, entries 5-7), allylic alcohol
3a is increasingly favored. Again, this corresponds to greater differentiation between the
substituents on phosphorus. Interestingly, the placement of a phenyl group at this position
erodes regioselectivity indicating an important balance of steric demand. A related observation
also highlights the sensitivity of the reaction to ligand size- larger ligands also catalyze addition
of an ethyl group to the alkyne ("alkylative" coupling, products 3c and 3d) which begins to
compete with the desired reductive coupling (entries 7-8). This phenomenon is probably
attributable to an acceleration of reductive elimination,61 that is, reductive elimination of the
ethyl group before the requisite 3-hydride elimination and subsequent reductive elimination of a
hydride can occur (see discussion of mechanism, pages 9-10).
Ligand 7a was chosen to examine the effect of solvent and temperature on selectivity in
formation of 3 via the coupling of 1 and 2. As shown in Table 7, temperature appears to play a
minor role in both the regioselectivity and enantioselectivity of the reaction (entries 1-3)
although reduced temperatures attenuated the overall reactivity of the system. Similarly,
selectivity was largely unaffected by the choice of solvent (entries 1, 4-6).
61 There are many reports of bulky phosphine ligands accelerating reductive elimination from transition metals. (a)
Jones, W. D.; Kuykendall, V. L. Inorg. Chem. 1991, 30, 2615-2622. (b) Hartwig, J. F.; Richards, S.; Barafiano, D.;
Paul, F. J. Am. Chem. Soc. 1996, 118, 3626-3633. (c) Mann, G.; Shelby, Q.; Roy, A. H.; Hartwig, J. F.
Organometallics 2003, 22, 2775. (d) Aranyos, A.; Old, D. W.; Kiyomori, A.; Wolfe, J. P.; Sadighi, J. P.; Buchwald,
S. L. J. Am. Chem. Soc. 1999, 121, 4369-4378.
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Table 7. Temperature and Solvent Effects.
entrya solvent temp (C) yield 3 b (3a: 3b)c ee (3a)d
1 EtOAc 23 65% 70:30 46%
2 EtOAc 0 40% 74:26 51%
3 EtOAc - 22 21% 68:32 48%
4 toluene 23 76% 70:30 43%
5 THF 23 65% 75:25 46%
6 acetone 23 40% 75:25 47%
aReaction as performed in Eq 2 with 7a. bCombined
isolated yield of 3a and 3b. c Determined by integration of
1H NMR spectrum. dMeasured by chiral GC analysis, B-
PH column.
Finally, the scope of aldehyde and alkyne in nickel-catalyzed couplings of alkyl-alkyl
alkynes was examined (Table 8). Benzaldehyde was found to be an excellent substrate for the
reaction (entries 1-5); ligand 7a once again proved to be superior in couplings of 4-octyne and
benzaldehyde providing the allylic alcohol in good yield and modest enantioselectivity. Both
straight-chain and branched aliphatic aldehydes were efficient coupling partners, undergoing
smooth coupling with 4-octyne in 55% ee (entries 6 and 7). Finally, unsymmetrical alkyne 1
was found to couple to n-butyraldehyde (albeit in lower yield than i-butyraldehyde) with a slight
increase in enantioselectivity and modest preference for allylic alcohol 15a (entry 8).62
62 The above results appear in the following report: Colby, E. A.; Jamison, T. F. J. Org. Chem. 2003, 68, 156-166.
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Table 8. Scope of Alkyne and Aldehyde Coupling Partners.
Ni(cod) 2 (10 mol%) OH OH
R 1 _ - R2 ligand 7 (10 mol%)
Et 3B (200 mol%) R 1 R3 R2 R3
R2 Ri
EtOAc, rt, 14h
O 12a-1 5a 12b-15b
H R 3 12: R 1 = R 2 = n-Pr, R3 = Ph
13: R1 = R 2 = R 3 = n-Pr
14: R 1 = R 2 = n-Pr, R 3 = i-Pr
15a,b: R1 = Cy, R 2 = Me, R3 = n-Pr
entry ligand R1 R2 R3 yield (product)a (a: b)b ee (a)c ee (b)c
1 7a n-Pr n-Pr Ph 85% (12) na 49% na
2 7c n-Pr n-Pr Ph 80% (12) na - 4% d na
3 7f n-Pr n-Pr Ph 81% (12) na 12% na
4 7g n-Pr n-Pr Ph 79% (12) na - 28% d na
5 7h n-Pr n-Pr Ph 87% (12) na - 3 6 %d na
6 7a n-Pr n-Pr n-Pr 80% (13) na 55% na
7 7a n-Pr n-Pr i-Pr 80% (14) na 55% na
8 7a Cy Me n-Pr 30% (15) 69:31 67% 68%
a Combined isolated yield of a and b. b Determined by integration of 1H NMR
spectrum. C Measured by chiral GC analysis, B-PH column. Absolute
configuration assigned by analogy to 3. d Opposite enantiomer favored.
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To date, we do not have direct evidence that unambiguously establishes which
mechanism (I, II, or other variant) is in operation for the reductive couplings of simple alkyl-
allkyl alkynes. On a basic level, the observations of enantioselectivity using chiral ligands and
changes in regioselectivity when different ligands are employed indicate that at least one
phosphine is bound to the nickel center upon union of the aldehyde and alkyne. A simple
predictive mnemonic is provided for the stereochemical outcome of Ni-catalyzed reductive
coupling reactions of alkyl-alkyl alkynes and aldehydes using P-chiral ferrocenyl phosphines
(Scheme 12).
Scheme 12. Asymmetric Induction with P-Chiral Ferrocenyl Phosphines.
-2 
1 Ni(cod)2 (10 mol%)
R2 - R1 FcPPh(R)(10 mol%)
+ Et3B (200 mol%)
0
H R 3
OH
R1 R 3
R2
Sense of Induction
Fe t RPh
FcPPh(R), 7a-h
OH
R s (smaller than Ph) R11R 3
(R = Me, n-Bu) R2
OH
RL (larger than Ph) R1 
R2(R = 2-substituted Ar,
bulky alkyl)
The modest levels of regioselectivity may be explained in the context of either proposed
mechanism. With respect to the mechanism I invoking an oxanickelacyclopentene intermediate,
the C-C bond-fonrming step of oxidative cyclization may be irreversible. Therefore, equilibration
to the more energetically-favored isomer would be impossible and the ratio of regioisomers
reflects the initial kinetic differentiation of the alkyne substituents. Similar limitations of
selectivity may exist if a hydrometalation mechanism is in operation (mechanism II). In the
event that P-hydride elimination from the alkenyl-nickel species (reversion to an alkyne-nickel
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complex) is slower than addition to the aldehyde, equilibration of the alkenyl-nickel species
would not be possible.
Conclusions and Further Utility of P-Chiral Ferrocenyl Phosphines
Enantioselective nickel-catalyzed, reductive coupling of alkyl-substituted alkynes and
aldehydes was accomplished using a class of P-chiral ferrocenyl phosphines. Expedient access
to these phosphine ligands was achieved by way of a four-step route from oxazaphospholidine-
borane 8. This synthetic sequence was amenable to variation of the steric and electronic demand
of the substituents on phosphorus. While such tuning of the phosphine structure successfully
allowed for an increase in both enantioselectivity and regioselectivity, total control over these
variables has yet to be realized. Despite the moderate levels of regioselectivity and
enantioselectivity of these coupling reactions, ligands 7a-h are the most efficacious ligands of
those that have been screened to date for this particular class of alkyne couplings.
Ligands of structure 7 have recently demonstrated utility in other projects completed
within the Jamison group and remain an ongoing area of research. Importantly, they have been
employed in total synthesis endeavors involving the reductive coupling of alkyl-substituted
alkynes and aldehydes. Phosphine 7a in particular has proved its superiority in a number of
coupling reactions, most notably promoting a key fragment coupling reaction in the synthesis of
terpestacin accomplished by former group member Dr. Johann Chan.63 Efforts to optimize this
coupling reaction led to synthesis of related phosphines of the structure (FcP(Ph)Ar) in which the
varied aryl group is 2- or 2,6-substituted (Scheme 13).
63 Reactions and ligand synthesis performed by Dr. Johann Chan. First report: (a) Chan, J.; Jamison, T. F. J. Am.
Chem. Soc. 2003, 125, 11514-11515. Full disclosure of optimization efforts: (b) Chan and Jamison, reference 24d.
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Scheme 13. Use of Ligand 7a and Analogs in the Total Synthesis of Terpestacin.24d
0
H -, OTBS
OTMS Me Me
H + Ni(cod)2 10 mol%
phosphine 10 mol%
£ -H -Me Et3B 200 mol%Me ptfAc-
OTMS
major isomer
Ligands related to 7a-h have also been used in nickel-catalyzed, enantioselective three-
component coupling reactions of alkynes and imines64 by former group member Dr. Sejal Patel.
As shown in Scheme 14, allylic amines are assembled in good yield and high enantiomeric purity
via the coupling of alkynes with imines and organoboranes. Again, phosphines of the structure
(FcP(Ph)Ar) in which the aryl group bears an ortho substituent proved to be efficient in
promoting enantioselective coupling.
Scheme 14. Catalytic, Enantioselective Assembly of Allylic Amines Mediated by P-Chiral
Monodentate Ferrocenyl Phosphines.
R -- R
TBSO.. N
H 'Ar
1. Ni(cod) 2 (5 mol%)
phosphine (5 mol%)
Et3B (300 mol%)
MeOH, MeOAc
2. TBAF; then
H5 10 6, MeNH 2
Et NH2
R Ar
R
R = alkyl
up to 89% ee
up to 65% yield
(over all steps)
64 Patel, S. J.; Jamison, T. F. Angew. Chem. Int. Ed. 2004, 43, 3941-3944.
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phosphine= Fe 'Ph
R = Me (ent-7a) 70% combined yield
2:1 regioselectivity, 3:1 dr
R = (2,5-dimethyl)Ph 85% combined yield
2.6 : 1 regioselectivity, 2:1 dr
phosphine =
Fe Phi-Pr
si~
_E, \9
Experimental Section
General Information. Unless otherwise noted, all reactions performed in organic solvents were
conducted under an atmosphere of argon with rigorous exclusion of moisture from reagents and
glassware. THF and Et 20 were distilled from a blue solution of sodium benzophenone ketyl.
CH2Cl2 was distilled from calcium hydride. Toluene was distilled from sodium metal.
Diethylamine and methanol were purchased in 99.5% purity, and were degassed before use by
bubbling argon through for 20 min. EtOAc was distilled from CaSO 4 and degassed before use
by bubbling argon through for 20 min. Isobutyraldehyde, n-butyraldehyde, and benzaldehyde
were distilled under argon before use. 4-octyne was purchased from Aldrich and used without
further purification. Analytical thin layer chromatography (TLC) was performed using EM
Science silica gel 60 F25 4 plates and UV light, 12-molybdophosphoric acid (PMA stain), or
potassium permanganate (KMnO4 stain) for analysis of the developed plates. Flash
chromatography was performed using silica gel 60 (40-63 m) from Silicycle. NMR spectra
were recorded on a Varian 300 or 500 MHz spectrometer. IR spectra were recorded on a Perkin-
Elmer 2000 FT-IR using NaCl plates. High resolution mass spectra (HRMS) were obtained on a
Bruker Daltonics APEXII 3 Tesla Fourier Transform Mass Spectrometer by Dr. Li Li of the
Massachusetts Institute of Technology Department of Chemistry Instrumentation Facility.
Melting points were measured on a Thomas Hoover capillary melting point apparatus. Analysis
by chiral GC was performed on a Hewlett-Packard 5890 Series II chromatograph equipped with
a Chiradex B-PH column. HPLC was performed on a Hewlett-Packard 1100 chromatograph
equipped with a variable wavelength detector and Chiralcel OD, AD, or OJ column (0.46 cm x
25 cm). Specific rotations ([a]D) values for chiral compounds were measured on a Perkin-Elmer
241 polarimeter at 589 nm.
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Me
1-Cyclohexyl-1-propyne (1).6 56 6 Carbon tetrabromide (26.6 g, 80.4 mmol) was dissolved in
120 mL CH2C12 and cooled to 0 C. Triphenylphosphine (42.0 g, 161 mmol) was added in one
portion and the bright orange solution was stirred 30 min. Cyclohexanecarboxaldehyde was
added via syringe (4.90 mL, 40.2 mmol) and the heterogeneous mixture was stirred at ambient
temperature 4 h. Hexane was added (200 mL) and the mixture was filtered through Celite. The
filtrate was partially concentrated, then passed through filter paper to remove triphenylphosphine
oxide. After concentration, the crude residue was purified via column chromatography (hexane)
to afford 2,2-dibromovinylcyclohexane (9.80 g, 91% yield). This dibromide was dissolved in
THF (90 mL) and cooled to -78 °C. Methyllithium (57.0 mL, 1.6 M, 91.2 mmol) was added
slowly via syringe and the resulting yellow solution was stirred 75 min at -78 °C. Methyl iodide
(6.3 mL, 100.4 mmol) was filtered through activated basic alumina and added via syringe. The
mixture was allowed to warm to ambient temperature over 5 h, then stirred 11 h at this
temperature. The reaction was quenched with saturated NH4C1 (15 mL) and H 2 0 (15 mL). The
layers were separated and the aqueous phase was extracted with Et 2O (3 x 40 mL). The
combined organic layers were washed with brine (2 x 100 mL), dried over MgSO 4, filtered and
concentrated. The crude residue was purified via column chromatography (hexanes) to afford
the title compound as a clear, colorless oil (3.86 g, 87% yield).
'Ii NMR (CDC13, 500 MHz): 8 2.24-2.32 (m, 1H), 1.80 (d, J= 2.4 Hz, 1H), 1.74-1.80 (m, 2H),
1.65-1.73 (m, 2H), 1.47-1.57 (m, 1H), 1.32-1.42 (m, 2H), 1.21-1.31 (m, 3H).
I3C NMR (CDC13, 125 MHz): 6 84.5, 75.8, 33.8 (2C), 29.9, 26.6 (2C), 25.8, 4.2.
General Procedure for the Reductive Coupling of Alkynes and Aldehydes.
In a glovebox, Ni(cod) 2 (14 mg, 0.05 mmol) and solid ligand (0.05 mmol) were placed
into a flask which was then sealed with a rubber septum and removed from the glovebox. If a
liquid phosphine was employed, it was added via syringe immediately after removal from the
glovebox. A 2.0 M solution of Et3B in EtOAc was added (0.5 mL, 1.0 mmol) and the mixture
was stirred 10 min at ambient temperature. The aldehyde (1.0 mmol) and alkyne (0.5 mmol)
were added via syringe in succession, and the reaction was stirred 14 h at ambient temperature.
After this time, the solution was allowed to stir open to the air for 1 h. The solvent was
evaporated and the crude residue was purified via gradient column chromatography (50:1
hexanes-EtOAc, polarity gradually increased to 9:1) to afford the desired alcohol as a clear,
colorless oil.
65 Performed in analogy to the preparation of cyclohexylacetylene (with methyl iodide quench instead of proton
quench in the second step) as reported by: Harrity, J. P. A.; Kerr, W. J.; Middlemiss, D.; Scott, J. S. J. Organomet.
Chem. 1997, 532, 219-227.
661 is commercially available from GFS Chemicals.
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OH OH
Me M
Me Me
3a
Me
3b
(E)-l-Cyclohexyl-2,4-dimethyl-pent-l-en-3-ol (3a) and (E)-4-Cyclohexyl-2-methyl-hex-4-en-
3-ol (3b). Prepared according to the general procedure. Rf(90:10 hexane-EtOAc) = 0.38.
Enantiomeric excess determined by chiral GC analysis (B-PH, isothermal, 140 C, tR [(R)-3b] =
6.85 min, tR [(S)-3b] = 7.04 min, tR [(R)-3a] = 9.36 min, tR [(S)-3a] = 9.64 min).
IR (thin film): 3383, 2925, 2852, 1448, 1010 cm -.
1H NMR (CDC13, 500 MHz): 6 5.46 (q, 1H, 3b, J= 7.0 Hz), 5.18 (d, 1H, 3a, J= 9.2 Hz), 3.65
(d, 1H, 3b, J= 7.6 Hz), 3.29 (d, 1H, 3a, J= 8.2 Hz), 2.34-2.28 (m, 1H, 3b), 2.23-2.16 (m, 1H,
3a), 1.87-0.99 (m, 18H, 3a, 3b), 0.83 (d, 1H, 3b, J= 6.7 Hz), 0.77 (d, H, 3a, J= 6.7 Hz).
13C NMR (CDC13, 125 MHz): 6 146.7, 134.6, 134.1, 120.6, 84.4, 80.0, 39.1, 36.7, 33.2, 32.2,
31.6, 31.3, 31.2, 27.20, 27.19, 26.4, 26.3, 26.17, 26.14, 20.5, 19.6, 18.9, 18.2, 13.7, 11.4.
HRMS (ESI) [M+Na]+: m/z calcd for C13H24NaO 219.1719, obsd 219.1723.
General Procedure for the Preparation of Phosphines 7a-h.
Diethylamine was degassed and a 0.1 M solution of 11 was prepared (1 mmol in 10 mL
diethylamine). The solution was heated at reflux 14 h, cooled to ambient temperature, and the
diethylamine was removed by evaporation by rotary evaporation (after concentration was
complete, the rotovap was backfilled with N2). The crude orange residue was taken up in a
solution of 95:5 hexane-EtOAc (degassed by bubbling Ar through for 10 min) and passed
through a short column of silica gel eluting, under argon, with 95:5 hexane:EtOAc (also
degassed) to yield an orange solid (unless otherwise noted). The enantiomeric excess was
determined by reprotection with BH3 THF and analysis by chiral HPLC.
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Fe \I/PhMe
(S)-Ferrocenylmethylphenylphosphine (7a).
hexane-EtOAc) = 0.42. Mp: 84-85 °C.
Yield: 93% (343 mg, 1.1 mmol).
Enantiomeric excess: 87% ee determined by
propanol = 95:5, tR [(R)-lla] = 16.8 min, tR
hexane (90% yield) provided 7a in 96% ee.
chiral HPLC (Chiracel
[(S)-lla] = 24.7 min).
OJ, isocratic, hexane:2-
Recrystallization from
1EH NMR (CDC13, 300 MHz): 6 7.40-7.34 (m, 3H), 7.31-7.25 (m, 2H), 4.39-4.30 (m, 4H), 4.22-
4.21 (s, 5H), 1.64 (d, 3H, J= 3.0 Hz).
13C NMR (CDC13, 125 MHz): 6 131.3 (d, J= 18.4 Hz, 2C), 130.2 (d, J= 9.2 Hz), 128.5 (d, J=
11.5 Hz), 128.3 (d, J= 6.7 Hz, 2C), 74.5 (d, J= 28.5 Hz), 71.2, 69.8, 12.6 (d, J= 8.1 Hz).
31 P NMR (CDC1 3, 121 MHz): 6 -37.4.
H]RMS (El) [M]+: m/z calcd for C17H17FeP 308.0412, obsd 308.0422.
F e P h
Fe Ph
S='
Me
(S)-n-Butylferrocenylphenylphosphine (7b).
orange oil. Rf(90:10 hexane-EtOAc) = 0.48.
Yield: 88% (350 mg, 1 mmol), isolated as an
Enantiomeric excess: 80% ee determined by chiral HPLC (Chiracel
propanol = 97.5:2.5, tR [(R)-llb] = 10.0 min, tR [(S)-llb] = 12.0 min).
OJ, isocratic, hexane:2-
'[H NMR (CDC13, 500 MHz): 6 7.53-7.50 (m, 2H ), 7.34-7.33 (m, 3H), 4.40-4.38 (m, 2H), 4.33
(br s, 1H), 4.18 (br s, 1H), 4.16 (s, 5H), 2.03-1.96 (m, 2H), 1.55-1.40 (m, 4H), 0.92 (t, J= 7.0
Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 140.2 ( d, J= 13.8 Hz), 132.8 (d, J= 19.6 Hz, 2C), 128.7, 128.2
(d, J= 6.9 Hz, 2C), 77.6 (d, J= 8.1 Hz), 73.2 (d, J= 20.1 Hz), 70.7 (d, J= 4.6 Hz), 70.4 (d, J=
8.1 Hz), 70.1 (d, J= 2.3 Hz), 69.2 (s, 5C), 28.8 (d, J= 11.5 Hz), 28.7 (d, J= 2.3 Hz), 24.5 (d, J=
13.2 Hz), 14.0.
31P NMR (CDC13, 121.5 MHz): 6 -27.1.
HRMS (EI) [M]+: n/z calcd for C20H23FeP 350.0881, obsd 350.0880.
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Rf (95:5
(S)-Cyclohexylferrocenylphenylphosphine (7c). Yield: 84% (350 mg, 0.90 mmol). Rf(90:10
hexane-EtOAc) = 0.49. Mp: 99-101 C.
Enantiomeric excess: 98% ee by chiral HPLC (Chiracel OJ, isocratic, hexane:2-propanol =
97.5:2.5, tR [(R)-llc] = 8.3 min, tR [(S)-llc] = 10.0 min).
'H NMR (CDC13, 500 MHz): 6 7.67-7.63 (m, 2H ), 7.42-7.39 (m, 3H), 4.37-4.36 (m, 1H), 4.34-
4.43 (m, 1H) 4.28-4.26 (m, 1H), 4.03-4.02 (m, 1H), 4.00 (s, 5H), 1.96-1.93 (m, 1H), 1.86-1.84
(m, 1H), 1.79-1.78 (m, 1H), 1.68-1.66 (m, 2H), 1.48-1.45 (m, 1H), 1.29-1.17 (m, 4H), 1.09-1.05
(m, 1H).
13C NMR (CDC13, 125 MHz): 6 137.4 (d, J= 10.9 Hz), 134.5 (d, J= 20.7 Hz, 2C), 129.2, 128.2
(d, J= 8.1 Hz, 2C), 76.6 (d, J= 11.5 Hz), 74.1 (d, J= 24.8 Hz), 71.1 (d, J = 2.9 Hz), 70.5 (d, J=
1.7 Hz), 70.0 (d, J= 6.3 Hz), 69.2 (s, 5C), 38.1 (d, J= 6.3 Hz), 30.3, 30.2, 27.0 (d, J= 12.1 Hz),
26.9, 26.6.
3 1p NMR (CDC13, 121.5 MHz): 6 -12.0.
HRMS (EI) [M]+: m/z calcd for C22H25FeP 376.1038, obsd 376.1030.
(S)-Ferrocenylphenyl(2-methyl-2-phenyl-l-propyl)phosphine (7d).
0.94 mmol), isolated as an orange oil. Rf(90:10 hexane-EtOAc) = 0.47.
Enantiomeric excess: 96% ee by
propanol = 98:2, tR [(R)-lld] = 7.3
Yield: >99% (0.40 g,
chiral HPLC analysis (Chiracel AD, isocratic, hexane:2-
min, tR [(S)-lld] = 7.8 min).
'H NMR (CDC13, 500 MHz): 6 7.46-7.43 (m, 2H), 7.35-7.33 (m, 2H), 7.27-7.23 (m,
7.16 (m, 1H), 4.28-4.27 (m, 1H), 4.25-4.23 (m, 2H), 4.09-4.06 (m, 1H), 4.05 (s, 5H),
= 6.3, 13.9 Hz, 1H), 2.43 (d, J= 13.7 Hz, 1H), 1.46 (s, 3H), 1.43 (s, 3H).
5H), 7.17-
2.57 (dd, J
'
3C NMR (CDC13, 125 MHz): 6 145.5 (d, J= 3.4 Hz), 133.6 (d, J= 21.3 Hz, 2C), 128.8, 128.2
(d, J= 7.5 Hz, 2C), 128.0 (d, J= 1.2 Hz, 2C), 126.0, 72.8 (d, J= 19.0 Hz), 70.9 (d, J= 11.5 Hz),
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70.6 (d, J= 5.2 Hz), 70.0 (d, J= 2.9 Hz), 69.1 (s, 5C), 46.3 (d, J= 12.1 Hz), 38.2 (d, J= 15.5
Hz), 30.3, 30.2.
31P NMR (CDC1 3, 121.5 MHz): 6 -36.3.
HRMS (EI) [M]+: m/a calcd for C26 H27FeP 426.1194, obsd 426.1197.
OMe
(R)-Ferrocenyl(4-methoxyphenyl)phenylphosphine (7e).
isolated as an orange oil. Rf(95:5 hexane:EtOAc) = 0.25.
Enantiomeric excess: 94% ee by chiral HPLC (Chiracel
90:10, tR [(S)-11e] = 22.8 min, tR [(R)-lle] = 30.3 min).
Yield: 95% (86 mg, 0.21 mmol),
OJ, isocratic, hexane:2-propanol =
'H[ NMR (CDC13, 500 MHz): 6 7.40-7.30 (m, 7H), 6.91 (d, J= 7.9 Hz, 2H), 4.40-4.39 (m, 1H),
4.38-4.37 (m, 1H), 4.18-4.17 (m, 1H), 4.11 (s, 5H), 4.10-4.07 (m, 1H), 3.83 (s, 3H).
13C NMR (CDC13, 125 MHz): 6 160.4, 135.5 (d, J= 21.3 Hz, 2C), 133.0 (d, J= 19.0 Hz, 2C),
128.3, 128.2 (d, J:= 6.3 Hz, 2C), 114.0 (d, J= 8.1 Hz, 2C), 73.4 (d, J= 18.4 Hz, 1C), 72.4 (d, J=
10.9 Hz, C), 70.9 (d, J= 4.0 Hz, 2C), 69.3 (s, 5C), 55.3.
3 1P NMR (CDC1 3, 121 MHz): 6 -17.7.
HRMS (EI) [M]+: m/z calcd for C23H21FeOP 400.0674, obsd 400.0672.
(R)-Ferrocenyl(2-methoxyphenyl)phenylphosphine (70.4 7
Rf(90:10 hexane-EtOAc) = 0.31. Mp: 128-130 C.
Yield: 83% (261 mg, 0.65 mmol).
Enantiomeric excess: >98% e.e. by chiral HPLC analysis (Chiracel OJ, isocratic, hexane:2-
propanol = 99:1, tR [(R)-llf] = 43.8 min, tR [(S)-llf] = 56.9 min).
1H NMR (CDC13, 500 MHz): 6 7.50-7.46 (m, 2H), 7.35-7.29 (m, 4H), 6.94-6.91 (m, 1H), 6.89-
6.87 (m, 1H), 6.85-6.83 (m, 1H), 4.41-4.40 (m, 1H), 4.35-4.34 (m, 1H), 4.30-4.29 (m, 1H), 4.12
(s, 5H), 3.85-3.84 (m, 1H), 3.73 (s, 3H).
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'
3C NMR (CDC13, 125 MHz): 6 160.9 (d, J= 15.5 Hz), 138.0, 133.8 (d, J= 20.1 Hz, 2C), 130.2,
128.6, 128.0 (d, J = 7.5 Hz, 2C), 120.9, 110.3 (d, J= 1.7 Hz), 74.1 (d, J= 24.7 Hz), 72.3 (d, J =
4.6 Hz), 71.1 (d, J= 5.8 Hz), 70.6 (s, 1C), 69.3 (s, 5C), 55.8.
31P NMR (CDC1 3, 121 MHz): 6 -28.8.
HRMS (EI) [M]+: m/z calcd for C23H21FeOP 400.0674, obsd 400.0672.
(R)-Ferrocenyl(2-methylphenyl)phenylphosphine (7g). Yield: >99% (0.42 g, 1.1 mmol),
crystallized from diethylamine upon cooling and standing. The crystals were purified via
column chromatography. Rf(90:10 hexane-EtOAc) = 0.42. Mp: 116-117 °C.
Enantiomeric excess: >98% e.e. by chiral HPLC analysis (Chiracel OJ, isocratic, hexane:2-
propanol = 99:1, tR [(R)-llg] = 14.0 min, tR [(S)-llg] = 20.3 min).
'H NMR (CDC13, 500 MHz): 6 7.54-7.51 (m, 2H), 7.40-7.38 (m, 3H), 7.25-7.21 (m, 1H), 7.15-
7.11 (m, 2H), 6.99-6.97 (m, 1H), 4.48-4.47 (m, 1H), 4.41-4.38 (m, 2H), 4.14 (s, 5H), 3.80-3.79
(m, 1H), 2.31(s, 3H).
13C NMR (CDC13, 125 MHz): 6 141.1 (d, J= 23.6 Hz), 138.8 (d, J = 11.5 Hz), 136.8 (d, J= 7.5
Hz), 134.5 (d, J= 19.6 Hz, 2C), 132.1, 130.0 (d, J= 4.0 Hz), 129.1, 128.4, 128.3 (d, J= 7.5 Hz,
2C), 125.7, 75.8 (d, J= 4.0 Hz), 74.7 (d, J= 30.5 Hz), 71.9, 71.4 (d, J= 6.9 Hz), 70.7, 69.3 (s,
5C), 24.2 (d, J = 20.1 Hz).
31P NMR (CDC1 3, 121 MHz): -23.4.
HRMS (EI) [M]+: m/z calcd for C23H21FeP 384.0725, obsd 384.0735.
Fe h
(R)-Ferrocenyl(2-biphenylyl)phenylphosphine (7h). Yield: 94% (0.30 g, 0.7 mmol). Rf(90:10
hexane-EtOAc) = 0.40. Mp: 63-65 °C.
Enantiomeric excess: 96% e.e. by chiral HPLC analysis (Chiracel AD, isocratic, hexane:2-
propanol = 99.4:0.6, tR [(R)-llh] = 13.2 min, t R [(S)-llh] = 14.3 min).
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'IH NMR (CDC13, 500 MHz): 8 7.38-7.23 (m, 11H), 7.21-7.18 (m, 1H), 7.13-7.12 (m, 2H), 4.43-
4.43 (m, 1H), 4.37-4.36 (m, 1H), 4.34-4.33 (m, 1H), 4.0 (s, 5H), 3.86-3.85 (m, 1H).
3C NMR (CDC13, 125 MHz): 6 146.9 (d, J= 24.4 Hz), 141.9 (d, J= 5.2 Hz), 139.1 (d, J= 15.0
Hz), 138.3 (d, J= 8.1. Hz), 134.5 (d, J= 20.1 Hz, 2C), 132.9, 130.0 (d, J= 3.5. Hz), 129.8 (d, J=
3.5 Hz, 2C), 128.7, 128.2, 128.0 (d, J= 8.1 Hz, 2C), 127.7 (s, 2C), 127.1 (s, 2C), 76.6 (d, J= 7.5
Hz), 74.9 (d, J= 31.9 Hz), 72.0, 71.2 (d, J= 6.9 Hz), 70.7, 69.2 (s, 5C).
31 p NMR (CDCl 3, 121 MHz): -22.0.
HRMS (EI) [M]+: m/z calcd for C28H23FeP 446.0887, obsd 446.0871.
(2Sp, 4R, 5S)-(-)-3,4-Dimethyl-2,5-diphenyl-1,3,2-oxazaphospholidine borane (2).50 A
solution of (+)-ephedrine (14.2 g, 85.6 mmol) in 400 mL tetrahydrofuran was cooled to 0 °C.
Diisopropylethylamine (30.0 mL, 171 mmol) was added via syringe; then
dichlorophenylphosphine (11.8 mL, 85.6 mmol) was added slowly via syringe. The
heterogeneous mixture was allowed to warm to ambient temperature, then refluxed 24 h (white
precipitate never fully dissolved). After cooling to ambient temperature, BH3 THF was added
(63.0 mL, 1.5 M in THF, 94.5 mmol) and the heterogeneous mixture was stirred 18 h. H 2 0 was
added and the aqueous layer was extracted with diethyl ether. The combined organic layers were
washed with saturated aqueous NaCl, dried with MgSO 4, filtered, and concentrated in vacuo.
Recrystallization from methanol provided the title compound (14.6 g, 51.2 rmnol, 59% yield) as
a white crystalline solid. Rf (80:20 hexane-EtOAc) = 0.23. Mp: 103-104 °C.
IR (thin film): 3428, 3062, 2977, 2935, 2381, 1644, 1497, 1454, 1436, 1207, 1177, 1113, 1057,
965, 878, 851, 748 700 cm 
lH NMR (CDC13, 500 MHz): 6 7.84-7.81 (m, 2H), 7.55-7.50 (m, 3H), 7.40-7.28 (m, 5H), 5.60
(dd, J= 3.1, 6.0 Hz, 1H), 3.71-3.67 (m, 1H), 2.69 (d, J= 11.0 Hz, 3H), 0.84 (d, J= 6.7 Hz, 3H),
1.3-0.7 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 136.4 (d, J= 5.4 Hz), 132.6 (d, J= 2.2 Hz), 131.1 (d, J= 12.1
Hz, 2C), 128.8 (d, J= 9.8 Hz, 2C), 128.54 (s, 2C), 125.52, 126.8 (s, 2C), 84.5 (d, J = 7.6 Hz),
59.3 (d, J= 1.9 Hz), 29.9 (d, J= 8.1 Hz), 14.0 (d, J= 3.6 Hz).
3']p NMR (CDC13, 121 MHz): 8 132.8 (br q, J= 87 Hz).
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General Procedure for the Synthesis of Phosphinamides 9a-h (Typical Procedure).
A 1.0 M solution of 8 (20 mmol) in tetrahydrofuran was cooled to -78 C before addition of a
solution of alkyl- or aryllithium (40 mmol, commercially available unless noted). The mixture
was allowed to stir 3 h, warming slowly to 0 C. Water was added, and the aqueous phase was
extracted with diethyl ether. The combined organic layers were washed with saturated aqueous
NaCl, dried over MgSO 4, filtered, and concentrated in vacuo. The crude residue was purified via
column chromatography.
Me Me
Ph PnOOH
H3B Me Ph
(Sp, iS, 2R)- N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(methyl)-P-(phenyl)-
phosphinamide borane (3a).5° Purification: column chromatography (elution with 95:5
toluene-EtOAc). Small scale yield: 79% (0.10 g, 0.33 mmol), prepared and purified for spectral
analysis. Large scale crude yield: >99% (6.0 g, 20 mmol), used without purification. The
diastereomeric ratio of the isolated material was determined to be 9:1 by H NMR integration.
Rf (95:5 toluene-EtOAc) = 0.17. Mp: 108-109 °C.
IR (NaCl): 3446, 2968, 2369 cm '.
'H NMR (CDC13, 500 MHz): 6 7.46-7.26 (m, 8H), 7.11-7.07 (m, 2H), 4.74 (dd, 1H, J= 3.4, 7.2
Hz), 4.06-4.01 (m, 1H), 2.47 (d, 3H, J= 8.5 Hz), 1.94 (d, 1H, J= 3.7 Hz), 1.52 (d, 3H, J= 9.0
Hz), 1.24 (d, 3H, J= 6.7 Hz), 1.1-0.4 (br m, 3H).
'
3C NMR (CDC13, 125 MHz): 6 143.3, 133.5 (d, J= 65.6 Hz), 131.3, 131.2, 131.0, 130.9, 129.3,
129.2, 129.1, 129.1, 128.7, 127.5, 78.5 (d, J= 6.3 Hz), 58.7 (d, J= 8.6 Hz), 29.7, 14.8, 12.0 (d, J
= 41.5 Hz).
3 1P NMR (CDC1 3, 121 MHz): 6 66.1 (br q, J= 77 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C17H25BNNaOP 324.1659, obsd 324.1652.
n-Bu Me
Ph P-N - OH
H3B Me Ph
(Sp, S, 2R)-N-Methyl-N-(1-hydroxy-1-phenyl)prop-2-yl-P-(n-butyl)-P-(phenyl)-
phosphinamide borane (9b).5
Purification: column chromatography (95:5 toluene-EtOAc). Yield: 80% (1.67 g, 4.9 mmol),
isolated as a colorless oil. The diastereomeric ratio of the isolated material was determined to be
16:1 by 'H NMR integration. Rf(95:5 toluene-EtOAc) = 0.25.
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IR (thin film): 3503, 2957, 2872, 2379, 1455, 1436, 1025 cm -.
'H NMR (CDC13, 500 MHz): 6 7.44-7.42 (m, 2H), 7.36-7.28 (m, 8H), 4.87 (dd, J= 3.7, 5.5 Hz,
1H), 4.07-4.02 (m, 1H), 2.57 (d, J= 7.6 Hz, 3H), 2.00-1.96 (m, 1H), 1.88-1.84 (m, 1H), 1.83 (d,
J= 3.6 Hz, 1H), 1.69-1.62 (m, 1H), 1.47-1.38 (m, 3H), 1.19 (d, J= 6.7 Hz, 3H), 0.95 (t, J= 7.3
Hz, 3H), 1.05-0.4 (br m, 3H).
13C2 NMR (CDC13, 125 MHz): 6 143.2, 133.0 (d, J= 60.9 Hz), 131.2, 131.11, 131.10, 129.22,
129.19, 129.14, 126.7, 127.1 (2C), 79.4 (d, J= 4.0 Hz), 58.8 (d, J= 8.6), 30.0 (d, J= 2.9 Hz),
25.8 (d, J= 42.0 Hz), 25.5, 25.0 (d, J= 15.6 Hz), 14.4, 13.6 (d, J= 2.8 Hz).
31]P NMR (CDC13, 121.5 MHz): 6 70.3 (br q, J= 73 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C20H31BNNaOP 366.2129, obsd 366.2123.
Me
Ph". \/N OH
H3B Me Ph
(Sp, IS, 2R)-N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(cyclohexyl)-P-(phenyl)-
phosphinamide borane (9c). Cyclohexyllithium was prepared from chlorocyclohexane and
lithium-naphthalenide. 5 4 Lithium (35 mmol) and naphthalene (0.35 mmol) were combined in 7
mL tetrahydrofuran. The mixture was vigorously stirred at ambient temperature until it turned
dark green, at which point the mixture was cooled to -78 C. Chlorocyclohexane was added
dropwise via syringe (3.5 mmol) and the mixture was stirred 3 h at -78 C to generate
cyclohexyllithium which was added to a solution of 8 (1.7 mmol) at -78 C. Purification:
gradient silica gel chromatography (90:10 hexane:EtOAc, polarity gradually increased to 50:50
hexane-EtOAc). Yield: 88% (0.57 g, 1.5 mmol), isolated as a white foam. Only one
diastereomer was detected by H NMR integration. Rf (80:20 hexane-EtOAc) = 0.24.
IR (NaCl): 3495, 2934, 2854, 2382, 1480, 1435, 1023 cm-'.
'H NMR (CDC13, 500 MHz): 6 7.56-7.52 (m, 2H), 7.43-7.33 (m, 5H), 7.27-7.18 (m, 3H), 4.74
(d, J = 4.6 Hz, 1H), 4.09-4.04 (m, 1H), 2.60 (d, J= 7.0 Hz, 3H), 2.35 (dd, J= 2.6, 12.4 Hz, 1H),
2.0 (br s, 1H), 2.00-1.88 (m, 1H), 1.75 (m, 3H), 1.58-1.50 (m, 2H), 1.45-1.38 (m, 1H), 1.33-1.23
(n, 3H), 1.12 (d, J= 7.0 Hz, 3H), 1.1-0.5 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 142.7, 131.4 (d, J= 9.2 Hz), 131.1 (d, J= 40.1 Hz), 130.7 (d, J
= 1.7 Hz), 128.5 (d, J= 9.2 Hz), 128.4 (s, 2C), 127.6, 126.3 (s, 2C), 78.8, 58.5 (d, J= 8.6 Hz),
32.7 (d, J= 43.7 Hz), 29.5 (d, J= 3.5 Hz), 27.2 (d, J= 12.1 Hz), 26.93 (d, J= 8.6 Hz), 26.86,
26.2, 26.1, 12.4 (d, J := 4.0 Hz).
31p NMR (CDC13, 121.5 MHz): 6 72.2 (br q, J= 66 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C22H33BNNaOP 392.2285, obsd 392.2290.
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Ph
Me
Me Me
Ph" P- N O H
H3 B Me Ph
(Sp, S, 2R)-N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(2-methyl-2-phenyl-1-propyl)-P-
(phenyl)-phosphinamide borane (9d). Neophyllithium was prepared from 1-chloro-2-methyl-
2-phenylpropane (neophyl chloride) and lithium-naphthalenide as described for 9c. Purification:
gradient silica gel chromatography (90:10 hexane-EtOAc, polarity gradually increased to 50:50
hexane-EtOAc). Yield: 72% (1.53 g, 3.7 mmol), isolated as a white foam. Only one
diastereomer was detected by 'H NMR integration. Rf (90:10 hexane-EtOAc) = 0.12.
IR (NaCl): 3511, 2968, 2389, 1601, 1496, 1450, 1435 cm -'
'H NMR (CDC13, 500 MHz): 6 7.67-7.63 (m, 2H), 7.46-7.40 (m, 6H), 7.36-7.31 (m, 4H), 7.27-
7.21 (m, 3H) , 5.12 (br s, 1H), 4.09-4.07 (m, H), 2.70 (t, J= 16.3 Hz, 1H), 2.65 (d, J= 7.0 Hz,
3H), 2.25 (dd, J= 2.1, 15.3 Hz, 1H), 1.87 (d, J= 2.1 Hz, 1H), 1.67 (s, 3H), 1.64 (s, 3H), 0.95 (d,
J= 7.0 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 8 150.9 (d, J= 7.5 Hz), 142.8, 135.4 (d, J= 59.9 Hz), 130.5 (d, J
= 8.6 Hz, 2C), 130.3 (d, J= 1.7 Hz), 128.7 (d, J= 9.2 HZ, 2C), 128.4 (d, J= 4.0 Hz, 2C), 127.4,
126.2, 125.9 (s, 2C), 125.6 (s, 2C), 79.8, 58.2 (d, J= 10.4 Hz), 41.1 (d, J= 36.3 Hz), 38.0, 31.2
(d, J= 5.2 Hz), 31.1 (d, J= 3.5 Hz), 28.4 (d, J= 4.6 Hz), 10.4 (d, J= 5.2 Hz).
31p NMR (CDC13, 121.5 MHz): 6 67.4 (br q, J= 53 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C26H35BNNaOP 442.2442, obsd 442.2464.
OMe
Me
P-N OHPh, N
H3B Me Ph
(Rp, S, 2R)-N-Methyl-N-(1-hydroxy-1-phenyl)prop-2-yl-P-(4-methoxyphenyl)-P-(phenyl)-
phosphinamide borane (9e). A 1.0 M solution of 4-bromoanisole (10 emmol) in diethyl ether
was cooled to -78 °C and treated with a solution of t-butyllithium (20 mmol). The solution was
allowed to stir 15 min at -78 °C, warmed to 0 °C and stirred an additional 30 min producing a
clear, yellow solution ofp-anisyllithium. The aryllithium reagent was transferred via cannula to a
1.0 M solution of 8 in tetrahydrofuran (5.0 mmol) at -78 °C. The mixture was allowed to stir 30
min at -78 °C, warmed to 0 °C to increase the solubility of salts, and stirred for an additional 2 h.
Water and diethyl ether were added, and the solution was warmed to ambient temperature.
Purification: gradient silica gel chromatography (90:10 hexane-EtOAc, polarity gradually
increased to 50:50 hexane-EtOAc). Yield: 80% (1.6 g, 4.0 mmol), isolated as a white solid. Only
50
one diastereomer was detected by H NMR integration. Rf (80:20 hexane-EtOAc) = 0.14. Mp:
51-52 °C.
IR (thin film): 3457, 2969, 2384, 1596, 1501, 1255 cm'.
1I NMR (CDCl 3, 500 MHz): 6 7.55-7.46 (m, 4H), 7.41-7.25 (m, 6H), 7.14-7.10 (m, 2H), 6.95
(dd, J = 1.7, 8.7 Hz, 2H), 4.82 (dd, J= 4.0, 6.3 Hz, 1H), 4.33-4.28 (m, 1H), 3.85 (s, 3H), 2.46 (d,
J= 7.9 Hz, 3H), 1.85 (d, J= 4.0 Hz, 1H), 1.24 (d, J= 6.7 Hz, 3H), 1.3-0.7 (br m, 3H).
'3C NMR (CDC13 , 125 MHz): 6 162.0, 142.7, 134.5 (d, J= 11.5 Hz, 2C), 132.1 (d, J = 9.8 Hz,
2C), 130.7, 128.8 (s, 2C), 128.4 (d J= 10.9 Hz, 2C), 128.1, 127.0 (s, 2C), 122.0 (d, J= 63.9 Hz),
114.2 (d, J= 10.9, 2C), 78.9 (d, J= 6.3 Hz), 58.2 (d, J= 10.4 Hz), 55.5, 30.4 (d, J,= 4.0 Hz),
1 3.8.
31P NMR (CDC13, 121.5 MHz): 6 69.2 (br q, J= 95 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C23H29BNNaO2P 416.1921, obsd 416.1918.
MeO' Me
Ph. P-N .OH
H3B Me Ph
(Rp, S, 2R)-N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(2-methoxyphenyl)-P-(phenyl)-
phosphinamide borane (9f). 47a, 48a-b, 5 o-Anisyllithium was prepared from the corresponding
bromide and the reaction was carried out as described for 9e. Purification: gradient silica gel
chromatography (90:10 hexane-EtOAc, polarity gradually increased to 50:50 hexane-EtOAc).
Yield: 93% (1.46 g, 3.7 mmol), isolated as a white solid. Only one diastereomer was detected by
1-I NMR integration. Rf (80:20 hexane-EtOAc) = 0.18. Mp: 108 °C.
IR (thin film): 3416, 3060, 2940, 2376, 1589, 1477, 1431, 1276, 1251 cm '.
IH NMR (CDC13, 500 MHz): 6 7.57 (ddd, J= 1.8, 7.6, 12.7 Hz), 7.50-7.46 (m, 3H), 7.39-7.23
(m, 8H), 7.03 (tdd, J= 0.9, 1.5, 7.5 Hz, 1H), 6.92 (dd, J= 4.1, 7.8 Hz), 4.91 (d, J= 5.2 Hz, 1H),
4.37-4.32 (m, 1H), 3.59 (s, 3H), 2.56 (d, J= 7.9 Hz), 1.91 (br s, 1H), 1.23 (d, J= 7.0 Hz, 3H).
'
3C NMR (CDC1 3, 125 MHz): 6 135.10 (d, J= 10.4 Hz), 133.4, 132.4 (d, J= 71.4), 131.0 (d, J=
10.4, 2C), 130.1, 128.5 (s, 2C), 128.1 (d, J= 10.9, 2C), 127.8, 126.8 (s, 2C), 121.0 (d, J= 10.9
Hz), 118.7 (d, J= 57 Hz), 111.7 (d, J= 4.6 Hz), 79.0 (d, J= 5.2 Hz), 58.3 (d, J= 10.4 Hz), 55.2,
31.1 (d, J= 4.0), 12.7.
3 1P NMR (CDC13, 121.5 MHz): 6 68.5 (br q, J= 84 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C23H29BNNaO2P 416.1921, obsd 416.1920.
51
Me .Me
Ph, '- N O H
H3B Me Ph
(Rp, S, 2R)-N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(2-methylphenyl)-P-(phenyl)-
phosphinamide borane (9g).67 o-Tolyllithium was prepared from the corresponding iodide and
the reaction was carried out as described for 9e. Purification: gradient silica gel chromatography
(90:10 hexane-EtOAc, polarity gradually increased to 50:50 hexane-EtOAc). Yield: 80% (1.2 g,
3.2 mmnol). Only one diastereomer was detected by H NMR integration. Rf (90:10 hexane-
EtOAc)= 0.09. Mp: 118 °C.
IR (NaC1, thin film): 3507, 3059, 2979, 2391, 1451, 1436, 1384, 1069, 1024 cm -'
'H NMR (CDC13, 500 MHz): 6 7.64-7.60 (m, 2H), 7.51-7.47 (m, 1H), 7.44-7.21 (m, 1 1H), 4.95
(t, J = 3.7 Hz, 1H), 4.39-4.35 (m, 1H), 2.65 (d, J= 7.3 Hz, 3H), 2.33 (s, 1H), 1.77 (d, J= 3.7 Hz,
1H), 1.26 (d, J= 6.7 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 142.7, 142.4 (d, J = 12.7 Hz), 132.8 (d, J = 8.1 Hz), 132.5,
132.4 (d, J= 9.2 Hz), 132.0 (d, J= 9.8 Hz, 2C), 131.1 (d, J= 2.3 Hz), 131.0 (d, J= 2.3 Hz),
129.1, 128.6 (d, J= 10.4 Hz, 2C), 128.4 (s, 2C), 127.6, 126.2 (s, 2C), 125.8 (d, J= 9.8 Hz), 79.1
(d, J= 2.3 Hz), 58.2 (d, J= 9.8 Hz), 31.5 (d, J= 3.5 Hz), 22.2 (d, J= 3.5 Hz), 11.7 (d, J = 4.6
Hz).
31p NMR (CDC13, 121.5 MHz): 6 69.9 (br q, J= 78 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C23H29BNNaOP 400.1972, obsd 400.1962.
Ph Me
,,,P ./OHPh,' '-NOHH3B Me Ph
(Rp, IS, 2R)-N-Methyl-N-(1-hydroxy-l-phenyl)prop-2-yl-P-(2-biphenylyl)-P-
(phenyl)-phosphinamide borane (9h).48b o-Biphenyllithium was prepared from the
corresponding bromide and the reaction was carried out as described for 3e. Purification:
gradient silica gel chromatography (90:10 hexane-EtOAc, polarity gradually increased to 80:20
hexane-EtOAc). Yield: 81% (1.8 g, 4.1 mmol). Rf(80:20 hexane-EtOAc) = 0.24. Mp: 110 °C.
IR (thin film): 3566, 3058, 2983, 2366, 1465, 1445, 1436 cm -.
67 Moulin, D.; Bago, S.; Bauduin, C.; Darcel, C.; Jug6, S. Tetrahedron. Asymmetry 2000, 11, 3939-3956.
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IH NMR (CDC13, 500 MHz): 6 7.72-7.68 (m, 2H), 7.51-7.47 (m, 1H), 7.44-7.18 (m, 16H), 4.88-
4.87 (m, 1H), 3.97-3.93 (m, 1H), 2.57 (d, J= 7.3 Hz, 3H), 1.50 (d, J= 3.1 Hz, 1H), 1.4-0.8 (br
m, 3H), 0.69 (d, J= 7.0 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 147.6 (d, J= 9.8 Hz), 142.7, 141.6 (d, J= 2.9 Hz), 134.3 (d, J =
9.8 Hz), 133.6 (d, J-= 58.2 Hz), 132.9 (d, J= 8.6 Hz), 132.4 (d, J= 9.8 Hz, 2C), 130.74 (d, J=
2.3 Hz), 130.70 (d, J= 2.3 Hz), 129.8, 129.0 (d, J= 66.2 Hz), 128.4, 128.31 (s, 2C), 128.29,
127.6 (is, 2C), 127.5, 127.3, 127.0 (d, J= 9.8 Hz), 125.8 (s, 2C), 79.0, 58.2 (d, J= 10.4 Hz), 32.0
(d, J= 4.0 Hz), 10.0 (d, J= 6.9 Hz).
31P NMR (CDC13, 121.5 MHz): 6 70.1 (br q, J= 55 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C28H31BNNaOP 462.2129, obsd 462.2127.
Synthesis of Phosphinite Boranes 10a-h (Typical Procedure). Concentrated sulfuric acid (120
mol%) was added slowly to a solution of phosphinamide borane 9 in methanol (0.1 M) at
ambient temperature. The solution was allowed to stir 18 h, partitioned between
dichloromethane and water, and the aqueous phase was extracted with dichloromethane. The
combined dichloromethane layers were washed with saturated, aqueous sodium bicarbonate,
dried with MgSO4, and concentrated. The crude residue was purified via column
clh:romatography (elution with 90:10 hexane-EtOAc) to give clear, colorless oils (unless
otherwise specified).
OMe
Ph",)P/ Me
H 3B
(R)-Methyl-(methylphenyl)phosphinite borane (10a).50 The general procedure was followed
except 9a was used without purification. Yield over two steps: 75% (2.52 g, 15 mmol). Rf (95:5
hexane-EtOAc) = 0.42.
IR (neat): 3058, 2988, 2944, 2842, 2382, 1037 cm
IH NMR (CDC 3, 500 MHz): 6 7.82-7.78 (m, 2H), 7.58-7.49 (m, 3H), 3.58 (d, 3H, J = 12.2 Hz),
1.71 (d, 3H, J= 9.2 Hz), 1.1-0.5 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 132.9 (d, J= 65.6 Hz), 131.5, 131.4, 129.53, 129.45, 54.4 (d, J
2.9 Hz), 16.8 (d, J= 47.2 Hz).
31p NMR (CDC1 3, 121 MHz): 6 113 (br q, J= 72 Hz).
HRMS (EI) [M-H+]: m/z calcd for C8H13BOP 167.0792, obsd 167.0794.
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Ph''/ Pn-Bu
H 3 B
(R)-Methyl-(n-butylphenyl)phosphinite borane (lOb).50 Yield: 62% (0.6 g, 2.9 rmmol). Rf
(90:10 hexane-EtOAc) = 0.32.
IR (thin film): 2958, 2872, 2375, 1437, 1033 cm -
'H NMR (CDC13, 300 MHz): 6 7.79-7.73 (m, 2H), 7.55-7.45 (m, 3H), 3.60 (d, J = 11.9 Hz, 3H),
2.00-1.86 (m, 2H), 1.52-1.32 (m, 4H), 0.88 (t, J= 7.2 Hz, 3H), 1.2-0.3 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 132.1 (d, J= 2.3 Hz), 131.5, 131.1 (d, J= 10.4 Hz, 2C), 128.9
(d, J= 9.8 Hz, 2C), 54.0 (d, J= 2.9 Hz), 30.4 (d, J = 45.5 Hz), 24.14, 24.11 (d, J= 13.8 Hz),
13.7. 31P NMR (CDCl3, 121.5 MHz): 6 116.6 (br q, J= 72 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for Cl lH20BNaOP 233.1237, obsd 233.1235.
OMe
Ph3B
H3B Y,
(R)-Methyl-(cyclohexylphenyl)phosphinite borane (10c). The general procedure was
followed except that the reaction was heated to 45 C after addition of sulfuric acid. Yield: 29%
(0.2 g, 0.9 mmol). Rf(90:10 hexane-EtOAc) = 0.38.
IR (NaCl, thin film): 2933, 2855, 2383, 1728, 1450, 1437 cm-'
'H NMR (CDC13, 500 MHz): 6 7.72-7.68 (m, 2H ), 7.54-7.46 (m, 3H), 3.61 (d, J= 12.1 Hz),
1.93-1.86 (m, 2H), 1.81-1.78 (m, 1H), 1.73 (br s, 1H), 1.66-1.61 (m, 2H), 1.34-1.30 (m, 1H),
1.26-1.13 (m, 4H), 1.1-0.4 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 131.9 (d, J= 2.3 Hz), 131.5 (d, J= 10.4 Hz, 2C), 130.3 (d, J=
51.2 Hz), 128.7 (d, J= 9.8 Hz, 2C), 54.3 (d, J= 3.5 Hz), 39.2 (d, J= 45.5 Hz), 26.5 (d, J= 4.5
Hz), 26.4 (d, J= 5.2 Hz), 26.0, 25.6, 25.2.
31p NMR (CDC13, 121.5 MHz): 6 119.5 (br q, J= 75 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C13H22BNaOP 259.1394, obsd 259.1384.
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H 3B
(R)-Methyl-[(2-methyl-2-phenyl-1l-propyl)phenyl]phosphinite borane (10d). Yield: 65%
(0.67 g, 2.3 mmol). Rf (90:10 hexane-EtOAc) = 0.29.
IR (NaC): 3058, 2967, 2945, 2384, 1496, 1437 cm .
'H NMR (CDC13, 500 MHz): 6 7.62-7.58 (m, 2H), 7.47-7.44 (m, 1H), 7.40-7.7.37 (m, 2H), 7.31-
7.29 (m, 2H), 7.24-7.21 (m, 2H), 7.16-7.13 (m, 1H), 3.42 (d, J = 11.9 Hz, 3H), 2.51 (t, J=
14.8Hz, 1H), 2.31 (dd, J= 5.2, 15.2 Hz, 1H), 1.55 (s, 3H), 1.50 (s, 3H), 1.2-0.5 (brm, 3H).
13C NMR (CDC13, 125 MHz): 6 148.6, 133.1 (d, J= 55.8 Hz), 131.6 (d, J= 2.9 Hz), 130.6 (d, J
= 10.4 Hz, 2C), 128.7 (d, J= 9.8 Hz, 2C), 128.2 (s, 2C), 126.1, 125.8 (s, 2C), 53.7, 47.3 (d, J=
38.6 Hz), 37.7, 30.4 (d, J= 5.2 Hz), 30.2 (d, J= 5.8 Hz).
3 1p NMR (CDCl 3, 121.5 MHz): 6 114.5 (br q, J= 69 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C17H24BNaOP 309.1550, obsd 309.1551.
OMe
I
H3B HO,,
OMe
(S)-Methyl-[(4-methoxyphenyl)phenyl]phosphinite borane (10e). Yield: 77% (0.7 g, 2.7
mmol). Rf (80:20 hexane-EtOAc) = 0.31.
IR (thin film): 3059, 3008, 2944, 2840, 2383, 1595, 1503 cm -
IH NMR (CDC13, 500 MHz): 6 7.74-7.67 (m, 4H), 7.52-7.45 (m, 3H), 7.0-6.96 (m, 2H), 3.85 (s,
3H), 3.72 (d, J= 12.2 Hz, 3H), 1.3-0.7 (br m, 3H).
13C NMR (CDC13, 125 MHz): 6 162.6 (d, J= 2.2 Hz), 133.5 (d, J= 12.6, 2C), 131.8 (d, J= 2.4
Hz), 132.1 (d, J= 65.6 Hz), 131.1 (d, J= 11.2 Hz, 2C), 128.7 (d, J= 10.5 Hz, 2C), 122.3 (d, J=
67.7 Hz), 114.4 (d, J= 11.4 Hz), 55.6, 54.1.
31P NMR (CDC13, 121.5 MHz): 6 105.9 (br q, J= 76 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C14H18BNNaO2P 283.1030, obsd 283.1024.
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H 3 B
(S)-Methyl-[(2-methoxyphenyl)phenyl]phosphinite borane (10f). 4 7 a 48a-b, 50 Yield: 76% (0.53
g, 2.0 mmol). Rf (10:90 hexane-EtOAc) = 0.18.
IR (thin film): 3060, 2943, 2840, 2382, 1590, 1478, 1432, 1278, 1252, 1064, 1033 cm .
'H NMR (CDC13, 500 MHz): 6 7.81 (ddd, J= 1.7, 7.6, 12.4, 1H) 7.77-7.73 (m, 2H), 7.53-7.47
(m, 2H), 7.45-7.42 (m, 2H), 7.08 (tdd, J= 0.9, 1.8, 7.5, 1H), 6.88 (dd, J= 4.3, 8.2 Hz, 1H), 3.75
(d, J= 12.2 Hz, 3H), 3.64 (s, 3H), 1.3-0.7 (br m, 3H).
'
3C NMR (CDC13, 125 MHz): 6 161.2 (d, J= 3.5 Hz), 134.13 (d, J= 1.7 Hz), 134.13 (d, J=
10.9 Hz), 132.2 (d, J= 66.2 Hz), 131.5 (d, J= 2.3 Hz), 131.3 (d, J= 11.5 Hz, 2C), 128.3 (d, J=
10.9 Hz, 2C), 121.0 (d, J= 10.9 Hz), 119.5 (d, J= 63.3 Hz), 111.8 (d, J= 5.2 Hz), 55.7, 54.1 (d,J
= 2.9 Hz).
31p NMR (CDC13, 121.5 MHz): 6 105.8 (br q, J= 76 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C14Hl8BNNaO 2P 283.1030, obsd 283.1026.
(S)-Methyl-[(2-methylphenyl)phenyllphosphinite borane (10g). Yield: 87% (0.62 g, 2.5
mmol). Rf(10:90 hexane-EtOAc) = 0.37.
IR (thin film): 3058, 2944, 2385, 1438, 1137, 1067, 1033 cm - .
'H NMR (CDC13, 500 MHz): 6 7.90 (dd, J= 7.6, 12.8, 1H, 7.68-7.64 (m, 2H), 7.54-7.51 (m,
1H), 7.47-7.44 (m, 3H), 7.34 (t, J= 7.3, 1H), 6.22 (dd, J= 3.7, 7.3 Hz, 1H), 3.76 (d, J= 12.2 Hz,
3H), 2.25 (s, 3H), 1.3-0.7 (br m, 3H).
'
3C NMR (CDC13, 125 MHz): 6 142.1 (d, J= 8.1 Hz), 133.9 (d, J= 15.0 Hz), 132.5 (d, J= 2.3
Hz), 132.0 (d, J= 64.5 Hz), 131.9 (d, J= 2.3 Hz), 131.8 (d, J= 8.6 Hz), 131.4 (d, J= 11.5, 2C
Hz), 129.2 (d, J= 60.4 Hz), 128.8 (d, J= 10.4 Hz, 2C), 125.9 (d, J= 11.5 Hz), 54.0, 21.4 (d, J=
4.0 Hz).
3 1 p NMR (CDC13, 121.5 MHz): 6 109.5 (br q, J= 72 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C14H, 8BNaOP 267.1081, obsd 267.1089.
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(S)-Methyl-[(2-biphenylyl)phenyl]phosphinite borane (10h).4 8b Yield: 77% (0.95 g, 3.1
mmol), isolated as a white solid. Rf (90:10 hexane-EtOAc) = 0.34. Mp: 62-63 °C.
IR (thin film): 3056, 2943, 2383, 1465, 1438, 1131, 1114, 1064, 1033 cm -.
'H NMR (CDC13, 500 MHz): 6 8.10-8.06 (m, 1H), 7.57-7.50 (m, 2H), 7.39-7.31 (m, 3H), 7.27-
7.21 (n, 4H), 7.14-7.11 (m, 2H), 6.94-6.92 (m, 2H), 3.58 (d, J= 12.2 Hz, 3H), 1.2-0.8 (br m,
311).
13C NMR (CDCl 3, 125 MHz): 6 146.8 (d, J= 7.5 Hz), 140.5 (d, J= 2.9 Hz), 133.7 (d, J= 5.0
Hz), 132.4 (d, J= 67.3 Hz), 131.8 (d, J= 7.4 Hz), 131.7 (d, J= 2.3 Hz), 131.3 (d, J= 2.3 Hz),
131.1 (d, J= 10.9 Hz, 2C), 130.3 (d, J= 60.4 Hz), 129.7 (s, 2C), 128.3 (d, J= 10.9 Hz, 2C),
127.4, 127.35 (s, 2C), 127.2 (d, J= 11.5 Hz), 53.8.
31p NMR (CDC13, 121.5 MHz): 6 108.6 (br q, J= 69 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C19H20BNaOP 329.1237, obsd 329.1251.
Synthesis of Phosphine Boranes la-h (Typical Procedure). A 0.075 M solution of
bromoferrocene (8 mmol) in diethyl ether was prepared and cooled to -78 °C. t-Butyllithium
(16 mmol) was slowly added and the solution was stirred 10 min at -78 °C. The solution was
warmed to 0 C and stirred an additional 15 min to generate FcLi. A 1.0 M solution of 4 (4
mmol) in THF was cooled to -78 °C, and the FcLi solution was transferred to it via cannula over
10 min. The solution was allowed to warm to ambient temperature and stirred 14 h. Water was
added, and the aqueous phase was extracted with diethyl ether. The combined organic layers
were washed with saturated, aqueous NaCl, dried with MgSO 4, filtered, and concentrated in
vacuo. The crude residue was purified via gradient column chromatography (elution with 80:20
hexane-CH 2Cl 2, polarity gradually increased to 50:50).
Me
Ph"iP
H3B
Fe
(S)-Ferrocenylmethylphenylphosphine borane (lla). Yield: 58% (0.75 g, 2.3 mmol), isolated
as an orange oil that was crystallized from hexane. Rf (50:50 hexane-CH 2C12) = 0.35. Mp: 73-
74. °C.
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Enantiomeric excess: 83% ee by HPLC analysis (Chiracel OJ, isocratic, hexane:2-propanol =
95:5, tR [(R)-lla] = 16.8 min, tR [(S)-lla] = 24.7 min).
IR (thin film): 3096, 2919, 2379 cm -1.
'H NMR (CDC13, 500 MHz): 6 7.67-7.63 (m, 2H), 7.44-7.40 (m, 3H), 4.51-4.48 (m, 3H), 4.45
(m, 1H), 4.29-4.28 (s, 5H), 1.80 (d, 3H, J= 10.4 Hz), 1.2-0.7(br m, 3H).
13C NMR (CDC13, 125 MHz): 6 133.1 (d, J= 56 Hz), 131.8 (d, 2C, J= 6.3 Hz), 131.5 (d, C, J=
2.8 Hz), 129.3 (d, 2C, J= 13.8 Hz), 72.5 (d, 1C, J= 8.6 Hz), 72.2 (d, 1C, J= 6.9 Hz), 71.1 (d,
1C, J= 6.3 Hz), 70.5 (5C), 13.9 (d, J= 42 Hz).
31p NMR 6 (CDC13, 121 MHz): 6.2 (br q, J= 76 Hz).
HRMS (El): m/z calcd for C 17H20BFeP 322.0740, obsd 322.0750.
[ac]20D= -32.3 (c = 0.60; CH2C12).
n-Bu
Ph" P
H3B
Fe
(S)-n-Butylferrocenylphenylphosphine-borane (11b). Yield: 90% (0.7 g, 1.8 mmol), isolated
as an orange oil. Rf(50:50 hexane-CH 2Cl 2) = 0.36.
Enantiomeric excess: 77% ee by HPLC analysis (Chiracel OJ, isocratic, hexane:2-propanol =
97.5:2.5, tR [(R)-llb] = 10.0 min, tR [(S)-llb] = 12.0 min).
IR (NaCl): 3386, 3097, 2957, 2870, 2380, 1436, 1172, 1107, 1065 cm
IH NMR (CDC13, 500 MHz): 8 7.79-7.75 (m, 2H ), 7.49-7.44 (m, 3H), 4.56-4.55 (m, 1H), 4.47-
4.46 (m, 1H), 4.44-4.42 (m, IH), 4.37-4.36 (m, 1H), 4.18 (s, 5H), 2.09-2.03 (m, 2H), 1.60-1.57
(m, 1H), 1.40-1.30 (m, 3H), 0.88 (t, J= 7.2 Hz, 3H), 1.3-0.7 (br m, 3H).
'
3 C NMR (CDC13, 125 MHz): 6 132.2 (d, J= 8.6 Hz, 2C), 131.1 (d, J= 2.3 Hz), 130.6 (d, J= 2.9
Hz), 128.7 (d, J= 9.8 Hz, 2C), 71.9 (d, J= 9.8 Hz), 71.8 (d, J= 3.5 Hz), 71.7, 71.3 (d, J= 7.5
Hz), 69.9 (s, 5C), 27.7 (d, J= 39.1 Hz), 25.5, 24.5 (d, J= 14.4 Hz), 13.8.
3"P NMR (CDC13, 121.5 MHz): 8 11.9 (br q, J= 75 Hz).
HRMS (EI): m/z calcd for C20H26BFeP 364.1209, obsd 364.1194.
[a]2D = - 4 8 .4 (c = 1.10; CH2C12).
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(S;)-Cyclohexylferrocenylphenylphosphine borane (llc). Yield: 66% (1.0 g, 2.6 mmol),
isolated as an orange solid. Rf(50:50 hexane-CH 2Cl 2) = 0.33. Mp: 95-96 °C.
Enantiomeric excess: 97% ee by chiral HPLC analysis (Chiracel OJ, isocratic, hexane:2-
propanol = 97.5:2.5, tR [(R)-llc] = 8.3 min, tR [(S)-llc] = 10.0 min).
IR (NaC): 2931, 2854, 2381 cm
'H NMR (CDCl 3, 500 MHz): 6 7.95-7.91 (m, 2H ), 7.54-7.53 (m, 3H), 4.66 (br s, 1H), 4.43 (br s,
1H), 4.40 (br s, 1), 4.24 (br s, 1H), 3.97 (s, 5H), 2.03 (dd, J= 12.4, 26 Hz, 1H), 1.77-1.76 (m,
1-1), 1.70-1.62 (m, 3H), 1.44-1.23 (m, 3H), 1.20-1.12 (m, 3H), 1.1-0.6 (br m, 3H).
'
3
,C NMR (CDCl 3, 125 MHz): 6 132.8 (d, J= 8.6 Hz, 2C), 131.3 (d, J= 2.9 Hz), 129.3 (d, J=
55.9 Hz), 128.7 (d, J= 9.2 Hz, 2C), 74.6 (d, J= 15.0 Hz), 71.8 (d, J= 6.3 Hz), 70.9 (d, J= 8.6
Hz), 70.6 (d, J= 4.0 Hz), 69.8 (s, 5C), 69.2 (d, J= 62.8 Hz), 37.2 (d, J= 37.4 Hz), 27.1, 26.9 (d,
J= 4.6 Hz), 26.9 (d, J= 19.6 Hz), 26.7, 26.0 (d, J= 1.2 Hz).
31p NMR (CDC13, 121.5 MHz): 19.3 (br q, J= 67 Hz).
HRMS (EI): m/z calcd for C22H28BFeP 390.1366, obsd 390.1351.
[O:]20 D = -281.8 (c = 03.55; CH 2C1 2).
Ph
Me
FePh" 'p
(S)-Ferrocenylphenyl(2-methyl-2-phenyl-1-propyl)phosphine borane (11d). Yield: 79%
(0.66 g, 1.5 mmol), isolated as an orange oil. Rf(80:20 hexane-CH 2C12) = 0.06.
Enantiomeric excess: 98% ee by chiral HPLC analysis (Chiracel AD, isocratic, hexane:2-
propanol = 98:2, tR [(R)-lld] = 7.3 min, tR [(S)-lld] = 7.8 min).
IR (NaCl): 3088, 3057, 2965, 2389, 1496, 1437, 1387, 1171, 1107, 1063 cm -
'H NMR (CDC13, 500 MHz): 6 7.74-7.70 (m, 2H ), 7.41-7.40 (m, 1H), 7.36-7.33 (m, 2H), 7.26-
7.24 (m, 2H), 7.20-7.16 (m, 2H), 7.13-7.11 (m, 1H), 4.55-4.54 (m, 1H), 4.41-4.40 (m, 1H), 4.37
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(m, 2H), 4.10 (s, 5H), 2.72 (t, J= 14.2 Hz, 1H), 2.63 (dd, J= 9.2, 14.6 Hz, 1H), 1.54 (s, 3H),
1.43 (s, 3H).
'
3C NMR (CDC13, 125 MHz): 6 148.8 (d, J= 6.9 Hz), 132.0 (d, J= 11.4 Hz, 2C), 131.6, 130.7
(d, J= 2.3 Hz), 128.4 (d, J= 9.8 Hz, 2C), 128.2 (s, 2C), 126.1, 125.7 (s, 2C), 72.6 (d, J= 66.2
Hz), 71.9 (d, J = 10.4 Hz), 71.6 (d, J= 7.5 Hz), 71.5 (d, J= 9.2 Hz), 70.9 (d, J= 7.5 Hz), 69.8 (s,
5C), 43.6 (d, J= 32.2 Hz), 38.3, 31.0 (d, J= 5.2 Hz), 29.2 (d, J= 4.6 Hz).
31P NMR (CDC13, 121.5 MHz): 6 6.3 (br q, J= 70 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C26H30BFeNaP 463.1420, obsd 463.1418.
[ao]20 D= -72.3 (c = 0.90; CH2C1 2 ).
OMe
H3B Fe
Fe
(R)-Ferrocenyl(4-methoxyphenyl)phenylphosphine borane (le).
mmol), isolated as an orange oil. Rf(50:50 hexane-CH 2C1 2) = 0.30.
Enantiomeric excess: 95% ee by chiral HPLC analysis (Chiracel
propanol = 90:10, tR [(S)-lle] = 22.8 min, tR [(R)-lle] = 30.3 min).
Yield: 85% (0.56 g, 1.4
OJ, isocratic, hexane:2-
IR (thin film): 3056, 2960, 2838, 2384, 1596, 1570, 1501, 1293, 1256, 1181, 1109, 1062 cm -
'H NMR (CDC13, 500 MHz): 6 7.58-7.53 (m, 4H), 7.45-7.43 (m, 1H), 7.41-7.38 (m, 2H), 6.95
(dd, J= 1.8, 8.9 Hz, 2H), 4.52-4.50 (m, 2H), 4.46-4.45 (m, 1H), 4.37 (m, 1H), 4.13 (s, 5H), 3.84
(s, 3H).
'
3C NMR (CDC13, 125 MHz): 6 161.9, 134.6 (d, J= 10.9 Hz, 2C), 132.5 (d, J= 9.2 Hz, 2C),
132.2 (d, J= 59.9 Hz), 130.8, 128.5 (d, J= 9.8 Hz, 2C), 121.9 (d, J= 64.5 Hz), 114.2 (d, J=
10.9 Hz, 2C), 73.1 (d, J= 10.9 Hz), 72.6 (d, J= 9.2 Hz), 72.0, 71.9, 71.84, 69.9 (s, 5C), 55.5.
31 p NMR (CDC13, 121.5 MHz): 6 14.8 (br q, J= 65 Hz).
HRMS (EI): m/z calcd for C23H2 4BFeOP 414.1002, obsd 414.0999.
[a] 20 D= +20.0 (c = 0.25; CH 2C12).
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(R)-Ferrocenyl(2-methoxyphenyl)phenylphosphine borane (11f).4 7a Yield: 92% (0.38 g, 0.9
mmol). Rf(90:10 hexane-EtOAc) = 0.18. Mp: 140 °C.
Enantiomeric excess: >98% e.e. by chiral HPLC analysis (Chiracel OJ, isocratic, hexane:2-
propanol = 99:1, tR [(R)-llf] = 43.8 min, tR [(S)- f] = 56.9 min).
IR (thin film): 3434, 3074, 2938, 2382, 1736, 1589, 1574, 1478, 1432, 1277, 1251, 1170, 1107,
1061 cm -.
IH NMR (CDC13, 500 MHz): 6 7.82-7.77 (m, 1H), 7.55-7.48 (m, 3H), 7.40-7.33 (m, 3H), 7.09-
7.06 (m, 1H), 6.89 (dd, J= 3.8, 8.1 Hz, 1H), 4.70-4.69 (m, 1H), 4.54 (br s, 1H), 4.51-4.49 (m,
2H), 404 (s, 5H), 3.47 (s, 3H).
13C NMR (CDC13, 125 MHz): 6 135.6, 133.5, 131.5 (d, J= 9.8 Hz, 2C), 130.1, 128.0 (d, J= 10.9
Hz, 2C), 121.0 (d, J = 10.9 Hz, 1C), 112.0, 74.1 (d, J= 12.1 Hz), 73.6 (d, J= 8.6 Hz), 71.8 (d, J
= 7.5 Hz), 71.6 (d, J= 8.1 Hz), 69.9 (s, 5C), 55.5.
3'p NMR (CDCl 3, 121 MHz): 6 14.1 (br q, J= 55 Hz).
HRMS (EI): m/z calcd for C23H2 4BFeOP 414.1002, obsd 414.1004.
[o]2 0 D = +60.0 (c =- 0.25; CH2C12).
Me
Ph"3B
Fe
(R)-Ferrocenyl(2-methylphenyl)phenylphosphine borane (11g). Yield: 70% (0.50 g, 1.3
mmol). Rf(80:20 hexane-EtOAc) = 0.50. Mp: 168-169 °C.
Enantiomeric excess: 83% e.e. by chiral HPLC analysis (Chiracel OJ, isocratic, hexane:2-
propanol = 99:1, tR [(R)-llg] = 14.0 min, tR [(S)-llg] = 20.3 min).
IR. (thin film): 3055, 2393, 1437, 1171, 1107, 1063 cm-
61
IH NMR (CDC13, 500 MHz): 6 7.80-7.76 (m, 2H), 7.58-7.54 (m, 1H), 7.52-7.49 (m, 2H), 7.33-
7.11 (m, 2H), 7.08-7.04 (m, 1H), 4.77-4.76 (m, 1H), 4.59-4.58 (m, 1H), 4.50-4.49 (m, 1H), 4.08-
4.07 (m, 1H), 4.07 (s, 5H), 2.09 (s, 3H).
'
3C NMR (CDC13, 125 MHz): 6 141.8 (d, J= 10.4 Hz), 133.4 (d, J= 8.1 Hz), 132.8 (d, J= 9.8
Hz, 2C), 131.7 (d, J= 9.2 Hz), 131.3, 130.9, 130.8, 130.4 (d, J= 16.1 Hz), 128.8 (d, J= 9.8 Hz,
2C), 125.7 (d, J= 9.8 Hz), 72.2 (d, J= 6.3 Hz), 72.0 (d, J= 10.4 Hz), 71.8, 70.1 (d, J= 70.2 Hz),
70.0 (s, 5C), 22.2 (d, J= 4.6 Hz).
3 1p NMR (CDC1 3, 121 MHz): 6 17.1 (br q, J= 60 Hz).
HRMS (ESI) [M+Na]+: m/z calcd for C23H24BFeNaP 421.0950, obsd 421.0952.
[c] 20D = -269.3 (c = 0.15; CH2C12).
Ph
Ph'
H3B 
Fe
(R)-Ferrocenyl(2-biphenylyl)phenylphosphine borane (llh). Yield: 69% (0.54 g, 1.2 mmol).
Rf(50:50 hexane-CH 2C 2) - 0.34. Mp: 135-137 °C.
Enantiomeric excess: 98% e.e. by chiral HPLC analysis (Chiracel AD, isocratic, hexane:2-
propanol = 99.4:0.6, tR [(R)-llh] = 13.2 min, tR [(S)-llh] = 14.3 min).
IR (thin film): 3055, 2385, 1464, 1438, 1169, 1108, 1060 cm -.
'H NMR (CDC13, 500 MHz): 6 7.64-7.60 (m, 2H), 7.46-7.40 (m, 2H), 7.36-7.33 (m, 2H), 7.31-
7.26 (m, 2H), 7.18-7.15 (m, 1H), 7.13-7.10 (m, 1H), 7.04-7.01 (m, 2H), 6.94 (br s, 2H), 4.75 (br
s, 1H), 4.49 (br s, IH), 4.43 (br s, 1H), 4.10 (br s, 1H), 3.90 (s, 5H).
13C NMR (CDC13, 125 MHz): 6 146.7 (d, J= 9.2 Hz), 140.5 (d, J= 3.5 Hz), 133.5 (d, J= 8.6
Hz), 133.0 (d, J= 9.2 Hz, 2C), 131.80 (d, J= 8.1 Hz), 131.79, 131.3 (d, J= 18.4 Hz), 130.9 (d, J
= 2.3 Hz), 130.7, 130.15, 130.1 (d, J= 2.3 Hz), 128.1 (d, J= 10.4 Hz, 2C), 127.1 (s, 2C), 127.0,
126.9 (d, J= 9.2 Hz).
31P NMR (CDC1 3, 121 MHz): 6 18.1 (br s).
HRMS (ESI) [M+Na] +: m/z calcd for C28H26BFeNaP 483.1107, obsd 483.1107.
[o] 2 D= -180.8 (c = 0.40; CH 2C12 ).
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OH
n-Pr/Y Ph
n-Pr
(E)-1-Phenyl-2-propyl-hex-2-en-l-ol (12).68 Prepared according to the general procedure for
the reductive coupling of alkynes and aldehydes (Table 8, entries 1-5). Rf (90:10 hexane-EtOAc)
= 0.28.
Enantiomeric excess determined by chiral HPLC analysis (Chiracel OD, isocratic, 99:1
hexane:isopropanol, 0.8 mL/min, tR [(R)-12] = 15.7 min, tR [(S)-12] = 17.4 min).
IR (thin film): 3365, 2958, 2930, 2871, 1493, 1453, 1377, 1035 cm-'
'H NMR (CDC13, 500 MHz): 6 7.38-7.31 (m, 4H), 7.29-7.25 (m, 1H), 5.64 (5, 1H, J= 7.3 Hz),
5.17 (d, 1H, J= 3.1 Hz), 2.09-2.05 (m, 2H), 2.01-1.96 (m, 1H), 1.86-1.81 (m, 1H), 1.81 (d, 1H, J
= 3.1 Hz), 1.48-1.40 (m, 2H), 1.34-1.19 (m, 3H), 0.94 (t, 3H, J= 7.3 Hz), 0.83 (t, 3H, J= 7.3
Hz).
13C NMR (CDC13, 125 MHz): 6 143.0, 141.4, 128.4, 127.54, 127.49, 126.8, 78.4, 30.2, 29.9,
23.2, 23.0, 14.7, 14.2.
HRMS (ESI) [M+Na]+: m/z calcd for C15H22NaO 241.1564, obsd 241.1564.
OH
n-Pr n-Pr
n-Pr
(E)-5-Propyl-non-5-en-4-ol (13). Prepared according to the general procedure for the reductive
coupling of alkynes and aldehydes (Table 8, entry 6). Rf(90:10 hexane-EtOAc) = 0.25.
Enantiomeric excess determined from the chloroacetate derivative by chiral GC analysis (B-PH,
isothenrmal, 120 °C, tR [(S)-13] = 21.2 min, tR [(R)-13] = 21.9 min).
IR (thin film): 3357, 2958, 2872, 1465, 1378, 1017 cm -.
H1- NMR (CDC13, 500 MHz): 6 5.39 (t, 1H, J= 7.3 Hz), 4.03 (td, 1H, J= 2.5, 6.5 Hz), 2.07-1.94
(m, 4H), 1.54-1.50 (m, 2H), 1.46-1.53 (m, 5H) 1.33-1.26 (m, 2H), 0.95-0.90 (m, 9H).
3C NMR (CDC13, 125 MHz): 6 142.2, 127.0, 76.9, 38.2, 29.9, 29.8, 23.5, 23.2, 19.4, 14.9, 14.3,
14 .1.
HRMS (ESI) [M+Na]+: m/z calcd for C12H24NaO 207.1719, obsd 207.1723.
68 Srebnik, M. Tetrahedron Lett. 1991, 32, 2449-2452.
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OH
n-Pr /'' i-Pr
n-Pr
(E)-2-Methyl-4-propyl-oct-4-en-3-ol (14). Prepared according to the general procedure for the
reductive coupling of alkynes and aldehydes (Table 8, entry 7). Rf (90:10 hexane-EtOAc) =
0.34.
Enantiomeric excess determined from the chloroacetate derivative
90 °C for 30 min then 140 °C for 15 min, tR [(S)-14] = 38.4 min, tR
by chiral GC analysis (B-PH,
[(R)-14] = 38.9 min).
IR (thin film): 3409, 2958, 2931, 2872, 1466, 1379, 1005 cm -1
1H NMR (CDC13, 500 MHz): 8 5.35 (t, 1H, J= 7.3 Hz), 3.65 (d, 1H, J= 7.3 Hz), 2.05-1.92 (m,
4H), 1.81-1.75 (m, 1H), 1.47-1.35 (m, 5H) 0.98-0.89 (m, 9H), 0.83 (t, 3H, J= 7.0 Hz).
13C NMR (CDC13, 125 MHz): 6 141.4, 127.9, 83.0, 31.8, 30.3, 29.8, 23.5, 20.1, 18.3, 14.9, 14.1.
HRMS (ESI) [M+Na]+: m/z calcd for C12H24NaO 207.1719, obsd 207.1716.
OH
'5? n-Pr
Me
15a
OH
Me n -Pr
15b
(E)-l-Cyclohexyl-2-methyl-hex-l-en-3-ol (15a) and (E)-3-cyclohexyl-hept-2-en-4-ol (15b).
Rf(90:10 hexane:EtOAc) = 0.33.
Enantiomeric excess determined by chiral GC analysis (B-PH, isothermal, 140 °C, tR [(R)-15b] =
7.86 min, tR [(S)-15b] = 8.03 min, tR [(R)-15a] = 11.40 min, tR [(S)-15a] = 11.66 min).
IR (thin film): 3348, 2926, 2852, 1448 cm-l.
'H NMR (CDC13, 500 MHz): 6 5.51 (q, 1H, 15b, J= 7.0 Hz), 5.20 (d, 1H, 15a, J= 8.8 Hz), 4.05
(t, 1H, 15b, J= 5.5 Hz), 3.96 (t, 1H, 15a, J= 6.7 Hz), 2.37-2.33 (m, IH, 15b), 2.21-2.15 (m, 1H,
15a), 1.78-0.87 (m, 21H, 15a, 15b).
13C NMR (CDC13, 125 MHz): 148.0, 135.4, 133.1, 119.6, 78.0, 73.6, 39.4, 38.9, 37.2, 36.7,
33.3, 33.2, 31.6, 31.4, 27.2, 26.4, 26.3, 26.18, 26.17, 19.7, 19.2, 14.28, 14.25, 13.5, 12.8, 11.3.
HRMS (ESI) [M+Na]+: m/z calcd for C 13H24NaO 219.1719, obsd 219.1724.
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Chapter 2
Total Syntheses of Amphidinolides TI and T4 via Catalytic,
Stereoselective Reductive Macrocyclizations
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Introduction- Amphidinolides
In the search for novel bioactive compounds, natural products isolated from marine
organisms have shown a wealth of pharmacological and structural diversity.' Unfortunately, the
sources of the active compounds (sponges in particular) contain very small amounts of the
desired products, limiting the quantities that may be isolated and studied. During the 1980s,
Jun'ichi Kobayashi and co-workers undertook the isolation of natural products originating from
marine symbiotic microorganisms (such as bacteria, fungi, and microalgae) with the intent to
cultivate the microorganisms and subsequently isolate larger amount of active compounds.a
Early on, Kobayashi focused on a marine microalga dinoflagellate from the genus Amphidinium,
found in the inner tissue of the Okinawan flatworm Amphiscolops. Four novel bioactive
macrolides were originally isolated, amphidinolides A-D2 (Chart 1), exhibiting cytotoxicity
against murine lymphoma cells (L1210) and human epidermoid carcinoma KB cells.
Chart 1
CH2 Me O
HO,, 
HO CH 2 Me . MeHO
HO W Me M
OH CH2
Amnhidinolide A
linolide B
:inolide D (epi-C 1 8)
M
M
Amphidinolide C
'(a) Kobayshi, J. J. Nat. Prod. 1989, 52, 225-238. For a review of marine natural products, see: (b) Blunt, J. W.;
Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Nat. Prod. Rep. 2005, 22, 15-61. For a review of
natural products in drug development, see: (c) Newman, D. J.; Cragg, G. M.; Snader, K. M. J. Nat. Prod. 2003, 66,
1022-1037.
2 Original report: (a) Kobayashi, J.; Ishibashi, M.; Nakamura, H.; Ohizumi, Y.; Yamasu, T.; Hirata, Y.; Sasaki, T.;
Ohta, T.; Nozoe, S. J. Nat. Prod. 1989, 52, 1036-1041. Structure elucidation: (b) A: Trost, B. M.; Harrington, P. E.
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Additional species of Amphidinium were subjected to the extraction procedure, leading to
the discovery of amphidinolides E-H. During the process of isolation, several fractions were
found to exhibit cytotoxicity of greater potency than any of the amphidinolides A-H. Further
investigation of these cultures led to the discovery of related macrolides, amphidinolides J-Y.3
Table 1 summarizes the notable anticancer activity of the amphidinolides, highlighting the
activity of B, C, G, H, and N which display the greatest potency.
Table 1.' Summary of the Cytotoxicity of the Amphidinolides.
Amphidinolide Cytotoxicity (IC50 ig/ml) Amphidinolide Cytotoxicity (IC50 1Lg/ml)
L1210 KB L1210 KB
A 2 5.7 M 1.1 0.44
B 0.00014 0.0042 N 0.00005 0.00006
C 0.0058 0.0046 0 1.7 3.6
D 0.019 0.08 P 1.6 5.8
E 2 10 Q 6.4 >10
F 1.5 3.2 R 1.4 0.67
GI 0.0054 0.0059 S 4 6.5
G2" 0.3 0.8 T1c 18 35
G3D 0.72 1.3 T2 c 10 11.5
H 1 0.00048 0.00052 T3c 7 10
H2D 0.06 0.06 T4c 11 18
H3 D 0.002 0.022 T5 a 15 20
H4D 0.18 0.23 U 12 20
H5D 0.2 0.6 V 3.2 7
J 2.7 3.9 We 3.9 -
K 1.65 2.9 T_ 0.6 7.5
L 0.092 0.1 Yg 0.8 8
(a), Data compiled and reported by Chakraborty, T. K.; Das, S. Curr. Med. Chem.-Anti-Cancer Agents 2001, 1, 131-
14'9. (b) Kobayashi, J.; Shimbo, K.; Sato, M.; Tsuda, M. J. Org. Chem. 2002, 67, 6585-6592. (c) Kobayashi, J.;
Kubota, T.; Endo, T.; Tsuda, M. J. Org. Chem. 2001, 66, 134-142. (d) Kubota, T.; Endo, T.; Tsuda, M.;
Kobayashi, J. Tetrahedron 2001, 57, 6175-6179. (e) Shimbo, K.; Tsuda, M.; Izui, N.; Kobayashi, J. J. Org. Chem.
200D2, 67, 1020-1023. () Tsuda, M.; Izui, N.; Shimbo, K.; Sato, M.; Fukushi, E.; Kawabata, J.; Katsumata, K.;
Horiguchi, T.; Kobayashi, J. J. Org. Chem. 2003, 68, 5339-5345. (g) Tsuda, M.; Izui, N.; Shimbo, K.; Sato, M.;
Fukushi, E.; Kawabata, J.; Kobayashi, J. J. Org. Chem. 2003, 68, 9109-9112.
J. Am. Chem. Soc. 2004, 126, 5028-5029. (c) B: Ishibashi, M.; Ishiyama, H.; Kobayashi, J. Tetrahedron Lett. 1994,
34, 8241-8242. (d) C: Kubota, T.; Tsuda, M.; Kobayachi, J. Org. Lett. 2001, 3, 1363-1366.
3 For reviews of the amphidinolides, see (a) Kobayashi, J.; Tsuda, M. Nat. Prod. Rep. 2004, 21, 77-93. (b)
Chakaborty, T. K.; Das, S. Curr. Med. Chem.-Anti-Cancer Agents 2001, 1, 131-149. (c) Kobayashi, J.; Ishibashi,
M. In Comprehensive Natural Products Chemistry. Mori, K., Ed.; Elsevier; New York, 1999; Vol. 8, 619-649.
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In addition to the striking biological activity of the amphidinolides, they possess several
interesting structural features. This family of macrolides shows diversity in size, including
lactones of odd-numbered ring size, and display an abundance of stereogenic centers, exo- and
endocyclic double bonds, and oxygen-containing substituents (including epoxides, THF and TFP
rings, hydroxyl groups, and ketones). Due to their remarkable biological activity and structural
functionality, the amphidinolides are ideal and challenging synthetic targets. Since the first
reports of the amphidinolide family, considerable effort has been focused on synthesizing these
macrolides, resulting in several innovative and efficient total syntheses.4
In particular, the amphidinolide T class (Chart 2) has garnered significant attention since
its discovery in 2000.5 Members of this subclass, amphidinolides T1-5 (1-5), contain a 19-
membered macrocycle, a trisubstituted tetrahydrofuran moiety, -hydroxy ketone, exocyclic
methylene group, and a homoallylic ester linkage. T3-T5 are the most closely related molecules,
all containing a ketone at C13, hydroxyl group at C12, and methyl group at C14, and they differ
only in their configuration at C12 and C14. Amphidinolide T2 (2) displays the same
functionality at C12-C14 as 3-5, but contains an additional hydroxymethyl substituent at C18
where the other four members have an n-propyl group. Amphidinolide T1 (1) differs from 3-5 in
the oxidation states at C 12 and C 13, possessing the reversed hydroxy ketone moiety.
4 Proposed structure of A: (a) Lam, H. W.; Pattendon, G. Angew. Chem. Int. Ed. 2002, 41, 508-511. (b)
Maleczka, R. E., Jr.; Terrell, L. R.; Geng, F.; Ward, J. S., III. Org. Lett. 2002, 4, 2841-2844. (c) Trost, B. M.;
Chisholm, J. D.; Wrobleski, S. T.; Jung, M. J. Am. Chem. Soc. 2002, 124, 12420-12421. Structural revision and
synthesis of Amphidinolide A: (d) Trost, B. M.; Harrington, P. E. J. Am. Chem. Soc. 2004, 126, 5028-5029.
Amphidinolide J: (e) Williams, D. R.; Kissel, W. S. J. Am. Chem. Soc. 1998, 120, 11198-11199.
Amphidinolide K: (f) Williams, D. R.; Meyer, K. G. J. Am. Chem. Soc. 2001, 123, 765-766. Amphidinolide P:
(g) Williams, D. R.; Myers, B. J.; Mi, L. Org. Lett. 2000, 2, 945-948. (h) Trost, B. M.; Papillon, J. P. N. J. Am.
Chem. Soc. 2004, 126, 13618-13619. Amphidinolide R: (i) Kissel, W. S. "The Asymmetric Total Syntheses of
Amphidinolides J and R," Ph.D. Thesis, Indiana University, 1998. Amphidinolide T1: (j) Ghosh, A. K.; Liu, C.
J. Am. Chem. Soc. 2003, 125, 2374-2375. Amphidinolide T1, T3, T4, T5: (k) Fiirstner, A.; AYssa, C.; Riveiros,
R.; Ragot, J. Angew.Chem. Int. Ed. 2002, 41, 4763-4766. (1) Aissa, C.; Riveiros, R.; Ragot, J.; Fiirstner, A. J.
Am. Chem. Soc. 2003, 125, 15512-15520. Amphidinolide W: (m) Ghosh, A. K.; Gong, G. J. Am. Chem. Soc.
2004, 126, 3704-3705. Amphidinolide X: (n) Lepage, O.; Kattnig, E.; Fiirstner, A. J. Am. Chem. Soc. 2004,
126, 15970-15971.
5 For the isolation, structure determination, and biological studies of Amphidinolides T1-5, see: (a) Tsuda, M.;
Endo, T; Kobayashi, J. J. Org. Chem. 2000, 65, 1349-1352. (b) Kobayashi, J.; Kubota, T.; Endo, T.; Tsuda, M.
J. Org. Chem. 2001, 66, 134-142. (c) Kubota, T.; Endo, T.; Tsuda, M.; Shiro, M.; Kobayashi, J. Tetrahedron
2001, 57, 6175-6179.
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Previous Syntheses of Amphidinolides T1 and T3-T5
Total syntheses of 1 and 3-5 were reported shortly after this work was begun.
Amphidinolide T4 was synthesized in 2002 by Ftirstner and coworkers by taking advantage of an
efficient ring closing metathesis to form the macrocycle.4 k Related strategies were applied by the
same group to the syntheses of T1, T3, and T5 reported in 2003.41 Amphidinolide T1 was first
synthesized by Ghosh and Liu in 2003, utilizing a macrolactonization reaction to form the 19-
rnembered ring.4j
Chart 2. Amphidinolide T Family of Natural Products.
H
1 amphidinolide T1 2 amphidinolide T2
Me
3 amphidinolide T3
Me
H
4 amphidinolide T4 5 amphidinolide T5
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Fiirstner's Syntheses of Amphidinolides Ti and T3-T5.
It was clear from Fiirstner's initial T4 communication 4 k and delineated in the later full
account41 that an ultimate synthetic strategy hinged upon a late-stage intermediate that would
provide a point of divergence to both the T1 and T3-5 frameworks (Scheme 1). This key
intermediate bears hydroxyl groups at both C12 and C13; ostensibly simple deprotection and
oxidation state adjustment was predicted to provide access to 1 and 3-5. The common
intermediate was envisioned to be rapidly assembled from three simpler fragments (6, 7, and 8).
Scheme 1. Frstner's Retrosynthetic Disconnections.
''1UK'
R3SiO Me
,. XT1 and T3-5 5
Me Cl CIAO
Me Me
-
Me
common intermediate 7 II 80
In the forward direction (Scheme 2), alkene 9 (easily prepared using an auxiliary-based
diastereoselective aldol reaction) was ozonolyzed to the ketone and silylated under basic
conditions to produce fragment 6. Lewis acid-mediated coupling with sulfone 7 proceeded
smoothly and in very high diastereoselectivity, affording ketone 10. Selective reduction using L-
Selectride produced the C12 S diastereomer (24:1 dr), while reduction with LiAlH 4/LiI afforded
the R configuration at C12 (7:1 dr). The newly-formed secondary alcohol was protected as a
TBDPS ether, allowing for selective deprotection of the primary alcohol and subsequent
iodination, giving 11a or 11b depending on the protocol used for reduction of ketone 10.
Fragment 8 was synthesized through the esterification of carboxylic acid 12 with alcohol 13,
deprotection of the t-Bu ester and conversion to an acid chloride. (Coupling partners 12 and 13
were readily prepared through an auxiliary-based, diastereoselective alkylation and catalytic
enantioselective reduction, respectively).
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OMOM
OTBS
Me Me
9
1. 03; PPh3 OMOM
2. TBSOTf, Et3N TR.C J , SnCI 4, 7
'- '---'l ¥ -OTBS
Me
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1. L-Selectride to 11a or
LiAIH4/Lil to 11b
2. KHMDS, TBDPSCI
3. TsOH, aq. MeOH
4.12, PPh3, imid
OMOM
TBDPSO,,, ,Me
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1 I
Me~\1a
Ila
0
OH
Me
12
O OH
t-BuO \-~ M
13
OMOM
TBDPSO, 'Me
lib11
1. EDCI, DMAP
2. F 3CCO 2H, Et3SiH
3. (COCI)2, cat. DMF
CI 
Me Me
0
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Union of alkyl halide 1 la and acid chloride 8 was accomplished by a palladium-catalyzed
acylation (Scheme 3). Macrocycle formation via ring closing metathesis proceeded smoothly and
in high yield (86%); subsequent hydrogenation delivered macrolactone 16.
Scheme 3
OMOM
TBDPSO,,
5Zn/Cu; then Pd2 (dba) 3
1ia P(2-furyl) 3, 8 n-Pr
16
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Methylenation of ketone 16 using Nysted's reagent (17, Scheme 4) produced alkene 18,
which was intended to be the key common intermediate in syntheses of 1 and 3-5. To this end, a
sequence of steps from 18 indeed resulted in the synthesis of 1. The silyl protective group was
selectively removed by treatment with a fluorosilicate reagent, and the alcohol was oxidized to
the C12 ketone. Deprotection of the MOM ether by exposure to acidic Dowex resin produced
amphidinolide T1. Complementing this sequence and leading to the reversed hydroxy ketone
array of 3-5, the order of deprotection was reversed so that the MOM ether was first removed
from 18 to liberate the C13 hydroxyl group. Oxidation and desilylation produced amphidinolide
T4 (4). As 4 is known to be partially epimerized to 5 when treated with K2CO3/MeOH, 5 a
formal synthesis of amphidinolide T5 was also achieved. Attempts to access T3 from 18 via
removal of the C13 MOM group, oxidation to the ketone, and C12 epimerization failed.
However, elaboration of iodide llb and elaboration in analogy to the sequence used for la
culminated in the successful synthesis of 3.
Scheme 4
OH
O ,,, Me
\ss' XCH2
1. [(Me 2 N)3 S][Me 3 SiF 2 Me nPr
2. Dess-Martin Me
3. Dowex AG 50W-X4 O
T1 (1) 
OI-Pr HO,,, _\Me
1. TMSCI, n-Bu4NBr /" * C H 2
2. Dess-Martin Me ,. . n-Pr
me 03. HF-pyridine T 0
T4(4) 
....................................................................................................................
1. Zn/Cu; then Pd 2(dba) 3
P(2-furyl) 3, 8
OH
TBDPSO ,,\Me
12 14
O CH 2
Me n-PrMe
19 
OHO 2 ,,Me
1. Dess-Martin
2. HF-pyridine CH2
Me 6 n-Pr
T3 (3) 
T3(3) 0
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BrZn- ZnBr
J 17Zn
16
TiCI 4
11b
2. 15
3. H2, Pd/C
4. 17,TiCI 4
Ghosh's Synthesis of Amphidinolide T1.
Shortly after Fiirstner's synthesis of T4 was published, Ghosh reported the first total
synthesis of amphidinolide T1. The target was dissected into two fragments of approximately the
same complexity, sulfone 20 and silyl enol ether 21 (Scheme 5). Fragment coupling via
oxocarbenium ion alkylation and later macrolactonization were envisioned to give access to 1.
Scheme 5. Key Disconnections in Ghosh's Synthesis of 1.
R3 '
SO2Ph
Me
.Me
21 OR
T1 (1)
In the forward direction (Scheme 6), lactone 22 was partially reduced, and a mixed acetal
with trimethylsilylethanol was formed. Subsequent removal of the benzyl protecting group,
oxidation and methylenation produced acetal 23. Cross-metathesis with alkene 24 and
hydrogenation of the newly-formed alkene proceeded in 94% yield. Cleavage of the auxiliary
and exchange of the 2-trimethylsilylethoxy substituent with phenylsulfinic acid provided the
target sulfone 20. The other key fragment was produced starting from intermediate iodide 25
(prepared using an auxiliary-based diastereoselective aldol reaction). Lithiation, addition to
aldehyde 26 (derived from (S)-glycidol), and oxidation provided ketone 27. Subsequent
methylenation and deprotection furnished diol 28. Treatment of 28 with N-bromosuccinimide
promoted cyclization to bromotetrahydrofuran 29. Oxidation of the primary alcohol, methyl
addition and re-oxidation furnished ketone 30, which was converted to a silyl enol ether (31).
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Scheme 6
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Me
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Fragment coupling was achieved by a Lewis acid-mediated alkylation reaction of 20 and
31 (Scheme 7). Removal of the TBS and benzyl groups was followed by macrolactonization,
affording macrocycle 33. Finally, reductive cleavage of the bromotetrahydrofuran moiety by
treatment with Zn unveiled amphidinolide T1 (1).
Scheme 7
Br
Me,,.... 1. HF-pyridine
2. H2 , Pd/C Me, Br
AICI3, Pr 3. 2,4,6-(CI 3)PhCOCI, I Zn, NH4 CI,
DTBMP TBSO i-PrNEt2, DMAP .. . . EtOH
20 + 31 O- T1 (1)
Me O Me Me 0 0 Pr
32 O33 Me
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Summary and Comparison of Amphidinolide T Synthetic Strategies.
Our interest in the amphidinolide T natural products stemmed from the presence of the x-
hydroxy ketone and homoallylic ester moieties, both of which are patterns of functional groups
that we have prepared using nickel-catalyzed, alkyne-electrophile reductive coupling reactions
developed in our laboratory. 6' 7'8 From the inception of our investigations, we planned to form the
19-membered macrocycle using an intramolecular variant of our alkyne-aldehyde coupling
reaction. Additionally, we intended to utilize an alkyne-epoxide coupling reaction to join key
fragments en route to the open-chain alkynal needed for the anticipated macrocyclization. This
synthetic strategy represents a novel approach to the T natural products, based on an alternate
ring-closing method (Scheme 8).9 In contrast to all previously reported syntheses of
amphidinolide natural products (i.e., T1 or otherwise), this approach features the installation of a
stereogenic center during the macrocyclization event.
6 (a) Huang, W.-S.; Chan, J.; Jamison, T. F. Org. Lett. 2000, 2, 4221-4223. (b) Colby, E. A.; Jamison, T. F. J.
Org. Chem. 2003, 68, 156-166. (c) Miller, K. M.; Huang, W.-S.; Jamison, T. F. J. Am. Chem. Soc. 2003, 125,
3442-3443. (d) Chan, J.; Jamison, T. F. J. Am. Chem. Soc. 2003, 125, 11514-11515.
7 Molinaro, C.; Jamison, T. F. J. Am. Chem. Soc. 2003, 125, 8076-8077.
8 Several other nickel-catalyzed carbon-carbon bond-forming reactions of alkynes have been developed by
Montgomery: (a) Montgomery, J. Angew. Chem. Int. Ed. 2004, 43, 3890-3908. (b) Mahandru, G. M.; Liu, G.;
Montgomery, J. J. Am. Chem. Soc. 2004, 126, 3698-3699. (c) Lozanov, M.; Montgomery, J. J. Am. Chem. Soc.
2002, 124, 2106-2107. (d) Tang, X.-Q.; Montgomery, J. J. Am. Chem. Soc. 1999, 121, 6098-6099. (e)
Oblinger, E.; Montgomery, J. J. Am. Chem. Soc. 1997, 119, 9065-9066.
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Scheme 8. Macrocyclization Bond Disconnections for Reported Syntheses of 1.
Me
Ghosh
iacrolactonization
Jamison <}
Ni-catalyzed
reductive macrocyclization
Filrstner
ring-closing metathesis
Retrosynthetic Analysis
The foundation of our strategy for the synthesis of both amphidinolide T frameworks (the
hydroxy ketone array found in 1 and its reversed positioning in 2-5) is the use of nickel-catalyzed
reductive coupling reactions of alkynes, the aforementioned intramolecular alkyne-aldehyde
coupling reaction, as well as an intermolecular reductive coupling of an alkyne and epoxide. As
shown in Scheme 9, the product of the former, an allylic alcohol, would serve as a latent a-
hydroxy ketone moiety.
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9 Colby, E. A.; O'Brien, K. C.; Jamison, T. F. J. Am. Chem. Soc. 2004, 126, 998-999.
Scheme 9. Intramolecular Nickel-Catalyzed a,o-Alkynal Reductive Coupling Strategies.
Me
Ph 
Me 
Ph ~. .Et3B~[Ni]HO Lo PR3
O Me, Et3B
Ph A-
3,4 R
'" .x'O I'"C -Me 36
Me
34
[Ni] Ph MeK>0
Et3B §Me X O Me
Me
Me
Me a ( = ;m'n)
37b (X = O)35a R1 = OH, R2 H 
35bR 1 = H, R2 = OH
(X = CHPh or O)
Our plan for installing the hydroxy ketone of 1 and the "reversed" hydroxy ketone of 4
hinged upon analogous nickel-catalyzed reductive cyclizations of alkynals 36 and 37 to form the
requisite macrocyclic allylic alcohols 34 and 35. As noted above, this process would not only
close the 19-membered ring, but also concomitantly install a stereogenic center. Control over the
configuration of this center would thus be critical to the syntheses.
Although the positions of the alkyne and aldehyde portion of the corresponding alkynal
cyclization substrates 36 and 37 are inverted relative to one another, earlier synthetic
intermediates nevertheless share many structural and stereochemical features (Scheme 10). The
synthesis of amphidinolide T1 necessitates alkynyl acid 38 and homoallylic alcohol 39, while
amphidinolide T4 requires alkenyl acid 40 and hydroxyenyne 41.
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Both homoallylic alcohols (39 and 41) were predicted to be available from intermolecular
nickel-catalyzed reductive coupling reactions of alkynes and epoxides. 7 Alcohol 39, for
example, would be the product of the reaction between alkyne 42 and (R)-n-propyloxirane (44).
While aryl alkynes couple with epoxides with excellent regioselectivity and good yield, in
preliminary investigations of alkynylsilanes as coupling partners, the homoallylic alcohol product
is not fonrmed under the same conditions, returning only recovered alkyne and epoxide.' 0 We
planned to exploit this difference in reactivity of alkynes in a group-selective coupling of diyne
43 with epoxide 44 to form a hydroxyenyne, which would be elaborated to 41.
10 Molinaro, C.; Jamison, T. F. Unpublished results.
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Scheme 10. Intermolecular Alkyne-Epoxide Coupling Strategies.
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Results and Discussion
Synthesis of Amphidinolide TI: Construction of
Alkyne-Epoxide Reductive Coupling.
C13-C21 Fragment via Intermolecular
We commenced our studies by targeting a,o-alkynal 36 in order to investigate catalytic,
stereoselective reductive macrocyclization en route to amphidinolide T1 (1). Chiral alkyne 42
was synthesized in a three-step sequence (Scheme 11), beginning with alkylation of an Evans
oxazolidinone with 3-bromo-l-phenyl-l-propyne. 1l Cleavage of the auxiliary with lithium
aluminum hydride followed by TBS protection furnished 42 in 70% yield and 98% ee. The
requisite enantiomerically enriched epoxide 44 was easily prepared by way of Jacobsen's
I Prepared from commercially available 3-phenyl-2-propyn-l-ol via treatment with MsCl/Et3N, then LiBr as
reported by (a) Yi, X.-H.; Meng, Y.; Hua, X.-G.; Li, C.-J. J. Org. Chem. 1998, 63, 7472-7480. Alkylation: (b)
Evans, D. A.; Ennis, M. D.; Mathre, D. J. J. Am. Chem. Soc. 1982, 104, 1737-1739. Alkylation with propargyl
bromides: (c) Savignac, M.; Durand, J.-O.; Genet, J.-P. Tetrahedron. Asymmetiy 1994, 5, 717-722.
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hydrolytic kinetic resolution (HKR).12 Nickel-catalyzed union of these fragments proceeded
smoothly, delivering homoallylic alcohol 39 in very good yield in >95:5 dr and with >95:5
regioselectivity with respect to both addition across the alkyne and opening of the epoxide.
Optimal conditions were found when excess epoxide was employed (700 mol% relative to the
alkyne) and the reaction was conducted without additional solvent. As enantiomerically pure 44
is readily available in one step from commercial racemic n-propyloxirane via Jacobsen's HKR,
this transformation constitutes an efficient fragment coupling reaction providing rapid access to
the C13-C21 portion of amphidinolide T1 in just four steps.
Scheme 11.
0 0 1. LDA, THF; mM e 44
N Me PhCCH 2Br >99% ee
Me 3. TBSCI, imid 2 Bu3P (20 mol%) Ph
Me 70% 42 Et 3B 39
over 3 steps 81% yield
>99% dr
Synthesis of Amphidinolide T1: Assembly of C1-C12 Fragment.
We next turned our attention to the synthesis of alkynyl acid 38. The key issues to
address would be the installation of a highly substituted tetrahydrofuran ring as well as a remote
carboxylic acid moiety with a stereogenic center at the a-position. We predicted that the first of
these problems could be solved by a Lewis acid-mediated addition of a propargyl equivalent to a
five-membered cyclic oxocarbenium ion. This type of reaction has been well-studied by ReiBig,
who demonstrated that substituted five-membered lactols undergo smooth addition reactions
with a variety of nucleophiles when treated with a Lewis acid, presumably through an
12 (a) Tokunaga, M.; Larrow, J. F.; Kakiuchi, F.; Jacobsen, E. N. Science 1997, 277, 936-938. (b) Schaus, S. E.;
Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, M. E.; Jacobsen, E. N. J.
Am. Chem. Soc. 2002, 124, 1307-1315.
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oxocarbenium ion intennediate. 13 Woerpel and coworkers have also conducted extensive studies
regarding the stereochemical course of similar transformations (Scheme 12). 14 It has been
established that 2-acetoxy-4,5-cis-disubstituted tetrahydrofuran derivatives such as 45 undergo
allylation with a very high degree of stereocontrol when treated with allyltrimethylsilane and
stannic bromide, delivering products possessing a 2,4,5-trans-cis relationship across the
tetrahydrofuran ring (46, Scheme 12).
Scheme 12. Woerpel's Study of Nucleophilic Addition to Oxocarbenium Ions (ref. 14).
AcOBn 1. SnBr4 OBnAcO 0 O. /
Me 2. Me 3Si ' 'MeMe
45 46, 93: 7 dr
Encouraged by this stereochemical precedent, we needed to choose an appropriate
propargyl nucleophile equivalent to effect the desired addition reaction. As shown in Scheme 13,
propargylmagnesium bromide has been reported to react with cyclic oxocarbenium ions derived
from 47, but the propargyl-allenyl selectivity is low (68:32, 48:49).15 The use of a propargyl
aluminum species has been reported as a means to avoid allenyl-derived products in the Lewis
acid-mediated reaction of 50, delivering pure alkyne 51.16 Finally, Danheiser's reports of
allenylsilanes as effective propargyl nucleophiles in related additions to acyclic acetals,
aldehydes and ketones also served as an important starting point for our investigations. 17
Specifically, treatment of allenylsilane 52 with a mixture of acyclic acetal 53 and titanium
tetrachloride afforded the corresponding homopropargyl alcohol 54 in 75% yield with complete
selectivity for the propargyl product and bond formation at the carbon distal to the silicon
3 Schmitt, A.; ReiBig, H.-U. Synlett 1990, 40-42.
'4 Larsen, C. H.; Ridgway, B. H.; Shaw, J. T.; Woerpel, K. A. J. Am. Chem. Soc. 1999, 121, 12208-12209.
i:5 Franck, X.; Hocquemiller, R.; Figadere, B. Chem. Commun. 2002, 160-161.
"5 Dankwardt, S. M.; Dankwardt, J. W.; Schlessinger, R. H. Tetrahedron Lett. 1998, 39, 4975-4978.
'7 Danheiser, R. L.; Carini, D. J. J. Org. Chem. 1980, 45, 3925-3927.
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substituent. Prompted by the high reactivity of the allenylsilanes toward oxocarbenium ions, we
therefore began our studies using a cyclic oxocarbenium ion and trimethyl(1-phenyl-1,2-
propadienyl)silane (52).
Scheme 13. Lewis Acid-Mediated Propargylation Precedents.
Figadere (ref. 15)
OTBS
AcO 0 H 1. Et 2 0 BF3
A C c 4H 9 2.> MgBr
59% yield,
65:35 dr
Schlessinger (ref. 16)
OTBS ZnCliOEt 2,H 
AcO 0 O- OTES AI, HgC 2
) %' MgBr
Me 50 SiPhMe 2
55% yield
>95:5 dr
OTBS
/ ' C4H9
48
+ OTBS
;.-J _~C 4H9
49
68:32, 48:49
OTES
I
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(formation of allenyl
product not reported)
Danheiser (ref. 17)
OMe
PhOMe
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TiCI 4
Ph
=.---
Me 3Si 52
75% yield
Ph
Ph OH
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(allenyl product not observed)
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Synthesis of the target oxocarbenium ion precursors began with an enantioselective
addition of a chiral (Z)-crotylborane developed by Brown'8 to aldehyde 55,19 ultimately setting
the C7-C8 syn relationship (Scheme 14). Hydroboration-oxidation of the crotylation product
furnished a diol which was oxidatively cyclized, delivering lactone 56 in good yield over the
three step sequence.2( Reduction of the lactone furnished lactol 57a (2.3-2.6:1 dr), while direct
acetate protection of this reduction product provided acetoxy acetal 57b (2.3-2.6:1 dr).
Allenylsilane 52 was prepared according to Vermeer. 2'
Scheme 14.
Me 1. DIBAL-H,
97% (57a) OR
1.(+)-Ipc 2B O 2. Ac 2 0, pyr,
0 2. BH3 -THF; DMAP (57b)
H. k(CH 2 )4 TBS H2 0 2, NaOH Me 80% over 2 steps Me
H% (CH2)4TBS
55 3. TPAP, NMO (CH2)4OTBS (CH 2)4 OTBS
31% over 3 steps 57a (R = H)
56, 93%SO ee 57b (R = Ac)
With lactol 57a, acetal 57b, and allenylsilane 52 in hand, an investigation of
propargylation conditions was conducted. Initial experiments were conducted following
Danheiser's conditions for allenylsilane additions using acetal 57b as the oxocarbenium ion
precursor. Treatment of 57b with TiC14 at -78 C followed by addition of allenylsilane 52 gave
no desired product. Disappointingly, variation of reaction temperature and time failed to effect
propargylation and resulted only in decomposition of the starting acetal. The reaction conditions
were consequently modified to emulate Woerpel's method; the acetal and allenylsilane were
18 Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919-5923.
19 Marshall, J. A.; Shearer, B. G.; Crooks, S. L. J. Org. Chem. 1987, 52, 1236-1245.
20 This sequence of functional group manipulations was performed as reported in reference 14.
2' Westmijze, H.; Vermeer, P. Synthesis 1979, 390-392.
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premixed and cooled to -78 C, Lewis acid was added and the mixture was warmed to ambient
temperature.
Table 2. Nucleophilic Addition of Allenylsilane 52 to Acetal 57b.a
OAc
Me 0
(CH2)4 0TBS
57b
Ph
Me 3Si 52
Lewis Acid
CH 2C1 2
,ph/~/'",'O (CH2)40R
Ph <
Me
58 (R = OTBS)
59 (R = OH)
Entry Lewis Acid [57b] M temperature Product(s)b
1 TiCI4 0.05 - 78 C to 23 °C 58 not observed
2 SnBr4 0.05 - 78 C to 23 °C 58 < 5 %c
3 TBDMS-OTf 0.05 -78 °C to 23 °C 58 1 7 %d + 59 11%d
4 BF3'OEt 2 0.05 - 78 °C to 23 °C 59 13%d
5 BF 3 OEt 2 0.50 - 78 °C to 23 °C 59 1 4 %d
6 BF3 OEt2 0.05 - 78 °C to 0°C 58 13%d
7 BF3'OEt2 0.25 - 78 °C 58 not observed
a) 400 mol% 52 and 100 mol% 57b were combined in CH 2CI2 and cooled to
-78 °C before addition of 120 mol% Lewis acid. b) Characterized by 1H NMR,
13C NMR, and nOe experiments. c) Observed by 1H NMR. d) Isolated yield.
We were pleased to find that 57b did indeed undergo the desired propargylation reaction
when treated with Lewis acids other than TiC14. As shown in Table 2, stannic bromide afforded
traces of the propargylated TBS-ether 58 while boron trifluoride diethyl etherate promoted
nucleophilic addition as well as removal of the TBS protective group, giving free alcohol 59.
Utilization of t-butyldimethylsilyltrifluoromethane sulfonate (TBSOTf) also caused addition and,
counterintuitively, protiodesilylation, but the latter process was incomplete, as both 58 and 59
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were isolated. In an effort to optimize this process with BF 3OEt 2, both concentration and
temperature parameters were varied. Surprisingly, increasing the concentration by a factor of ten
did not influence the outcome of the reaction (entries 4 and 5). Reducing the final temperature to
O '°C prevented loss of TBS (entry 6) but did not enhance the yield of 58, while further reduction
of the temperature to -78 °C (entry 7) completely suppressed propargylation. We next explored
the character of the oxocarbenium ion precursor, replacing 57b with lactol 57a (more closely
following ReiBig's conditions). Gratifyingly, the lactol proved to be a much better substrate,
providing the desired alcohol 59 in 41% yield and in >95:5 dr when treated with boron trifluoride
diethyl etherate and 52 (Scheme 15).
Scheme 15. Allenylsilane Addition to Lactol 57a.
Ph
=-= 52
Me 3Si
HO 0 (CH 2) 4 TBS Et2O0BF 3, CH2C12
Ph
-78 °C, then warm to Me
57Me 23 °C (- TBS) 59
57a
40%, >95:5 dr
The use of different Lewis acids, concentration, temperature, and addition rate of Lewis
acid were all parameters investigated in an endeavor to improve the yield of the reaction, but no
such efforts were fruitful in this regard. Accordingly, we concentrated on the nucleophilic
component, aiming to increase the nucleophilicity 22 of the allene toward the oxocarbenium ion
by using allenylstannane 6023 in place of allenylsilane 52. To our satisfaction, the addition
22 Allylstannanes are reported to be much more nucleophilic compared to corresponding allylsilanes: (a) Denmark,
S. E.; Weber, E. J. J. Am. Chem. Soc. 1984, 106, 7970-7971. (b) Yamamoto, Y.; Nishii, S.; Yamada, J. J.
Am. Chem. Soc. 1986, 108, 7116-7117. (c) Sato, T.; Otera, J.; Nozaki, H. J. Org. Chem. 1990, 55, 6116-6121.
Allenylstannanes have also been shown to add to thioacetals under Lewis acidic conditions: (d) Sato, T.; Okura,
S.; Otera, J. Nozaki, H. Tetrahedron Lett. 1987, 28, 6299-6302. (e) Takeda, T.; Ohshima, H.; Inoue, M.;
Togo, A.; Fujiwara, T. Chem. Lett. 1987, 1345-1348.
23 Reported to propargylate enones in a 1,4-addition mode under Lewis acidic conditions: Haruta, J.; Nishi, K.;
Matsuda, S.; Akai, S.; Tamura, Y.; Kita, Y. J. Org. Chem. 1990, 55, 4853-4859.
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proceeded very smoothly with concomitant complete protiodesilylation, delivering terminal
alkyne 61 in excellent yield and diastereoselectivity (Scheme 16). Subsequent Sonogashira
coupling with iodobenzene furnished target alcohol 59 in near quantitative yield, constituting a
vast improvement over the one-step propargylation with allenylsilane 52 that we had reported
previously. 9
Scheme 16. Allenylstannane Addition to Lactol 57a.
P*-- 60
Ph3Sn 0O
HO 0 (CH2 )40TBS Et2O BF3, CH2CI2 0 OH
-78 °C, then warm to Me
Me57aMe 23 °C (- TBS) 61
57a
88%, >95:5 dr
Phi, cat. Cul, o OH
cat. Pd(PPh 3) 4
Ph
pyrrolidine Me
98%
With the installation of the substituted tetrahydrofuran ring achieved by the
allenylstannane addition, introduction of the remaining stereogenic center of carboxylic acid 38
was the next challenge to address. This was accomplished using an auxiliary-controlled,
diastereoselective alkylation reaction. The pseudoephedrine-based method developed by Myers
was selected as it displays very high diastereoselectivity, allows for use of the iodide as the
limiting reagent, and is well-suited for the alkylation of unactivated primary alkyl electrophiles. 24
Alcohol 59 was converted to alkyl iodide 62 which was an effective electrophile for the desired
alkylation reaction, proceeding in near quantitative yield and in excellent diastereoselectivity
24 Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L. J. Am Chem. Soc. 1997,
119, 6496-6511.
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(Scheme 17). The alkylated amide underwent base-promoted hydrolysis to furnish alkynyl acid
38 in excellent yield and in >95:5 dr.
Scheme 17. Synthesis of Alkynyl Acid 38.
12, PPh3 , imid59-- Ph/w/ t Me
Me
62, 73%
1. LDA, LiCI Me
~~Me
Ph N Me 0 OH
,·I Ph 0
OH Me Me
2. NaOH, t-BuOH, MeOH 38, >95:5 dr
89% over 2 steps
Synthesis of Amphidinolide TI: Fragment Coupling and Reductive Macrocyclization.
Enantiomerically pure homoallylic alcohol 39 and enantiomerically pure alkynyl acid 38
were joined in a DCC-mediated ester formation, affording 63 in 72% yield (Scheme 18). While
this C-O bond fomation was certainly satisfactory, we investigated an alternative, stereoselective
fragment coupling via alkylation of an enolate derived from the propionate ester of alcohol 39.
This approach would indeed save one step relative to the route described above, but it would
nevertheless have to surpass the very high efficiency and complete stereocontrol provided by the
Myers' asymmetric alkylation method. Treatment of ester 64 with LDA and iodide 62 did indeed
afford 63 (converging with the original route), but this process was nearly nonselective (1.6:1 dr,
favoring the undesired diastereomer). Clearly, therefore, this strategy modification did not result
in any improvement in the preparation of ester 63.
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Scheme 18. Contrasting Fragment Coupling Strategies.
Me
Me38, DCC, 16 2 Q 11
TBSO P OH4-PPY TBSO M0'P
%e ~ OH Me PM S X 72%, >95:5 dr Ph Me h
39 CH 3 63
(CH3 CH2CO)2 0
"lNAAP nv
TBSO - Me
1:1.6 dr at C2
(favoring
diastereomer
not shown)
Me ), I _ _
MPh j, ° Me
64 o Ph
62 Me
After two functional group manipulations (TBS removal with TBAF and oxidation with
the Dess-Martin periodinane reagent), we were poised to investigate conditions to form the 19-
membered ring via an intramolecular alkyne-aldehyde reductive coupling reaction (Scheme 19).
We began our studies with an achiral catalyst consisting of Ni(cod) 2 and tributylphosphine (see
Table 3), which had been very successful in other alkyne-aldehyde intramolecular reductive
coupling reactions in our group.25 In these cases, 14- and 15-membered rings containing three
(E)-trisubstituted double bonds were successfully formed via reductive macrocyclization of
alkynals. The alkynal needed for the T1 synthesis (36) differs from these previously studied
substrates in that it contains only one trisubstituted double bond (probably more flexible) and
would fonn a 19-membered ring upon cyclization.
Scheme 19
1. TBAF O Me
2. Dess-Martin o 063 , H
80% Me 0P
"~'Ph
Me 36
25 Chan, J.; Jamison, T. F. J. Am. Chem. Soc. 2004, 126, 10682-10691.
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Table 3. Summary of Macrocyclization Optimization Experiments.
Ni(cod)2, xx%
H
ligand, xx%
Et3B, 200%
H
Me 8
Me
6
mol%
entry ligand Ni(cod)2/ligand solvent conc. temp. product(s)a
1 PBu 3 10/20 toluene 0.05 M 23 °C 8 only
2 PBu 3 10/20 toluene 0.10 M 23 °C 8 only
3 (R)-NMDPP 10/20 EtOAc 0.02 M 23 °C 8 only
4 (R)-NMDPP 10/20 EtOAc 0.06 M 23 °C 8 only
5 (R)-NMDPP 10/20 EtOAc 0.12 M 23 °C 8 only
6 (S)-FcP(Ph)Me 10/20 EtOAc 0.10 M 23 °C 8 only
7 (R)-FcP(Ph)(o-anisyl) 10/20 EtOAc 0.10 M 23 °C 8 and <5% 6
8 PBu3 10/20 toluene 0.10 M 60 °C 6, 30% >10:1 dr
9 (R)-NMDPP 10/20 EtOAc 0.08 M 55 °C decomposition
10 PBu3 20/40 toluene 0.10 M 60 °C 6, 44% >10:1 dr
a When 8 was observed to be the only product by TLC and 1H NMR, it could be recovered in
60-80% yield (indicated by "8 only"). Yield and dr were determined by 1H NMR of purified
product.
A dilute solution of alkynal 36 (0.05 M in toluene), 10 mol% Ni(cod) 2, 20 mol%
phosphine and triethylborane was stirred at ambient temperature, but no reaction was observed
(only 36 was isolated, entry 1). Screening of phosphine ligands and concentrations was
conducted, but the desired cyclization was not observed in any case (entries 2-7). We next
explored the use of elevated temperature and were pleased to find that tributylphosphine/Ni(cod) 2
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promoted cyclization when the reaction mixture was heated to 60 °C, albeit in low yield (25-
30%, entry 8). Nevertheless, the stereoselectivity of the cyclization was outstanding; macrocyclic
allylic alcohol 34 was isolated in greater than 10:1 diastereoselectivity possessing the (S)-
carbinol configuration, corresponding to that found in the natural product, amphidinolide T1
(1).2 6 Further optimization efforts revealed that an NMDPP-derived catalyst was unstable toward
heating (entry 9). Returning to tributylphosphine as a ligand, we were pleased to find that higher
catalyst loading improved the yield; the best conditions proved to be a 20 mol% Ni(cod) 2/40
mol% tributylphosphine combination, giving 34 in 44% yield and in >10:1 dr (entry 10).27
Two features of the macrocyclization are noteworthy. First, the complete diastereocontrol
observed in the reductive macrocyclization was quite surprising as intermolecular couplings of
aldehyde 65 and alkyne 58 were virtually nonselective (Scheme 20), affording allylic alcohol 66
in 1.5:1 dr. Moreover, we observed that the sense of induction matches the Felkin-Anh product2 8
of nucleophilic addition to chiral aldehydes, and we therefore hypothesized that the configuration
at C14 of the alkynal is largely responsible for the sense of stereoinduction in the intramolecular
coupling (macrocyclization). Second, the intramolecular alkyne-aldehyde reductive coupling
reaction used in Table 3 shortens the overall synthesis by several steps relative to an
intermolecular coupling strategy that would require protection of both alkynyl acid 38 and
alcohol 39 (and subsequent deprotection (prior to macrolactonization)).
Scheme 20. Intermolecular Reductive Coupling Strategy.
26 Determined by Mosher ester analysis and ultimate conversion to 1.
27 Remaining material appeared to be a number of decomposition products of the alkynal that could not be
identified. The dr was measured by H NMR on purified material as crude NMR data was distorted by the
presence of nickel. None of the side products were identified to be the minor diastereomer; in subsequent
cyclizations of epimeric alkynals, the minor diastereomer of the allylic alcohol product co-eluted with the major
diastereomer and could be detected by NMR (vide supra).
28 (a) Ch6rest, M.; Felkin, H.; Prudent, N. Tetrahedron Lett. 1968, 18, 2199-2204. (b) Ch6rest, M.; Felkin, H.
Tetrahedron Lett. 1968, 18, 2204-2208. (c) Anh, N. T.; Eisenstein, O. Nouv. J. Chimie. 1977, 1, 61-70. (d)
Anh, N. T. Topics in Current Chemistry 1980, 88, 145-162.
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Synthesis of Amphidinolide TI: Endgame.
Macrocyclization of alkynal 36 overcame a significant hurdle in the synthesis of 1; all of
the stereogenic centers of 1 had been set, and all of the carbon atoms within the ring framework
of 1 were present in 34. The remaining challenge was differentiation of the two benzylidene
groups at C12 and C16. Specifically, oxidative cleavage of the C12 benzylidene to a ketone and
conversion of the C16 benzylidene to an exo-methylidene group were required (Scheme 21). We
decided to exploit the difference in steric congestion around the carbon atoms at issue and
accordingly protected the allylic hydroxyl group at C13 with a silyl group of an appropriate size.
Subsequent global ozonolysis would thus afford a diketone with very different environments
around the two carbonyl groups. We predicted that the resultant C16 carbonyl (flanked by two
CH 2 groups) would be more susceptible to nucleophilic attack than the C12 carbonyl (flanked by
a bulky silyl ether and a tetrahydrofuran to C12), and treatment with a methylenating reagent
would lead to the functional group pattern present in 1.
Scheme 21. Strategy for C12-C16 Differentiation.
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Moving forward with this plan, we chose to protect alcohol 34 with a TBS group,
smoothly effected by treatment of 34 with TBSOTf and 2,6-lutidine. Ozonolysis indeed
produced diketone 67 in moderate yield (43%). As we set our sights upon selective
methylenation, we took into account that both carbonyl groups possessed -oxygen substituents
that might act as leaving groups under strongly basic conditions. We first investigated the
Oshima reagent (Zn, CH2Br2, TiC14),2 9 as well as the Lombardo-modified reagent "low-
temperature aged",30 but in both cases only diketone was recovered. Standard Takai conditions
(Zn, CH212, TiCl4)3 1 were also unsuccessful, but replacement of TiCl4 by ZrCl4 and the addition
of lead (II) chloride32 resulted in clean methylenation at the C16 carbonyl furnishing the desired
29 Takai, K.; Hotta, Y.; Oshima, K.; Nozaki, H. Tetrahedron Lett. 1978, 19, 2417-2420.
30 Lombardo, L. Org. Syn. 1987, 65, 81.
3' Hibino, J.; Okazoe, T.; Takai, K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5579-5580.
32 Lead effects: (a) Takai, K.; Kakiuchi, T.; Kataoka, Y.; Utimoto, K. J. Org. Chem. 1994, 59, 2668-2670.
Zirconium alkylidene reagents: (b) Hartner, F. W., Jr.; Schwartz, J.; Clift, S. M. J. Am. Chem. Soc. 1983, 105,
640-641. (c) Tucker, C. E.; Knochel, P. J. Am. Chem. Soc. 1991, 113, 9888-9890.
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monoketone in 65-75% yield.33 Finally, treatment of this product with HF-pyndine promoted
clean conversion (>90% yield) to amphidinolide T1 (Scheme 22), whose spectroscopic,
spectrometric, and physical properties matched those reported for natural product 1 (Figure 1).
Scheme 22. Synthesis of 1 via Selective Methylenation.
1. TBSOTf,
2,6-lut
2. 03; Me2 S
36%
TBS
Me 3434
1. CH2 12 , Zn,
ZrCI 4, PbC12
2. HF py
70%
amphidinolide T1 (1)
:3 Work in our laboratory has shown that this system
ketones. Jeso, V.; Jamison, T. F. Unpublished results.
is effective for the methylenation of sterically hindered
167
-
Figure 1. Comparison of H NMR spectra of synthetic and natural 1.
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Synthesis of Amphidinolide T4 Framework.
Completion of the total synthesis of 1 indicated that our strategy of reductive
macrocyclization was indeed a viable route to amphidinolide T1. Nevertheless, a critical issue in
using this strategy for the synthesis of other members (T2-5) was the reversed hydroxy ketone
pattern at C12 and C13 (see Chart 2, p. 143). In our next synthetic undertaking, we set out to
address this issue by studying the reductive cyclization of alkynal 37, and whether it would exert
a high degree of substrate diastereocontrol in a cyclization using an achiral catalyst system as it
contains P-branching with respect to the aldehyde instead of a-branching (Scheme 11).
Synthesis of Amphidinolide T4 Framework: Construction of C13-C21 Fragment via Site-
Selective, Intermolecular Diyne-Epoxide Reductive Coupling.
Synthesis of the requisite alkynal 37 began with an investigation of the viability of a site-
selective alkyne-epoxide reductive coupling of diyne 43. Alcohol 68 (previously synthesized in
the T1 synthesis, Scheme 11) was oxidized to the aldehyde, converted to the dibromo olefin and
finally exposed to methyllithium and chlorotrimethylsilane to arrive at diyne 43 (Scheme 23).
Scheme 23.
1. Dess-Martin Me 3Si
2. CBr4, PPh3
HO 3. MeLi; then Me3SiCI
Me Ph 58% over 3 steps Me Ph
68 43
We found that 43 did indeed undergo coupling with (R)-propyloxirane to give the desired
hydroxyenyne 69 with >95:5 regioselectivity and >95:5 diastereoselectivity (Scheme 24). While
the crude product mixture was contaminated with products of polymerization of the alkyne, there
was no evidence of epoxide coupling at the alkynylsilane. Coupling product 69 was converted to
the target homoallylic alcohol 41 by treatment with TBAF and subsequent Sonogashira coupling
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with iodobenzene. The chemoselective epoxide coupling streamlined the synthesis of the C13-
C21 fragment by directly introducing the necessary alkyne at C13 rather than starting from T1
coupling product 39 and elaborating to the alkyne. The former route saves several steps, thus
compensating for the moderate yield of the diyne coupling reaction.
Scheme 24. Site-Selective Diyne-Epoxide Reductive Coupling.
Me3Si
Me Ph
43
Me 3Si
Ni(cod) 2 10 mol%
PBu 3 20 mol%
Et 3B, Me
40- 44
40-44%, >95:5 dr
1. TBAF, THF
2. Phi, cat. Cul,
cat. Pd(Ph3)4
69% over 2 steps
Ph
Me
Ph
16
Me
41 OH
1.
2.
3.
4.
Me '5.
TBSO Me--------- 6.
Me j OH
Ph
39
protection (C18)
deprotection (C13)
oxidation
alkynylation
(1 or 2 steps)
Phi coupling
deprotection (C18)
Synthesis of Amphidinolide T4 Framework: Construction of C1-C12 Alkenyl Acid,
Fragment Coupling and Alkynal Synthesis.
Alkenyl acid 40 was targeted next to advance the investigation of the T3/T4 synthesis.
This acid was synthesized in a route similar to alkynyl acid 38 (Scheme 25). Lewis acid-
mediated allylation of lactol 57a by allyltrimethylsilane proceeded in excellent yield to deliver
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the primary alcohol, which underwent smooth iodination to afford iodide 70. The iodide was
incorporated into an asymmetric Myers' alkylation-hydrolysis sequence similar to that used in the
T1 synthesis affording acid 40 in 88% yield over two steps and in >95:5 dr.
Scheme 25. Synthesis of Alkenyl Acid 40.
1. Me 3 Si 
Et 2 0 -BF 3, CH2CI2
57a
-78 °C to 23 °C
2. PPh3, 12, imid
1. LDA, LiCI
Me O
OH Me
2. NaOH, t-BuOH, MeOH
Me
70
76% over 2 steps
>95:5 dr
Me
OH
Me
40, >95:5 dr
88% over 2 steps
Fragment coupling was carried out by way of a DCC-mediated esterification, affording 71
in good yield (Scheme 26). As we sought to study ring-closing reductive cyclizations, we
examined methods of selective, oxidative cleavage of the terminal alkene in 71, which would
afford alkynal 37a. This target compound (with the benzylidene group at C16 intact) was the
logical starting point for the "reversed" reductive coupling strategy as the T1 alkynal also
possessed a benzylidene at this position and underwent cyclization successfully. We found that
37a could indeed be prepared by a dihydroxylation-periodate cleavage sequence, but over-
oxidation produced 37b, and moreover, the overall mass recovery of the process was low (< 20%
yield on 10 mg scale, 3:2 ratio of 37a to 37b). Given these difficulties, we reconsidered our
tactics and realized that a ketone might possibly be tolerated at C16 as ketones are much less
reactive than aldehydes under our nickel-catalyzed reductive coupling conditions and, in most
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cases, inert.34 This alternative oxidation was accomplished via double ozonolysis of 71, cleaving
both alkenes while leaving the alkyne intact to deliver 37b in very good yield.35
Scheme 26. Routes to Alkynals 37a-b.
Ph
40, DCC,
4-PPY
41 b
72% Me
Ph'
1. cat. OS0 4,
2. NalO 4
to 37a
Me
)'~, ,, ~"~0
0 ,~
Me
71
NMO 03; Me2S/PPh 3
to 37b
Ph Me
Me X O e. H
Me
Me
37a (X = CHPh)
37b (X = 0)
34 Many alkyne-aldehyde couplings may be conducted in acetone without a decrease in yield. Nevertheless, a
notable exception exists, that being an intramolecular, Ni-catalyzed alkyne-ketone coupling observed during
studies directed toward the synthesis of terpestacin, reference 25.
35 Ozonolysis was followed by exposure to dimethyl sulfide affording 37b and another product, determined to be
the ozonide at terminal position. Treatment of the ozonide with triphenylphosphine promoted clean conversion
to 37b giving an 80% combined yield of 37b. Direct reductive work-up with triphenylphosphine resulted in
much lower yields. See experimental section for more detail. While most ozonolysis reactions are safely
conducted using MeOH as a cosolvent, the use of MeOH promoted the formation of undesired methyl acetal
and hemiacetal products.
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Synthesis of Amphidinolide T4 Framework: Reductive Macrocyclization and Elaboration
to T4.
Both 37a and 37b were subjected to the nickel-catalyzed reductive coupling conditions
found to promote macrocyclization in our earlier synthesis of 1. Upon addition to a warm
solution of Ni(cod)2, tributylphosphine and triethylborane, 37a and 37b underwent reductive
cyclization to afford the desired macrocyclic allylic alcohols (Scheme 27). In both cases, the
diastereoselectivity was very high (>10:1 dr) and in the case of 37b, the yield was 58%. TBS
protection and ozonolysis of the two alcohols led to diketone 72 which was selectively
methylenated and deprotected with HF-pyridine. The H NMR data of the final product matched
that of amphidinolide T4 (4) and differed significantly from its C12 diastereomer T3 (3),
revealing the stereochemical outcome of the reductive cyclization. A comparison of the
diagnostic region of the H NMR spectra of natural 3, natural 4, and synthetic 4 is shown in
Figure 2.
Scheme 27. Reductive Macrocyclizations of 37a-b and Synthesis of 4.
1. Ni(cod) 2 20 mol/
PBu 3 40 mol%
Et 3B, toluene
37a 60 °C
or
37b 2. TBSCI, imid.
3. 03; Me 2S
1. CH2 12 , Zn,
ZrCI4, PbC12
2. HF py
74% H
over 2 steps
Me ,,I L4
>10:1 dr
31% yield from 37b
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Figure 2. Diagnostic Region of the 1H NMR spectra of 3 and 4.
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Synthesis of Amphidinolide T4 Framework: Comparison of Inter- and Intramolecular
Reductive Coupling Strategies.
As we had done in the T1 series (Scheme 20), we sought to compare the corresponding
intermolecular alkyne-aldehyde reductive coupling for the 3-4 framework. Interestingly, nickel-
catalyzed coupling of ketoalkyne 73 and tetrahydrofuranyl aldehyde 74 resulted in a mixture of
products that have been tentatively assigned as various elimination products and the
intramolecular hemiketal of the desired allylic alcohol. In attempt to identify reaction products
with certainty, the coupling was repeated with immediate silyl protection of the crude product
mixture. As shown in Scheme 28, the isolated product was dihydropyran 75 as a 2:1 mixture of
diastereomers, confirming our hypothesis that the coupling product was undergoing hemiketal
formation and dehydration upon treatment with TBSC1. Not only did this result once again point
to a strong conformational bias in the cyclization process that does not exist in the intermolecular
process, but also that the macrocycle prevents formation of undesired byproducts such as
dihydropyrans related to 75.
Scheme 28. Intermolecular Coupling Study.
Ph
Ph Me
Me 1. Ni(cod) 2 20 mol%
PBu 3 40 mol% _ OAc
73 OAc Et3 B, toluene = -
-_.O Me
0 2. TBSCI, imid, DMFH'~ O
+ 0 OTBS
Me /
Me 75
a-m_,OTBS 2:1 dr
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Investigation of Substrate Control in Reductive Macrocyclizations and Development of a
Stereoselectivity Model.
With the successful nickel-catalyzed macrocyclization of 37b using an achiral catalyst
system, we endeavored to employ a chiral catalyst to overcome the inherent bias for the (S)-
carbinol configuration of T4 (4) which, if successful, would provide an entry into the T3
stereochemical pattern. We first examined the ligand (S)-neomenthyldiphenylphosphine
(NMDPP)3 6 in combination with Ni(cod)2 and triethylborane, but were disappointed to find that
the catalyst system was not stable toward heating and cyclization did not occur. We next turned
to P-chiral ferrocenyl ligands developed in our laboratory.6c We were pleased to find that 37b
did indeed undergo cyclization when heated with a catalytic amount of Ni(cod) 2 and (S)-
ferrocenylmethylphenylphosphine and stoichiometric triethylborane, producing allylic alcohol
35b in 30% yield and >10:1 dr. Interestingly, when the opposite enantiomer of the ligand was
utilized, 35b was also afforded in >10:1 dr (and 25% yield) with the same configuration at C12
(T4 configuration, Scheme 29).
36 During intermolecular reductive coupling studies of aldehydes and aryl alkynes in our laboratory (reference 6c),
NMDPP emerged as a uniquely powerful promoter of asymmetric Ni-catalyzed coupling reactions.
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Scheme 29. Reductive Cyclizations of 37b with P-Chiral Ferrocenyl Ligands.
Ni(cod)2 20 mol%
Ph Me L* 40 mol%
Mek\ Of <0,, Et3B, toluene 60 °C
Me 0 " M| Me
Me
1 L_ Me
35b
>10:1 dr
\ Me
L* Fe or Fe \ ;~'/eMe
This result demonstrated that these stereoselective macrocyclizations are under complete
substrate control, and are consistent with our growing hypothesis that both alkynals 36 and 37b
are highly conformnationally constrained during the reductive macrocyclization process. As noted
above, we initially suspected that the configuration of the C14 methyl group in both cases
(adjacent to the aldehyde group in 36 and adjacent to the alkyne in 37) played a significant role in
inducing this bias.
To probe this hypothesis, we synthesized alkynals 76 and 77 with the opposite
configuration at C14 (Scheme 30). Syntheses of both epi-C14 alkynals commenced with ent-68
(prepared using the R enantiomer of the Evans auxiliary) and followed the respective T1 and T4
syntheses exactly. The inverted methyl configuration did not affect either of the alkyne-epoxide
or selective diyne-epoxide reductive coupling reactions and subsequent elaboration afforded the
alkynals (details included in the Experimental Section).
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Scheme 30. Synthesis of Epi-C14 Alkynals.
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With the alkynals in hand, we were poised to examine reductive macrocyclization
conditions. We found that the alkynal 76 underwent cyclization when heated in the presence of
20 mol% Ni(cod) 2, 40 mol% tributylphosphine and excess triethylborane in 35% yield with high
diastereoselectivity (8:1 dr). Analysis of macrocyclic alcohol 80 using the Mosher method3 7
revealed that the major diastereomer possessed the S configuration at the carbinol center (Scheme
31). Interestingly, under the same conditions, alkynal 77 did not undergo cyclization (the only
recovered compound was unreacted 77).
37 Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512-519.
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Scheme 31. Inverted C14 Methyl Effect on Reductive Macrocyclizations.
Me
Ni(cod) 2 20 mol%
PBu 3 40 mol%
Et3B, toluene
65 °C
80
8:1 dr
Ni(cod)2 20 mol%
PBu3 40 mol%
Et3B, toluene77 ,t no cyclization product
65 C 40% recovered 77
The results of this set of coupling reactions are summarized in Table 4 and required
significant revision of our model of stereoinduction in the catalytic macrocyclizations. Contrary
to our original hypothesis and as evidenced by entries 1 and 2, the Felkin-Anh model clearly does
not apply in the case of the T1 series. That is, the configuration of the stereogenic center
adjacent to the aldehyde undergoing reductive coupling with the alkyne has no effect whatsoever
on the sense of induction. A minimum of 8:1 diastereoselectivity favoring the (S) configuration
was observed in both cases.
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Table 4. Macrocyclization Experiments.
entry macrocyclization experiment ligand dr configuration ofmajor diastereomer
1 T1 (36, Table 3 entry 10) PBu3 >10:1 (S) C13
2 14-epi-T1 (76, Scheme 31) PBu3 8:1 (S) C13
3 T4 (37a, Scheme 27) PBu3 >10:1 (S) C12
4 T4 (37b, Scheme 27) PBu3 >10:1 (S) C12
5 T4 (37b, Scheme 29) Fe Me,, >10:1 (S) C12
6 T4 (37b, Scheme 29) me >10:1 (S)C12
7 14-epi-T4 (77, Scheme 31) PBu3 n.a. (macrocyclization not observed)
The results of the T4 series of macrocyclizations (entries 3-6) are especially striking since
the same sense and degree of stereoselectivity are observed for two different alkynals (37a
(benzylidine at C16) and 37b (ketone at C16)) and, in the case of 37b, for three very different
ligands (achiral, (R), or (S)). That the analogous "epi-methyl" (entry 7) experiment did not afford
the desired product unfortunately prevents direct analysis of the effect of this stereogenic center
upon the sense and degree of induction in the reductive macrocyclizations.
While we hesitate to infer too much information from a direct comparison of the T1 and
T4 series of macrocyclizations, in which the positions of the alkyne and aldehyde have been
reversed, we nevertheless propose a simple model of stereoinduction that is applicable to both of
these cases (Figure 3). The elements of the analysis that led to this rationale are as follows:
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(1) We have invoked an oxanickelacyclopentene 6 c 25 38 asan approximation of the transition state
of the reductive coupling. (2) Although clearly an oversimplification, the primary consideration
in our conformational analysis was strain (torsional and steric) developing in the vicinity of the
site of reactivity.
Both possible product diastereomers were subjected to the same analysis, and a rough
comparison was made between the two. Figure 3a represents our proposed model that minimizes
the unfavorable interactions in the transition state of the catalytic macrocyclization used to
prepare amphidinolide T1. For clarity, three key 1,3-interactions are highlighted although many
more are incorporated into the proposed model. The conformation shown possesses the fewest
number of gauche+-gauche- ("syn-pentane"),3 9 Al' 3 strain40 and related 1,3-interactions for this
diastereomer. For example, orienting the bonds highlighted (in bold) in the same direction
generates no syn-pentane-like interactions in any of these three cases. (Not emphasized in this
drawing is the fact that several other 1,3-interactions are also avoided.) On the contrary, all other
possible conformations induce at least one syn-pentane-like interaction.
The net effect of this arrangement is that the carbon-carbon bonds connected by the loop
representing the rest of the macrocycle are pointed in the same direction (see asterisked bonds).
The remaining 12 atoms in the macrocycle are thus easily accommodated without inducing
severe steric and/or torsional interactions.
When the same analysis was applied to the diastereomer not observed in this cyclization,
the structure in Figure 3b was generated. As can be seen, the bonds that are connected by the
loop are now pointed in different directions, approximately 120 ° relative to one another.
Moreover, the loop in this case represents only 9 additional atoms, and model building suggests
38 (a) Oblinger, E.; Montgomery, J. J. Am. Chem. Soc. 1997, 119, 9065-9066. (b) Miller, K. M.; Jamison, T. F.
J. Am. Chem. Soc. 2004, 126, 15342-15343.
39 Hoffman, R. W. Chem. Rev. 1989, 89, 1841-1860.
40 Wiberg, K. B.; Murcko, M. A. J. Am. Chem. Soc. 1988, 110, 8029-8038.
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that requiring this shorter chain to span the required distance is not nearly as straightforward as
was the case in the other diastereomer (Figure 3a).
Figure 3.
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A particularly satisfying feature of this model is that it can in fact be used to explain the
observed stereochemical outcomes of the macrocyclizations that were used in the synthesis of
amphidinolide T4. In other words, despite the fact that the "ends are reversed" so to speak,
minimization of a very similar set of developing steric interactions accounts for the sense of
induction in both the T1 and T4 series. As shown in Figure 3c and 3d, the net effect of this
analysis for the T4 series is also strikingly similar to that in the T1 series. In Figures 3a (T1) and
3c (T4), 12 atoms are available to join the two ends (which are pointed in the same direction),
whereas Figures 3b and 3d suggest that a much greater demand would be required of the 9 atoms
in the chain.
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A comparison of the results of the T1 series of macrocyclizations and of the 14-epi-T1
series is also worthy of comment (Figures 3a-b, 4, and 5). The goal of these exercises was to
account for the initially counterintuitive observation that the stereogenic center adjacent to the
site of the aldehyde had no effect on the sense of induction. One must be careful, however, in
drawing too much from this comparison, especially since the diastereoselectivity in the 1 4-epi-T1
series was not "complete", as it was in the T1 and T4 series. To a first approximation, 8:1 dr at
60 C represents a difference in energy of the two transition states of about 1.4 kcal-mol - ', a
rather small value when compared to all the possible interactions in these complex systems.
Nevertheless, as shown in Figure 4, low energy conformations for the diastereomers
observed in the macrocyclizations in the "epi-methyl-T1" series were generated using the criteria
in the other cases, and they are reminiscent of those for the corresponding diastereomers in the
T1 series (Figures 3a and 3b). The essence of this comparison is summarized in Figure 5.
Figure 4.
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(a)
Me
Me
14-epi-TI series 14-epi-Ti series
major diastereomer minor diastereomer
To summarize, our conclusion from these analyses is that the strongest effect upon the
sense of induction is minimization of 1,3-interactions near the site of reactivity in the transition
state. Moreover, branching (i.e., 2 substituents that are not hydrogen) at the carbon adjacent to
the aldehyde (C14 in these cases) can be accommodated without energetic penalty since C12 is
sp'? hybridized. That is, because of the absence of a substituent at C12, there are no 1,3-
interactions with the substituents at C14, and thus the effect on stereoselectivity of branching
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adjacent to the aldehyde is dramatically attenuated. In other words, as long as the remainder of
the nascent macrocycle can be accommodated without inducing severe unfavorable interactions,
the configuration adjacent to the reacting aldehyde is of no consequence in determining the
stereochemical outcome. Rather, it is the minimization of other interactions around the site of
reaction that has the greatest effect. This hypothesis is not new in its own right of course,4 but it
does suggest a unifying strategy that might be exploited in related stereoselective
macrocyclizations.
Figure 5.
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eliminates syn-pentane4ike interaction
with any of the substituents at C 14 in macrocyclizations
leading to both TI and 14-epi-TI
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41 For an in-depth study of situations in which developing 1,3-interactions (syn-pentane-like) better account for the
observed sense of stereoinduction in additions to chiral aldehydes than the Felkin-Anh model, see: Roush, W. R. J.
Org. Chem. 1991, 56, 4151-4157.
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Conclusion
In summary, we have found that intramolecular alkyne-aldehyde couplings are efficient
methods for closing the 19-membered ring present in the amphidinolide T framework. The
simultaneous installation of the carbinol stereogenic center found in 1 and 4 occurred with
complete disastereocontrol. Our strategy presents a very different approach from the previous
syntheses of amphidinolides T1 and T4 by Ghosh and Ftirstner as the ring closing process not
only formed a carbon-carbon bond, but also set a stereogenic center. This reductive
macrocyclization approach proved to be far superior to the corresponding intermolecular
reductive coupling strategy not only with respect to stereoselectivity, but also in the overall
number of steps necessary to synthesize the natural products (seventeen linear steps in the case of
anmphidinolide T1 and fifteen linear steps for T4 from aldehyde 55). Additionally, intermolecular
alkyne-epoxide reductive fragment couplings provided facile access to key intermediates,
streamlining the total syntheses and reducing the number of total synthetic operations to twenty-
one for T 1 and twenty-four for T4.
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Experimental Section
General Information. The experimental procedures are in order of compound number (lowest
to higher). Unless otherwise noted, all reactions performed in organic solvents were conducted
under an atmosphere of argon with rigorous exclusion of moisture from reagents and glassware.
THF and Et 20 were distilled from a blue solution of sodium benzophenone ketyl. CH 2C12 was
distilled from calcium hydride. Toluene was distilled from sodium metal. Anhydrous DMF and
CH3CN were purchased from Aldrich and used without purification. Analytical thin layer
chromatography (TLC) was performed using EM Science silica gel 60 F254 plates and UV light,
12-molybdophosphoric acid (PMA stain), or potassium permanganate (MnO 4 stain) for analysis
of the developed plates. Flash chromatography was performed using silica gel 60 (40-63 m)
from Silicycle. NMR spectra were recorded on a Varian 500 MHz spectrometer in CDC13 or
C6D6. IR spectra were recorded on a Perkin-Elmer 2000 FT-IR. High resolution mass spectra
(HRMS) were obtained on a Bruker Daltonics APEXII 3 Tesla Fourier Transform Mass
Spectrometer by Dr. Li Li of the Massachusetts Institute of Technology Department of Chemistry
Instrumentation Facility. GC analysis was performed on a Varian CP-3800 gas chromatograph
fitted with Chiraldex B-PH, B-DA, and G-TA capillary columns. HPLC was performed on a
Hewlett-Packard 1100 chromatograph equipped with a variable wavelength detector and
Chiralcel OD, AD, or OJ column. Specific rotations ([a]D) values for chiral compounds were
measured on a Perkin-Elmer 241 polarimeter at 589 nm.
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(+)-Amphidinolide T1 (1). A 2 mL plastic Eppendorf tube was charged with a solution of 59
(2.2 mg, 0.004 mmol) in CH 3CN (0.70 ml) and a Teflon-coated stirbar. Anhydrous HF-pyridine
was added via syringe (0.10 ml), and the reaction was stirred 72 h at ambient temperature. After
this time, the mixture was partitioned between H20 and EtOAc (1 mL each), and the layers were
separated. The aqueous phase was extracted with EtOAc (5 x 1 mL) and the combined organic
layers were washed with brine (1 x 2 mL), dried over Na2SO 4, filtered and concentrated. The
crude residue was purified via Pasteur pipet column chromatography (9:1 hexane-EtOAc) to give
the title compound as a clear, colorless oil (1.6 mg, 94% yield). Rf (80:20, hexane-EtOAc) =
0.32.
IR (thin film/NaCl): 3485, 2925, 2854, 1727 cm'.
'H NMR (C6D6, 500 MHz): 6 5.37-5.32 (m, H), 5.13 (s, 1H), 4.92 (s, 1H), 4.51-4.46 (m, H),
4.:30 (dd, J= 1.5, 5.8 Hz, 1H), 3.64 (ddd, J= 2.5, 4.4, 10.8 Hz, 1H), 3.60 (d, J= 5.8 Hz, 1H),
2.53 (dd, J= 10.4, 13.4 Hz, 1H), 2.47-2.41 (m, 3H), 2.33-2.23 (m, 3H), 1.88 (dd, J= 2.7, 14.3
Hz, 1H), 1.70-1.65 (m, 1H), 1.62-1.48 (m, 5H), 1.46-1.20 (m, 7H), 1.19-1.11 (m 1H), 1.07 (d, J
= 7.0 Hz, 3H), 1.05-1.02 (m, 1H), 0.93 (d, J= 6.4 Hz, 3H), 0.86 (t, J= 7.3 Hz, 3H), 0.62 (d, J=
7.0 Hz, 3H).
13C NMR (C6D6 , 125 MHz): 6 212.5, 175.4, 144.0, 116.7, 78.9, 78.6, 74.1, 72.2, 45.5, 42.3, 41.7,
40.5, 40.2, 37.0, 36.1, 35.6, 32.4, 30.2, 27.3, 26.7, 19.6, 18.6, 14.6, 14.5, 14.3.
HRMS (ESI) [M+Na]+: m/z calcd for C25H42NaO5 445.2924, obsd 445.2938.
[a]D = +6.7 (23 °C, c = 0.3, CHC13)
187
(-)-Amphidinolide T4 (4). A 2 mL plastic Eppendorf tube was charged with a solution of 68
(3.0 mg, 0.0055 mmol) in CH3CN (0.70 ml) and a Teflon-coated stirbar. Anhydrous HF-pyridine
was added via syringe (0.10 ml), and the reaction was stirred 17 h at ambient temperature. After
this time, the mixture was partitioned between H20 and EtOAc (5 mL each), and the layers were
separated. The aqueous phase was extracted with EtOAc (5 x 3 mL). The combined organic
phase was dried over Na2SO 4, filtered and concentrated. The crude residue was purified via
Pasteur pipet column chromatography (9:1 hexane-EtOAc) to give the title compound as a clear,
colorless oil (2.0 mg, 87% yield). Rf (80:20 hexane-EtOAc) = 0.17.
IR (thin film/NaCl): 3465, 2960, 2873, 1725, 1071 cm' l.
'H NMR (C6D6, 500 MHz): 6 5.23-5.18 (m, 1H), 4.83 (s, 2H), 4.56-4.53 (m, 1H), 4.33-4.29 (m,
1H), 4.03 (d, J= 6.7 Hz, 1H), 3.79-3.75 (m, 1H), 3.36-3.32 (m, 1H), 2.73 (dd, J= 4.0, 14.0 Hz,
1H), 2.54 (dd, J= 4.9, 13.4 Hz, 1H), 2.42-2.40 (m, 1H), 2.10 (dd, J= 8.7, 13.6 Hz, 1H), 2.02
(dd, J= 10.1, 14.0 Hz, 1H), 1.99-1.94 (m, 1H), 1.88-1.86 (m, 1H), 1.71-1.66 (m, 1H), 1.63-1.26
(br m, 13H), 1.19-1.13 (m, 1H), 1.10 (d, J= 7.0 Hz, 3H), 0.97 (d, J= 6.7 Hz, 3H), 0.85 (t, J= 7.3
Hz, 3H), 0.70 (d, J= 7.3 Hz, 3H).
13C NMR (C6D6, 125 MHz): 6 216.2, 176.0, 143.5, 116.0, 79.7, 75.4, 75.0, 72.3, 41.5, 41.2,
40.64, 40.57, 39.9, 38.8, 36.5, 35.9, 34.3, 29.1, 27.1, 26.4, 19.2, 18.5, 16.4, 14.6, 14.4.
HRMS (ESI)[M+Na]+: m/z calcd for C25H42NaO 5 445.2924, obsd 445.2929.
[a]D = - 7.5 (23 °C, c = 0.8, CHC13)
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(-)-11,15-Dibenzylidene-(14S)-hydroxy-(6S,13R,19R)-trimethyl-(9R)-propyl-8,20-dioxa-
bicyclo[15.2.1]icosan-7-one (34). A stock solution of catalyst was prepared in the following
manner: in a glovebox, Ni(cod) 2 (26 mg, 0.095 mmol) was placed in a flask containing a stirbar.
The flask was sealed with a rubber septum, removed from the glovebox, and immediately placed
under argon. Tributylphosphine (26 LL, 0.19 mmol), toluene (4.74 ml, previously degassed by
bubbling argon through for 10 minutes), and triethylborane (0.26 ml, 1.8 mmol) were added
sequentially, producing a clear yellow catalyst solution. A 2 ml Woodward reaction tube
equipped with a stirbar, rubber septum, and septum screw cap on the side-arm was purged with
argon. Stock catalyst solution was added to the tube (500 1tL), and the tube was immediately
placed in an oil bath at 60 °C for 3 min. A solution of 36 in degassed toluene (27 mg, 0.047
mmol in 500 gL) was added to the tube dropwise, causing the solution to turn red-brown. The
reaction was allowed to stir at 60 °C for 14 h. After this time, the solution was cooled to ambient
temperature, diluted with 1.5 ml EtOAc, and stirred open to the air 1 h; then concentrated. The
crude residue was purified via Pasteur pipet column chromatography (90:10 hexane-EtOAc) to
give the title compound as a clear, yellow oil (12 mg, 44% yield). Rf (90:10, hexane-EtOAc) =
0.20.
IR (thin film/NaC1): 3377, 2959, 2932, 2872, 1726, 1599, 1462, 1453 cm 'l.
'H NMR (CDC13, 500 MHz): 6 7.32-7.13 (m, 10H), 6.49 (s, 1H), 6.45 (s, 1H), 5.29-5.27 (m,
1H), 4.15-4.08 (m, 2H), 3.98 (d, J= 4.6 Hz, 1H), 3.90-3.87 (m, 1H), 2.73 (dd, J= 5.8, 13.7 Hz,
1IH), 2.53-2.42 (m, 3H), 2.37 (dd, J= 7.5, 13.9 Hz, 1H), 2.21 (dd, J= 7.3, 13.4 Hz, 1H), 2.14-
2.10 (m, 2H), 2.06-1.98 (m, 1H), 1.75-1.69 (m, 1H), 1.68-1.28 (br m, 13H), 1.20 (d, J= 7.0 Hz,
3H), 0.93 (t, J= 7.3 Hz, 3H), 0.91 (d, J= 6.1 Hz, 3H), 0.83 (d, J = 7.3 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 176.2, 142.7, 139.1, 138.5, 138.1, 129.01, 128.98 (2C), 128.96
(2C?), 128.5 (2C), 128.4 (2C), 128.0, 126.5 (2C), 79.3, 77.3, 72.7, 42.9, 41.7, 40.4, 38.5, 36.5,
36.3, 35.0, 34.8, 34.1, 30.2, 27.5, 25.9, 18.64, 18.62, 14.9, 14.5, 14.3 (missing one C under
CDC13 signal; when spectrum taken in C6D6 there are four signals in the 70-80 ppm region: 6
79.7, 77.6, 76.8, 72.5).
HRMS (ESI) [M+Na]+: m/z calcd for C38H52NaO4 595.3758, obsd 595.3746.
[aD = --67.8 (23 °C, c = 1.8, C6D6 )
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(-)-14-Benzylidene-(15S)-hydroxy-(6S,13R,19S)-trimethyl-(9R)-propyl-8,20-dioxa-
bicyclo[15.2.1]icosane-7,11-dione (35b). A stock solution of catalyst was prepared in the
following manner: in a glovebox, Ni(cod) 2 (26 mg, 0.095 mmol) was placed in a flask containing
a stirbar. The flask was sealed with a rubber septum, removed from the glovebox, and
immediately placed under argon. Tributylphosphine (26 p.L, 0.19 mmol), toluene (4.74 ml,
previously degassed by bubbling argon through for 10 minutes), and triethylborane (0.26 ml, 1.8
mmol) were added sequentially, producing a clear yellow catalyst solution. A 2 ml Woodward
reaction tube equipped with a stirbar, rubber septum, and septum screw cap on the side-arm was
purged with argon. Stock catalyst solution was added to the tube (240 L), and the tube was
immediately placed in an oil bath at 60 C for 3 min. A solution of 37b in degassed toluene (12
mg, 0.024 mmol in 760 L) was added to the tube dropwise, causing the solution to turn red-
brown. The reaction was allowed to stir at 60 C for 14 h. After this time, the solution was
cooled to ambient temperature, diluted with 1.5 ml EtOAc, and stirred open to the air 1 h; then
concentrated. The crude residue was purified via gradient Pasteur pipet column chromatography
(85:15 hexane-EtOAc polarity increased to 73:30 hexane-EtOAc) to give the title compound as a
clear, yellow oil (7.0 mg, 58% yield). Rf(50:50 hexane-EtOAc) = 0.41.
IR (thin film/NaCl): 3432 (br), 2960, 2935, 2873, 1780, 1732, 1458 cm l'.
'H NMR (C6D6 , 500 MHz): 7.33-7.31 (m, 2H), 7.18 (app t, J= 7.6 Hz, 2H), 7.03 (app t, J= 7.3
Hz, 1H), 6.86 (s, 1H), 5.36-5.31 (m, 1H), 4.58 (d, J= 8.9 Hz, 1H), 4.44-4.39 (m, 1H), 3.71-3.63
(m, 2H), 2.52-2.46 (m, 2H), 2.41 (dd, J= 7.9, 17.1 Hz, 1H), 2.37-2.33 (m, 1H), 2.11 (dd, J= 5.0,
14.5 Hz, 1H), 2.05 (br s, 1H), 1.83-1.79 (m, 1H), 1.74-1.60 (m, 3H), 1.57-1.37 (m, 7H), 1.33-
1.24 (m, 2H), 1.23-1.09 (m, 4H), 1.08-1.05 (m, 6H), 0.78-0.74 (m, 6H).
13C NMR (C6D6, 125 MHz): 6 206.9, 175.1, 150.4, 138.9, 130.4, 127.2 (2C), 125.2 (2C), 122.0,
79.2, 74.4, 71.9, 69.0, 50.0, 47.8, 46.0, 40.72, 40.70, 37.3, 37.0, 35.3, 30.7, 30.6, 27.6, 27.3, 21.1,
18.9, 17.1, 14.9, 14.4.
HRMS (ESI)[M+Na]+: m/z calcd for C31H44 05Na 519.3081, obsd 519.3077.
[a]D = -2.5 (23 C, c = 2.4, C6 H6 )
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(+)-(2S)-Methyl-6- [(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yl]-
hexanoic acid 3-benzylidene-(5R)-methyl-6-oxo-(1R)-propyl-hexyl ester (36). Dess-Martin
periodinane was dissolved in CH 2C12 (124 mg, 0.30 mmol, 2.4 mL) and a solution of 84 in
CH2C12 was added dropwise via syringe (80 mg, 0.14 mmol, 1.2 mL). The resulting solution was
stirred at ambient temperature for 75 min, diluted with Et2O (15 ml), and poured into 10 ml
saturated NaHCO 3 containing 2.5 g Na2 S203. When the organic layer cleared, the layers were
separated. The organic phase was washed with saturated NaHCO 3 (1 x 15 ml), H20 (1 x 15 ml),
and brine (1 x 15 ml), then dried over Na2SO4, filtered, and concentrated. The crude residue was
purified via column chromatography (90:10 hexane-EtOAc) to give the title compound as a clear,
colorless oil (67 mg, 84% yield). Rf(70:30, hexane-EtOAc) = 0.55.
IR. (thin film/NaCl): 2961, 2934, 2873, 1726, 1599, 1491, 1460 cm' .
'H NMR (C6D6, 500 MHz): 6 9.21 (d, J= 1.8 Hz, 1H), 7.50-7.48 (m, 2H), 7.16-7.13 (m, 5H),
7.05-6.97 (m, 3H), 6.40 (s, 1H), 5.28-5.23 (m, 1H), 4.24-4.19 (m, 1H), 3.88-3.85 (m, 1H), 2.79-
2.73 (m, 1H), 2.60 (dd, J= 4.9, 16.5 Hz, 1H), 2.51 (dd, J= 7.0, 16.5 Hz, H), 2.43-2.30 (m, 4H),
2.22 (dd, J= 4.9, 14.0 Hz, 1H), 2.03-1.98 (m, 1H), 1.88 (ddd, J= 7.0, 9.0, 10.8 Hz, 1H), 1.79-
1.74 (m, 1H), 1.63-1.58 (m, 1H), 1.55-1.42 (m, 4H), 1.40-1.21 (m, 6H), 1.11 (d, J= 7.0 Hz, 3H),
0.88 (d, J= 7.3 Hz, 3H), 0.75 (d, J= 7.0 Hz, 3H), 0.71 (d, J= 6.7 Hz, 3H).
13C NMR (C6D6, 125 MHz): 6 203.4, 176.5, 138.3, 136.7, 132.3 (2C), 131.0, 129.5 (2C), 128.95
(2C), 128.92 (2C), 128.7, 127.2, 125.0, 88.2, 82.7, 82.2, 75.6, 71.5, 45.1, 43.3, 40.4, 39.9, 37.2,
36;.7, 34.6, 31.7, 31.2, 28.2, 27.8, 27.4, 19.5, 17.9, 14.49, 14.47, 13.8.
HRMS (ESI) [M+Na]+: m/z calcd for C38H50NaO4 593.3601, obsd 593.3601.
[a]D = +0.60 (23 C, c = 3.4, CH 2C1 2)
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(-)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(2-oxo-ethyl)-tetrahydro-furan-(2S)-yl]-hexanoic acid
(5R)-methyl-3-oxo-7-phenyl-(R)-propyl-hept-6-ynyl ester (37b). A solution of 71 in CH2Cl2
(91 mg, 0.16 mmol in 50 mL) was cooled to -78 C. Ozone was bubbled through the solution
until a blue color persisted. Argon was immediately bubbled through until the solution was
colorless. Dimethylsulfide was added (0.80 ml) and the solution was allowed to slowly warm to
ambient temperature over 3 h. The solution was concentrated and immediately purified by
gradient column chromatography (85:15 hexane-EtOAc, polarity increased to 70:30 hexane-
EtOAc). Two products were isolated: a diastereomeric ketoalkynyl-ozonide (less polar) and the
desired ketoalkynal 37b (more polar). The ozonide was dissolved in 10 ml CH2C12 and stirred
with triphenylphosphine (256 mg) for 40 min. Concentration and purification on a silica gel
column (elution with 80:20 hexane-EtOAc) afforded pure ketoynal which was combined with the
original portion (combined: 63 mg, 80% overall yield). Rf (50:50 hexane-EtOAc) = 0.46.
IR (thin film/NaCl): 2962, 2935, 2874, 1727 (br) cm' l.
'H NMR (C6 D6 , 500 MHz): 6 9.51 (dd, J= 1.8, 2.8 Hz), 7.48-7.46 (m, 2H), 7.16-6.97 (m, 3H),
5.50-5.45 (m, 1H), 4.23-4.18 (m, 1H), 3.66-3.63 (m, 1H), 3.25-3.21 (m, 1H), 2.52-2.46 (m, 2H),
2.41-2.37 (m, 1H), 2.27-2.21 (m, 2H), 2.16 (dd, J= 7.0, 16.5 Hz, 1H), 1.96 (ddd, J= 1.7, 5.3,
15.9 Hz, 1H), 1.85-1.81 (m, 1H), 1.77-1.72 (m, 1H), 1.58-1.38 (m, 5H), 1.36-1.19 (m, 8H), 1.16
(d, J= 6.7 Hz, 3H), 1.13 (d, J= 7.0 Hz, 3H), 0.82 (t, J= 7.3 Hz, 3H), 0.69 (d, J= 7.3 Hz, 3H).
'
3C NMR (C6D6 , 125 MHz): 6 205.8, 201.9, 176.4, 131. 8 (2C), 128.4 (2C), 128.0, 123.7, 93.2,
81.7, 81.2, 71.7, 69.9, 50.7, 50.1, 47.9, 40.2, 39.8, 36.5, 36.0, 33.8, 30.4, 27.6, 26.7, 22.4, 21.0,
18.7, 17.2, 14.06, 14.04.
HRMS (ESI)[M+Na]+: m/z calcd for C31H44O5Na 519.3081, obsd 519.3077.
[a]D =- 2 .5 (23 C, c = 2.4, C6H6)
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(+)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yll-
hexanoic acid (38).42 A flask containing lithium chloride (549 mg, 13.0 mmol) was flame-dried
under a stream of Ar for five minutes, cooled to ambient temperature, and charged with THF (2.5
mL) and diisopropylamine (0.62 mL, 4.4 mmol). The heterogenous mixture was cooled to -78
°C' and n-butyllithium was added (1.63 mL, 2.5M in hexane, 4.1 mmol). The mixture was stirred
5 min at -78 °C, warmed to 0 °C for 30 min, then re-cooled to -78 °C. An ice-cooled solution
of N-(2-hydroxy-l -methyl-2-phenyl-ethyl)-N-methyl-propionamide in THF (474 mg, 2.14 mmol
in 4.6 mL) was added slowly via cannula, followed by a 1.0 mL wash portion of THF. The
mixture was allowed to stir 60 min at -78 °C, 15 min at 0 °C, and 5 min at ambient temperature
before re-cooling to 0 °C. An ice-cooled solution of 62 in THF (391 mg, 1.02 mmol, in 1.8 mL)
was added, followed by a 1.0 ml wash portion of THF. The mixture was stirred at 0 °C for 5h, at
which point the reaction was quenched with saturated NH4Cl (5 ml). H 2 0 and EtOAc were
added (5 ml each), the layers were separated, and the aqueous phase extracted with EtOAc (3 x
10ml). The combined organic phases were dried over Na2SO4, filtered and concentrated to give a
crude orange oil. The crude oil was purified by gradient column chromatography (90:10 CH2Cl2-
EtOAc, polarity increased to 50:50) to afford the alkylated amide (Rf 50:50 CH 2Cl2-EtOAc -
0.47). The amide was taken up in a 1:1 mixture of t-BuOH and CH3OH (3.4 mL) and transferred
to a sealable reaction tube equipped with a magnetic stirbar. NaOH was added (3.3 mL, 3.22N
aqueous solution), the tube was sealed, and the mixture was heated to refluxed 48h. After
cooling to ambient temperature, the volatile organic components were removed in vacuo. The
remaining residue was stirred in CH2Cl 2 and H2 0 (20 ml each), forming an emulsion which was
carefully acidified to pH < 2 by the addition of 6 N H2SO4 . The resulting layers (now clearly
distinct) were separated and the aqueous layer was extracted with CH 2Cl 2 (3 x 20 ml). The
combined organic phases were dried over Na2SO4, filtered and concentrated to give a clear, pale
yellow oil which was >95:5 dr by H NMR (298 mg, 89% yield over two steps). Rf (EtOAc)
0.30.
IR (thin film/NaCl): 3055 (br), 2936, 2860, 2241, 1950, 1705 cm l'.
IH NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.29-7.27 (m, 3H), 4.33-4.28 (m, 1H), 4.00-
3.97 (m, 1H), 2.68 (dd, J= 4.6, 16.6 Hz, 1H), 2.60 (dd, J= 7.0, 16.6 Hz, 1H), 2.50-2.43 (m, 1H),
2.35-2.28 (m, 1H), 2.09-2.03 (m, 1H), 1.87 (ddd, J= 3.7, 7.0, 12.5, 1H), 1.75-1.68 (m, 1H), 1.52-
1.25 (m, 7H), 1.18 (d, J= 6.7 Hz, 3H), 0.94 (d, J= 7.0 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 182.7, 131.8 (2C), 128.4 (2C), 127.9, 124.0, 87.1, 82.3, 82.0,
75.2, 39.44, 39.37, 36.1, 33.7, 30.4, 27.6, 27.2, 26.7, 17.0, 14.2.
HRMS (ESI)[M-H]: m/z calcd for C21 H270 3 327.1966, obsd 327.1963.
42 Followed procedure for asymmetric alkylation according to reference 24.
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(+)-2-[3-(tert-Butyldimethylsilanyloxy)-(2R)-methylpropyl]-1-phenyl-hept-1-en-(4R)-ol (39).
In a glovebox, Ni(cod) 2 (28 mg, 0.10 mmol) was placed in a 10 ml flask which was then sealed
with a rubber septum. The flask was removed from the glovebox and placed under Ar. To this
flask was added tributylphosphine (28 pL, 0.20 mmol), (R)-n-propyloxirane (44) (degassed by
bubbling Ar through for 10 min, 0.70 ml, 6.8 mmol), triethylborane (0.30 mL, 2.0 mmol), and 42
(290 mg, 1.00 mmol). The resulting dark brown solution was stirred at ambient temperature 14
h, then opened to the air for 1 h. Volatile organics were evaporated, and the crude residue was
purified via gradient column chromatography (50:1 hexane-EtOAc, polarity gradually increased
to 9:1) to afford the title compound as a clear, colorless oil (304 mg, 81% yield, 1 diastereomer
by 'H NMR). Rf(90:10, hexane-EtOAc) = 0.22.
IR (thin film/NaCl): 3376, 2956, 2930, 2857, 1463 cm .
'H NMR (CDC13, 500 MHz): 6 7.33-7.30 (m, 2H), 7.27-7.26 (m, 2H), 7.22-7.19 (m, 1H), 6.44 (s,
1H), 3.85-3.82 (m, 1H), 3.40 (dd, J= 6.0, 9.7 Hz, 1H), 3.32 (dd, J= 6.2, 9.9 Hz, 1H), 2.50 (dd, J
= 6.4, 13.7 Hz, 1H), 2.42 (dd, J= 4.3, 13.7 Hz, 1H), 2.28-2.23 (m, 1H), 2.09-1.90 (m, 1H), 1.85
(s, 1H), 1.58-1.50 (m, 3H), 1.46-1.40 (m, 1H), 0.98 (t, J= 7.0 Hz, 3H), 0.88 (s, 9H), 0.85 (d, J=
6.7 Hz, 3H), 0.02 (s, 3H), 0.01 (s, 3H).
13C NMR (CDC13, 125 MHz): 6 139.1, 138.0, 129.5, 129.1 (2C), 128.3 (2C), 126.4, 69.4, 68.2,
46.5, 39.5, 34.5, 34.3, 26.1 (3C), 19.2, 18.5, 17.1, 14.4, -5.21, -5.23.
HRMS (ESI) [M+Na]+: m/z calcd for C23H40NaO2Si 399.2690, obsd 399.2675.
[a]D = +10.5 (23 C, c = 15.2, CH2 C12 ).
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(+)-6-[(5R)-Allyl-(3S)-methyl-tetrahydro-furan-(2S)-yl]-(2S)-methyl-hexanoic acid (40). A
flask containing lithium chloride (490 mg, 11.6 mmol) was flame-dried under a stream of Ar for
five minutes, cooled to ambient temperature, and charged with THF (2.0 mL) and
diisopropylamine (0.48 mL, 3.4 mmol). The heterogenous mixture was cooled to -78 °C and n-
butyllithium was added (1.26 mL, 2.5M in hexane, 3.2 mmol). The mixture was stirred 5 min at
-78 °C, warmed to 0 °C for 30 min, then re-cooled to -78 °C. An ice-cooled solution of N-(2-
hydroxy-l-methyl-2-phenyl-ethyl)-N-methyl-propionamide in THF (350 mg, 1.58 mmol in 3.3
mL) was added slowly via cannula, followed by a 1.0 mL wash portion of THF. The mixture
was allowed to stir 60 min at -78 °C, 15 min at 0 °C, and 5 min at ambient temperature before
re-cooling to 0 °C. An ice-cooled solution of iodide 70 in THF (262 mg, 0.85 mmol, in 1.2 mL)
was added, followed by a 1.0 ml wash portion of THF. The mixture was stirred at 0 °C for 3h, at
which point the reaction was quenched with saturated NH4 Cl (5 ml). H2 0 and EtOAc were
added (5 ml each), the layers were separated, and the aqueous phase extracted with EtOAc (3 x
10ml). The combined organic phases were dried over Na2SO4, filtered and concentrated to give a
crude yellow oil. The crude oil was purified by gradient column chromatography (90:10 CH2C12-
EtOAc, polarity increased to 50:50) to afford the alkylated amide (Rf 50:50 CH2Cl 2-EtOAc =
0.:35). The amide was taken up in a 1:1 mixture of t-BuOH and CH 30H (2.64 mL) and
transferred to a 25 mL flask equipped with a magnetic stirbar. NaOH was added (2.64 mL,
3.22N aqueous solution), the flask was equipped with a reflux condenser, and the mixture was
heated to reflux 48h. After cooling to ambient temperature, CH 2C12 and H20 were added (20 ml
each). Acidification to pH < 2 was effected by the addition of 6 N H2SO4 . The resulting layers
were separated and the aqueous layer was extracted with CH 2C12 (3 x 20 ml). The combined
organic phases were dried over Na2SO4, filtered and concentrated to give a clear, pale yellow oil
which was diastereomerically pure by H NMR (191 mg, 88% yield over two steps). Rf (EtOAc)
= 0.85.
IR (thin film/NaCl): 3077 (br), 2965, 2937, 2862, 1706, 1642 cm 'l.
'H NMR (CDC13, 500 MHz): 6 10.8 (br s, 1H), 5.83-5.75 (m, 1H), 5.09-5.02 (m, 2H), 4.15-4.09
(m, 1H), 3.87-3.83 (m, 1H), 2.48-2.41 (m, 1H), 2.36-2.30 (m, 1H), 2.25-2.16 (m, 2H), 1.79-1.65
(mi, 3H), 1.52-1.33 (m, 6H), 1.32-1.25 (m, 1H), 1.16 (d, J= 7.0 Hz, 3H), 0.89 (d, J= 7.0 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 183.0, 135.2, 117.0, 81.5, 76.2, 41.2, 39.5, 39.4, 36.0, 33.7,
30.4, 27.6, 26.7, 17.0, 14.2.
HRMS (ESI)[M-H]-: m/z calcd for C15H250 3 253.1798, obsd 253.1801.
[a-ID = +8.4 (23 °C, c = 4.5, CH2C12)
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(+)-6-Benzylidene-(8R)-methyl-10-phenyl-dec-9-yn-(4R)-ol (41). Copper (I) iodide (100 mg,
0.54 mmol) and palladium tetrakis(triphenylphosphine) (39 mg, 0.033 mmol) were combined in
a round bottom flask. The flask was evacuated and back-filled with Ar three times. Pyrrolidine
(3.0 mL), alkyne 91 (132 mg, 0.51 mmol in 0.5 ml pyrrolidine), and iodobenzene (200 AtL, 1.79
mmol) were added sequentially and the mixture was stirred at ambient temperature 16 h. Et20O
was added (20 mL) and the mixture was filtered through a plug of silica gel. Solvent was
evaporated, and the crude residue was purified via column chromatography (9:1 hexane-EtOAc)
to afford the title compound as a clear, yellow oil (147 mg, 86% yield). Rf (90:10, hexane-
EtOAc) = 0.15.
IR (thin film/NaCl): 3417, 2958, 2930, 2871, 1598, 1491, 1442 cm 'l.
'H NMR (CDC13, 500 MHz): 6 7.40-7.32 (m, 6H), 7.28-7.22 (m, 4H), 6.56 (s, 1H), 3.90-3.86 (m,
1H), 2.99-2.93 (n, 1H), 2.74 (dd, J = 9.8, 13.7 Hz, 1H), 2.68-2.56 (m, 1H), 2.35 (dd, J= 5.8,
13.7 Hz, 1H), 2.26 (dd, J= 9.8, 13.8 Hz, 1H), 1.87 (br s, 1H), 1.57-1.39 (m, 4H), 1.27 (d, J= 6.7
Hz, 3H), 0.96 (t, J= 7.0 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 137.9, 137.7, 131.7 (2C), 130.7, 129.1, 128.39 (2C), 128.36
(2C), 127.8 (2C), 126.7, 123.8, 93.8, 81.9, 69.3, 45.6, 39.5, 37.4, 25.3, 21.5, 19.2, 14.4.
HRMS (ESI) [M+Na]+: m/z calcd for C24H28ONa 355.2032, obsd 355.2021.
[a]D = +12 (23 C, c = 3.2, CDC13)
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(+-)-1-(t-butyldimethylsiloxy)-(2R)-methyl-5-phenyl-4-pentyne (42). A 50 mL round bottom
flask was charged with 68 (1.10 g, 6.3 mmol), imidazole (0.79 g, 11.6 mmol), t-
butyldimethylsilylchloride (1.60 g, 10.6 mmol) and DMF (6.3 ml). The solution was stirred 20 h
at ambient temperature, then partitioned between H20 and Et20 (80 mL each). The ethereal layer
was washed with H20 (3 x 100 mL), brine (3 x 100 mL), dried over MgSO 4, filtered and
concentrated in vacuo. The crude residue was purified via gradient column chromatography
(5;0:1 hexane-EtOAc, polarity gradually increased to 19:1) to afford the title compound as a clear,
colorless oil (1.74 g, 96% yield). Rf (hexane) = 0.21.
IFR (thin film/NaCl): 2956, 2929, 2857, 1490, 1471 cm'.
'H NMR (CDC13, 500 MHz): 6 7.42-7.40 (m, 2H), 7.32-7.27 (m, 3H), 3.60-3.54 (m, 2H), 2.52
(dd, J= 5.8, 16.5 Hz, 1H), 2.37 (dd, J= 7.0, 16.7 Hz, 1H), 1.97-1.93 (m, 1H), 1.05 (d, J= 6.7
Hz, 3H), 0.93 (s, 9H), 0.09 (s, 6H).
13C NMR (CDC13, 125 MHz): 6 131.7 (2C), 128.4 (2C), 127.7, 124.3, 89.1, 81.7, 67.1, 35.7,
26.2, 26.1, 23.2, 18.6, 16.4, -5.13, -5.15, -5.18.
HRMS (ESI) [M+Na]+: m/z calcd for C18H28 NaOSi 311.1802, obsd 311.1806.
[C]D = +1.2 (23 C, c = 10.7, CH2C12).
ent-42: [a]D = -1 5 (23 C, c = 4. 1, CH2C12).
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(-)-Trimethyl-[(3R)-methyl-6-phenyl-hexa-1,5-diynyl]-silane (43). A solution of dibromide
89 in THF (421 mg, 1.29 mmol in 3.5 mL) was cooled to -78 C. A 1.6 M solution of
methyllithium in Et 2O was added dropwise (2.0 mL, 3.2 mmol) and the solution was stirred 1.5 h
at -78 C. Chlorotrimethylsilane was filtered through basic alumina and immediately added
dropwise (0.49 ml, 3.9 mmol) to the reaction. The solution was stirred 14 h, warming to ambient
temperature slowly. Saturated NH4C1 was added (1 mL), and the mixture was diluted with Et 2O
and H20 (2 ml each). The aqueous phase was extracted with Et 2O (3 x 5 mL), and the combined
organic layers were washed with brine (3 x 15 ml), dried over MgSO 4, filtered and concentrated.
The crude residue was purified via gradient column chromatography (50:1 hexanes:EtOAc,
polarity gradually increased to 19:1) to afford the product as a clear, colorless oil (284 mg, 92%
yield). Rf (90:10, hexane:EtOAc) =0.62.
IR (thin film/NaCl): 2962, 2932, 2907, 2170, 1491, 1280 cm 'l.
1H NMR (CDC13, 500 MHz): 6 7.43-7.41 (m, 2H), 7.30-7.29 (m, 3H), 2.80-2.73 (m, 1H), 2.67
(dd, J= 5.5, 16.8 Hz, 1H), 2.52 (dd, J= 7.9, 16.8 Hz, 1H), 1.34 (d, J= 7.0 Hz, 3H), 0.17 (s, 9H).
13 C NMR (CDC13, 125 MHz): 6 131.8 (2C), 128.4 (2C), 127.9, 123.9, 110.3, 87.7, 85.2, 82.4,
27.5, 27.0, 20.4, 0.4 (3C).
HRMS (ESI) [M+Na]+: m/z calcd for C 16H2oNaSi 263.1226, obsd 263.1227.
[a]D = - 3.0 (23 C, c = 5.4, CH2C12).
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(+)-(R)-1,2-epoxypentane (44). Prepared according to Jacobsen's HKR protocol; yields are best
using at least 2 mol°/o catalyst.' 2 A flask was charged with (+/-)-1,2-epoxypentane (20.8 mL,
200 mmol) and (R,R)-N,N'-bis(3,5-di-t-butylsalicylidene)-1,2-cyclohexanediamino cobalt (III)
acetate (4.0 g, 6.0 mmol). The mixture was cooled to 0 °C and H20 (1.98 mL) was added over 5
miin. The mixture was allowed to warm to ambient temperature and stirred 21 h. Separation of
the volatile epoxide and H20 from the 1,2-diol was accomplished by distillation (essentially
vacuum transfer). Residual H20 was removed by treatment with MgSO4 and subsequent
filtration to afford the resolved epoxide (4.5 g, 26% yield, >98% ee). Spectral data matched
those previously reported.4 3
Determination of ee: Derivitization was necessary. The epoxide was opened by PhLi in the
presence of BF3'OEt2, followed by acetate protection by treatment with acetic anhydride, DMAP
and pyridine. Chiral GC analysis of the acetate: (B-PH, 60 °C for 4 min, then increase by 2 °C
per min until 130 °C, tR [(S) = 34.56 min, tR [(R)] = 34.80 min).
43 Prepared from (R)-1,2-pentanediol by treatment p-toluenesulfonyl chloride and pyridine.
MacMillan, J. B.; Molinski, T. F. J. Am. Chem. Soc. 2004, 126, 9944-9945.
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(-)-(5S)-[4-(tert-Butyldimethylsilanyloxy)-butyl]-(4S)-methyl-dihydro-furan-2-one (56).4 4
A 100 mL flask was charged with 3A powdered molecular sieves (8.1 g) and 4-N-
methylmorpholine-N-oxide (5.70 g, 49.1 mmol). A solution of 82 in dry CH3CN (4.75 g, 16.4
mmol in 160 mL) was added via cannula and the mixture was stirred 5 min.
Tetrapropylammonium perruthenate was added slowly (0.86 g, 2.5 mmol), and the mixture was
stirred 14h. Silica gel was added, and the solvent was evaporated. The dry silica gel was loaded
onto a slurry-packed column (70:30 hexanes-EtOAc), eluted and concentrated to give the title
compound as a clear, colorless oil (3.35 g, 71% yield, 93% ee). Rf (70:30, hexane-EtOAc) =
0.34.
IR (thin film/NaCl): 2930, 2858, 1780 cm
'H NMR (CDC13, 500 MHz): 6 4.45-4.41 (m, 1H), 3.64-3.59 (m, 2H), 2.69 (dd, J= 7.9, 17.0 Hz,
1H), 2.60-2.55 (m, 1H), 2.19 (dd, J= 3.8, 17.0 Hz, 1H), 1.70-1.59 (m, 1H), 1.58-1.47 (m, 4H),
1.45-1.40 (m, 1H), 1.00 (d, J= 7.0 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H).
13C NMR (CDC13, 125 MHz): 6 177.1, 83.8, 63.0, 37.7, 33.1, 32.7, 29.9, 26.1 (3C), 22.5, 18.5,
14.0, -5.1 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C15H30 NaO 3Si 309.1856, obsd 309.1840.
[a]D = -37.0 (23 C, c = 10.6, CH2C12).
Chiral GC analysis was performed on the acetate derivative (OAc instead of OTBS): (G-TA,
isothermal, column = 150 C, injector = 200 C, flow (H2) = 1.5 ml/min): tR[(S,S)] = 21.32 min;
tR[(R,R)] = 21.86 min).
Relative configuration confirmed by nOe studies:
Summary of nOe data: Hd 0Hc,'
Ha(irradiated)'Hb: 5.7% Me O
Ha(irradiated)-Hc: 1.8% H H
HMe(irradiated)-Hb: 2 .0% a
HMe(irradiated)-Hd: 2.3% OTBS
44 Prepared in analogy to lactones and tetrahydrofuran acetates reported in reference 14.
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(5;S)-[4-(tert-Butyldimethylsilanyloxy)-butyl]-(4S)-methyl-tetrahydro-furan-2-ol (57a).4 4
Diisobutylaluminum hydride (4.3 ml, 1.0 M in hexane, 4.3 mmol) was added to a cooled solution
(--78 C) of 56 in CH2C12 (1.02 g, 3.60 mmol, in 70 ml CH2C12). The solution was stirred 1 h,
then quenched with saturated NH4Cl (5 ml) and allowed to warm to ambient temperature. The
aqueous phase was extracted with CH2C12 (3 x 10 ml), and the combined organic layers were
dried over Na2SO4, filtered, and concentrated to give the title compound as a clear, colorless oil
that was used without purification (1.00 g, 97% yield, 2.4:1 d.r.). Rf (70:30, hexane-EtOAc)
0.29
IR (thin film/NaCl): 3411, 2935, 2858 cm
'H NMR (CDC13, 500 MHz): 6 major 5.52-5.51(m, 1H), minor 5.43 (m, 1H), major 4.13-4.10
(m, 1H), 3.92 (s, 1H, OH) minor 3.88-3.86 (m, 1H), 3.61-3.58 (m, 2H), major 2.40-2.33 (m, 1H),
minor 2.23-2.21 (m, 1H), 2.00-1.96 (m, 1H), 1.79-1.75 (m, 1H), 1.61-1.52 (m, 2H), 1.50-1.30
(rm, 4H), minor 1.03 (d, J= 6.9 Hz, 3H), 0.87-0.83 (m, 9H + 3H from major diastereomer), 0.03
(s, 6H).
13C NMR (CDC13, 125 MHz): 6 98.4 (minor 97.4), 82.9 (minor 80.7), 63.3 (minor 63.2), 42.1
(minor 41.3), 34.5 (minor 35.0), 33.1 (minor 33.0), 30.3 (minor 31.0), 26.1, 22.89 (minor 22.93),
18.5, 14.6 (minor 14.8), -5.1.
HRMS (ESI) [M+Na]+: m/z calcd for C 15H32NaO3Si 311.2013, obsd 311.2004.
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Acetic acid (5S)-[4-(tert-butyldimethylsilanyloxy)-butyl]-(4S)-methyl-tetrahydro-furan-2-yl
ester (57b). A solution of 56 in CH2Cl2 was cooled to -78 °C (0.86 g, 3.0 mmol, in 60 mL).
DIBAL-H was added via syringe (3.6 mL, 1.0 M in CH 2C12, 3.6 mmol) and the solution was
stirred at -78 °C for 2h. 4-Dimethylaminopyridine (0.44 g, 3.6 mmol), acetic anhydride (2.8 mL,
30 mmol), and pyridine (1.9 mL, 24 mmol) were added sequentially. The mixture was stirred at
-78 °C for 15 min, then allowed to warm to ambient temperature and stir 18h. The reaction was
quenched by addition of saturated NH 4Cl (30 mL), and the layers were separated. The aqueous
phase was extracted with CH2Cl 2 (5 x 30 mL) and concentrated. The crude residue was
partitioned between Et20 and H20 (50 mL each). The ethereal layer was washed with saturated
NH4Cl (2 x 25 mL) and brine (2 x 50 mL), dried over MgSO 4, filtered and concentrated. The
crude oil was purified via column chromatography (90:10 hexanes:EtOAc) to afford the title
compound as a clear, slightly yellow oil (0.79 g, 80% yield, 1.3:1 d.r.). Rf (95:5, EtOAc:hexane)
=0.14.
IR (NaCl): 2931, 2858, 1749, 1250 cm '.
1H NMR (CDC13, 500 MHz): 6 major 6.24 (dd, J= 2.3, 5.6 Hz, 1H), minor 6.16 (dd, J= 1.8, 6.1
Hz, 1H), major 4.12-4.08 (m, 1H), minor 3.98-3.96 (m, 1H), 3.61-3.57 (m, 2H), 2.43-2.36 (m,
1H), major 2.10 (ddd, J= 2.4, 7.3, 13.7 Hz, 1H), 2.02 (s, 3H), major 1.88 (dt, J= 5.8, 13.7 Hz,
1H), minor 1.75 (ddd, J= 2.0, 4.3, 13.6 Hz, 1H), 1.57-1.32 (m, 6H), minor 1.02 (d, J= 7.0 Hz,
3H), major 0.91 (d, J= 7.0 Hz, 3H), 0.87 (s, 9H), 0.03 (s, 6H).
13C NMR (CDC13, 125 MHz): 6 170.8 (minor 170.7), 98.3 (minor 98.8), 82.6 (minor 84.4), 63.2,
40.6 (minor 40.1), 33.9 (minor 34.3), 33.0, 30.2 (minor 30.7), 26.1, 22.7 (minor 22.8), 21.60
(minor 21.64), 18.5, 14.4 (minor 14.3), -5.1.
HRMS (ESI) [M+Na]+: m/z calcd for C1 7H34NaO4Si 353.2119, obsd 353.2108.
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tert-Butyldimethyl- {4-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-2-yl]-
butoxy}-silane (58). Obtained in some reactions following the procedure described in Table 2
(see also the following procedure for 59). Rf (90:10, hexane-EtOAc) = 0.34.
IR (thin film/NaC1): 2956, 2930, 2857, 1254 cm
Hl NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.29-7.28 (m, 3H), 4.30 (d4 , J= 4.9, 7.0, 7.0,
7.0 Hz, 1H), 3.99 (m, 1H), 3.65-3.60 (m, 2H), 2.68 (dd, J= 4.7, 16.6 Hz, 1H), 2.60 (dd, J= 7.2,
16.6 Hz, 1H), 2.34-2.28 (m, 1H), 2.06 (ddd, J= 7.3, 9.0, 10.8 Hz, 1H), 1.87 (ddd, J= 3.4, 7.0,
12.5 Hz, 1H), 1.60-1.32 (m, 6H), 0.94 (d, J= 7.0 Hz, 3H), 0.90 (s, 9H), 0.05 (s, 6H).
13C NMR (CDC13, 125 MHz): 6 131.8 (2C), 128.4 (2C), 127.9, 124.0, 87.1, 82.3, 81.9, 75.2,
63.3, 39.4, 36.1, 33.2, 30.4, 27.2, 26.20, 26.19 (3C), 22.9, 14.2, -5.0 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C24 H38 NaO2Si 409.2535, obsd 409.2529.
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(+)-4- [(3S)-Methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yll-butan-l-ol (59).
A solution of 57a (480 mg, 1.65 mmol) and trimethyl-(1-phenyl-propa-1,2-dienyl)-silane (52)4 5
(1.39mL, 0.89 g/mL, 6.6 mmol) in 3.3 mL CH2C12 was cooled to -78 °C. BF3 OEt 2 (0.63 mL,
4.9 mmol) was added dropwise via syringe, and the mixture was stirred for 2 h, then allowed to
warm to ambient temperature slowly over 14 h. The reaction was quenched by dropwise addition
of saturated NaHCO 3 (2 mL). The aqueous phase was extracted with CH2C12 (3 x 4 mL), dried
over Na2SO4, filtered and concentrated. The crude residue was purified by gradient column
chromatography (90:10 CH2Cl2-EtOAc, polarity increased to 50:50) to afford the title compound
as a clear, yellow oil (180 mg, 41% yield). Rf (50:50, EtOAc-CH 2C12) = 0.47.
Also prepared from terminal alkyne 61: Copper (I) iodide (83 mg, 0.44 mmol) and palladium
tetrakis(triphenylphosphine) (170 mg, 0.15 mmol) were combined in a round bottom flask with
alkyne 61 (296 mg, 1.48 mmol). The flask was evacuated and back-filled with Ar three times.
Pyrrolidine (5.0 mL) and iodobenzene (0.50 mL, 4.5 mmol) were added sequentially and the
mixture was stirred at ambient temperature 3.5 h. Et2O was added (10 mL) and the mixture was
filtered through a plug of silica gel. Solvent was evaporated, and the crude residue was purified
via column chromatography (70:30 hexane-EtOAc, polarity gradually increased to 50:50 hexane-
EtOAc) to afford the title compound as a clear, yellow oil (395 mg, 98% yield).
IR (thin film/NaCl): 3395, 2936, 2870, 2361 cm .
'H NMR (CDC13, 500 MHz): 8 7.41-7.39 (m, 2H), 7.29-7.28 (m, 3H), 4.33-4.28 (m, 1H), 4.02-
3.98 (m, 1H), 3.67 (t, J = 6.6 Hz, 2H), 2.67 (dd, J = 4.8, 16.6 Hz, 1H), 2.60 (dd, J = 7.0, 16.6 Hz,
1H), 2.34-2.32 (m, 1H), 2.07 (ddd, J= 7.0, 9.0, 10.8 Hz, 1H), 1.89 (ddd, J= 3.7, 7.0, 12.5 Hz,
1H), 1.65-1.61 (m, 2H), 1.54-1.50 (m, 2H), 1.46-1.41 (m, 2H), 0.94 (d, J= 7.0 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 131.8 (2C), 128.4 (2C), 127.9, 124.0, 87.1, 82.3, 82.0, 75.3,
63.1, 39.4, 36.2, 33.0, 30.3, 27.2, 23.0, 14.2.
HRMS (ESI) [M+H]+: m/z calcd for C 18H250 2 273.1849, obsd 273.1856.
[a]D = +1.0 (23 °C, c = 7.8, CH 2 C12).
Relative configuration confirmed by nOe studies:
Summary of nOe data: Ph
Ph>x He O
Ha(irradiated)-Hb: 3.4%; Ha(irradiated)-Hc: 0.3% 0 H OH
He(irradiated)-Hd: 2.9%; He(irradiated)-Hf/Hf : 2.9% Hf OH
H c' ~ Me
Hc Hb
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45 Prepared as reported in reference 21.
0 OH
Me
(-)-4-[(3S)-Methyl-(5R)-(prop-2-ynyl)-tetrahydro-furan-(2S)-yl]-butan-l-ol (61). A solution
of' 57a (340 mg, 1.20 mmol) and triphenyl-propa-1,2-dienyl-stannane (60)46 (930 mg, 2.39
mmol) in 3.6 mL CH 2C12 was cooled to -78 C. BF3-OEt2 (0.46 mL, 3.6 mmol) was added
dropwise via syringe, and the mixture was stirred for 2 h, then allowed to warm to ambient
temperature slowly over 14 h. The reaction was quenched by dropwise addition of saturated
NaHCO 3 (2 mL). The aqueous phase was extracted with CH2Cl 2 (3 x 5 mL), dried over Na2SO4,
filtered and concentrated. The crude residue was purified by gradient column chromatography
(90:10 hexane-EtOAc, polarity increased to 50:50) to afford the title compound as a clear,
colorless oil (207 mg, 88% yield). Rf (50:50, EtOAc-hexane) = 0.26.
IR (thin film/NaCl): 3384, 3294, 2934, 2870, 2119 cm-'.
HIE NMR (CDC13, 500 MHz): 6 4.25-4.19 (m, 1H), 3.97-3.93 (m, 1H), 3.65 (t, J= 6.7 Hz, 2H),
2.44 (ddd, J= 2.6, 5.2, 16.6 Hz, 1H), 2.37 (ddd, J= 2.7, 6.8, 16.6 Hz, 1H), 2.32-2.27 (m, 1H),
1.99-1.93 (m, 1H), 1.82 (ddd, J= 3.7, 7.0, 12.5 Hz, 1H), 1.64-1.58 (m, 2H), 1.55-1.46 (m, 2H),
1.43-1.35 (m, 2H), 0.92 (d, J= 7.3 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 82.2, 81.5, 75.0, 69.8, 63.0, 39.3, 36.1, 33.0, 30.2, 26.2, 22.9,
14.1.
HRMS (ESI) [M+Na]+: m/z calcd for C12H20NaO 2 219.1356, obsd 219.1351.
[a]D =-1.0 (23 °C, c = 3.0, CH 2C12)
46 Victor Gehling generously donated 60 which he had previously prepared according to reference 23.
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(+)-(2S)-(4-Iodo-butyl)-(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan (62). A
solution of 59 in a 2:3 mixture of CH3CN-Et 2O (383 mg, 1.40 mmol, in 4.2 mL) was cooled to 0
°C. Imidazole (124 mg, 1.82 mmol), triphenylphosphine (440 mg, 1.68 mmol), and iodine (497
mg, 1.96 mmol) were added sequentially, and the brown heterogeneous mixture was stirred at 0
°C for 3.5 h. Silica gel was added, and the solvents were removed in vacuo. The dry silica gel
was loaded onto a slurry-packed column (95:5 hexane-EtOAc), the title compound was eluted
and concentrated to give a clear, pale yellow oil (391 mg, 73% yield). Rf (90:10 hexane-EtOAc)
= 0.30.
IR (thin film/NaCl): 3055, 2960, 2934, 2872, 1598 cm 'l.
1H NMR (CDC13, 300 MHz): 6 7.43-7.38 (m, 2H), 7.33-7.26 (m, 3H), 4.31 (ddd, J= 5.0, 6.8,
14.0 Hz, 1H), 4.03-3.97 (m, 1H), 3.22 (t, J= 6.9 Hz, 2H), 2.70 (dd, J= 5.0, 16.5 Hz, 1H), 2.62
(dd, J= 6.9, 16.5 Hz, 1H), 2.39-2.31 (m, 1H), 2.13-2.04 (m, 1H), 1.95-1.85 (m, 3H), 1.61-1.39
(m, 5H), 0.97 (d, J= 6.9 Hz, 3H).
'
3C NMR (CDC13, 75 MHz): 6 131.6 (2C), 128.2 (2C), 127.7, 123.8, 87.0, 81.92, 81.89, 75.2,
39.4, 36.2, 33.9, 29.6, 27.8, 27.3, 14.3, 7.3.
HRMS (ESI) [M+Na]+: m/z calcd for ClsH 23INaO 405.0763, obsd 405.0679.
[a]D = + 16 (23 C, c = 7.5, CHC13)
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Ph
(+-)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yl]-
hexanoic acid 3-benzylidene-6-(tert-butyl-dimethyl-silanyloxy)-(5R)-methyl-(1R)-propyl-
hexyl ester (63). A flask containing 38 (21 mg, 0.064 mmol) was charged with 39 (31 mg, 0.083
mmol), dicyclohexylcarbodiimide (21 mg, 0.10 mmol), 4-pyrrolidinopyridine (15 mg, 0.10
mmol), and CH2C12 (0.42 ml). The mixture was stirred 24 h at ambient temperature. Silica gel
was added, and the solvents were removed in vacuo. The dry silica gel was loaded onto a slurry-
packed column (90:10 hexane-EtOAc) and the title compound was eluted to give a clear,
colorless oil (28 mg, 72% yield) upon concentration. Rf(90:10, hexane-EtOAc) = 0.39.
IR (thin film/NaCl): 2933, 2857, 1730, 1463 cm'.
'H NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.31-7.28 (m, 5H), 7.19-7.16 (m, 3H), 6.36 (s,
1H), 5.14-5.11 (m, 1H), 4.31-4.26 (m, 1H), 3.96-3.92 (m, 1H), 3.40 (dd, J= 5.5, 9.8 Hz, 1H),
3.:23 (dd, J= 6.6, 9.8 Hz, 1H), 2.68 (dd, J= 4.9, 16.5 Hz, 1H), 2.59 (dd, J= 7.0, 16.5 Hz, 1H),
2.44-2.34 (m, 3H), 2.32-2.27 (m, 1H), 2.14 (dd, J= 8.2, 14.0 Hz, 1H), 2.05 (ddd, J= 7.0, 9.0,
10.8 Hz, 1H), 1.92-1.84 (m, 2H), 1.69-1.63 (m, 1H), 1.60-1.56 (m, 2H), 1.51-1.22 (m, 10OH), 1.09
(d, J= 6.7 Hz, 3H), 0.93 (t, J= 7.3 Hz, 3H), 0.92 (d, J= 7.0 Hz, 3H), 0.86 (s, 9H), 0.82 (d, J=
6.'7 Hz, 3H), -0.01 (s, 3H), -0.02 (s, 3H).
13C NMR (CDCl13 125 MHz): 6 176.7, 138.3, 138.0, 131.8 (2C), 129.3, 129.1
(2C), 128.4 (2C), 128.2 (2C), 127.9, 126.3, 124.0, 87.1, 82.3, 81.9, 75.2, 71.9, 68.2, 42.8, 40.0,
39.4, 36.6, 36.1, 34.3, 34.01, 33.95, 30.5, 27.7, 27.2, 26.7, 26.1 (3C), 18.9, 18.5, 17.4, 17.1,
14.23, 14.19, -5.20, -5.22.
HRMS (ESI) [M+Na]+: m/z calcd for C44H66NaO4Si 709.4623, obsd 709.4611.
tCID = +1.0 (23 C, c = 4.9, CDC1 3 )
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(+)-Propionic acid 3-benzylidene-6-(tert-butyl-dimethyl-silanyloxy)-(5R)-methyl-(R)-
propyl-hexyl ester (64). To a solution of alcohol 39 in CH2C12 (96 mg, 0.25 mmol, in 1.5 mL)
was added propionic anhydride (50 L, 0.38 mmol), pyridine (31 tL, 0.38 mmol), and 4-
dimethylaminopyridine (3 mg, 0.025 mmol). The solution was allowed to stir at ambient
temperature 16h. After concentration, the crude residue was taken up in 30 mL Et2O, washed
with saturated NH 4Cl (3 x 15ml) and brine (3 x 15 mL), dried over MgSO 4, filtered and
concentrated. Purification via column chromatography (50:1 hexanes-EtOAc) afforded the title
compound as a colorless oil (110 mg, >99% yield). Rf (95:5, hexane-EtOAc) = 0.28.
IR (thin film/NaCl): 2958, 2930, 2857, 1735, 1463 cm .
H NMR (CDC13, 500 MHz): 6 7.30-7.28 (m, 2H), 7.20-7.16 (m, 2H), 7.06-7.03 (m, 1H), 6.46 (s,
1H), 5.40-5.35 (m, 1H), 3.40 (dd, J= 5.5, 9.8 Hz, 1H), 3.27 (dd, J= 6.1, 9.8 Hz, 1H), 2.61 (dd, J
= 6.4, 14.0 Hz, 1H), 2.47 (dd, J= 7.9, 13.5 Hz, 1H), 2.38-2.31 (m, 2H), 2.15-2.12 (m, 2H), 2.09-
2.04 (m, 1H), 1.65-1.46 (m, 2H), 1.43-1.32 (m, 2H), 1.00 (t, J= 7.6 Hz, 3H), 0.96 (s, 9H), 0.91-
0.87 (m, 6H), 0.034 (s, 3H), 0.028 (s, 3H).
13C NMR (CDC13, 125 MHz): 6 173.8, 139.0, 138.7, 130.0, 129.6 (2C), 128.8 (2C), 126.9, 72.1,
68.6, 43.7, 37.1, 35.0, 34.6, 28.3, 26.5 (3C), 19.5, 18.9, 17.4, 14.5, 9.8, -4.9 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C26H44NaO 3Si 433.3132, obsd 433.3123.
[a]D = +0.77 (23 C, c = 2.6, CH2C12).
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(--)-(14S)-(tert-Butyl-dimethyl-silanyloxy)-(6S,13R,19R)-trimethyl-(9R)-propyl-8,20-dioxa-
bicyclo[15.2.1]icosane-7,11,15-trione (67). A solution of 86 in CH2Cl 2 was prepared (9.1 mg,
0.013 mmol in 2.0 ml) and cooled to -78 C. Ozone was bubbled through the solution until a
persistent blue color was observed. The ozone source was removed, and the saturated solution
was stirred 15 min. After this time, Ar was bubbled through the solution until it was colorless.
Methyl sulfide (0.10 ml) was added via syringe. The solution was allowed to warm to ambient
temperature over 6 h; then concentrated. The crude residue was purified via Pasteur pipet
gradient column chromatography (50:1 hexane-EtOAc, polarity gradually increased to 9:1
hexane-EtOAc) to give the title compound as a clear, yellow oil (3.0 mg, 43% yield). Rf(90:10,
hexane-EtOAc) = 0.21.
IR (thin film/NaCl): 2960, 2932, 2857, 1730, 1728, 1713, 1259 cm' l.
'H NMR (C6D6, 500 MHz): 6 5.64-5.59 (m, 1H), 4.71-4.66 (m, 1H), 4.47 (d, J= 1.5 Hz, 1H),
3.82-3.80 (m, 1H), 3.08-3.03 (m, 1H), 3.05 (dd, J= 10.7, 14.0 Hz, 1H), 2.67 (dd, J= 10.1, 19.2
Hz, 1H), 2.43-2.37 (m, 2H), 2.17 (dd, J= 2.4, 19.2 Hz, 1H), 1.97 (dd, J = 2.4, 14.8 Hz, 1H), 1.83
(dd, J= 1.7 Hz, 14.2 Hz, 1H), 1.67-1.62 (m, 1H), 1.61-1.53 (m, 2H), 1.50-1.43 (m, 2H), 1.41-
1.35 (m, 3H), 1.31-1.20 (m, 3H), 1.18-1.09 (m, 4H), 1.08-1.07 (m, 12H), 1.01 (d, J= 7.0 Hz,
3H), 0.80 (t, J= 7.0 Hz, 3H), 0.65 (d, J= 7.0 Hz, 3H), 0.25 (s, 3H), 0.03 (s, 3H).
'
3C NMR (C6 D6, 125 MHz): 6 208.7, 208.2, 174.3, 81.1, 77.7, 74.6, 71.2, 50.1, 46.5, 46.3, 43.2,
40.8, 37.3, 37.1, 37.0, 31.4, 28.2, 27.6, 27.3, 26.5 (3C), 26.3, 18.9, 18.8, 14.6, 14.5, 14.2, -3.8, -
4.9.
HRMS (ESI) [M+Na]+: m/z calcd for C3 0H54NaO 6Si 561.3582, obsd 561.3587.
[0']D = -5 (23 C, c = 0.8, CDC1 3)
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(+)-(2R)-methyl-5-phenyl-pent-4-yn-l-ol (68). A solution of 81 (0.69 g, 2.3 mmol in 8 mL
THF) was cooled to 0 C. LiAlH4 was added slowly in one portion (0.26 g, 6.9 mmol). The
slurry was stirred 1 h at 0 C, then quenched with 0.75 mL H20. Saturated Rochelle's salt
solution (10 mL) and Et 2O (15 mL) were added, and the mixture was stirred 30 min to aid in
disrupting the emulsion. After this time, the opaque aqueous phase was extracted with EtOAc (3
x 20 mL). The combined organic layers were washed with brine (3 x 40 mL), dried over MgSO 4,
filtered and concentrated in vacuo. The crude residue was purified via column chromatography
(95:5 CH2Cl2-EtOAc) to afford the title compound as a pale yellow oil (0.32 g, 79% yield, 98%
ee). Rf(95:5, CH2Cl2-EtOAc) = 0.35.
IR (thin film/NaCl): 3330, 2958, 2924, 2873, 1490 cm
1H NMR (CDCl 3, 500 MHz): 6 7.42-7.39 (m, 2H), 7.32-7.28 (m, 3H), 3.68-3.64 (m, 2H), 2.51
(dd, J= 6.1, 16.8 Hz, 1H), 2.45 (dd, J= 6.4, 16.8 Hz, 1H), 2.02-1.96 (m, 1H), 1.65 (br s, 1H),
1.08 (d, J= 6.7 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 131.7 (2C), 128.4 (2C), 127.9, 123.9, 88.3, 82.2, 67.3, 35.5,
23.4, 16.5.
HRMS (EI) [M+]': m/z calcd for C1 2H14 0 174.1039, obsd 174.1035.
[c]D = +2.0 (23 C, c = 3.0, CH 2C12).
ent-68: [a]D = -12 (23 C, c = 7.2, CH 2C1 2).
Chiral HPLC analysis was performed on the Mosher ester derivative37 (alcohol was coupled with
R-MTPA using DCC/DMAP conditions): (OD, isocratic, 98:2 hexane:i-propanol, 1 ml/min):
tR[(R,R)] = 9.23 min; tR[(R,S)] = 11.86 min).
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(i+)-6-Benzylidene-(8R)-methyl-10-trimethylsilanyl-dec-9-yn-(4R)-ol (69). In a glovebox,
Ni(cod)2 (36 mg, 0.13 mmol) was placed in a 10 ml flask which was then sealed with a rubber
septum. The flask was removed from the glovebox and placed under Ar. To this flask was
added tributylphosphine (36 pL, 0.26 mmol), 44 (degassed by bubbling Ar through for 10 min,
0.70 ml, 6.7 mmol), triethylborane (0.36 mL, 2.3 mmol), and diyne 43 (267 mg, 1.11 mmol).
The resulting dark brown solution was stirred at ambient temperature 14 h, then opened to the air
for 1 h. Volatile organics were evaporated, and the crude residue was purified via gradient
column chromatography (50:1 hexane-EtOAc, polarity gradually increased to 9:1) to afford the
tit:le compound as a clear, yellow oil (158 mg, 45% yield). Rf(90:10, hexane-EtOAc) = 0.23.
IR' (thin film/NaCl): 3416 (br), 2959, 2931, 2873, 2162, 1599 cm 'l .
'H NMR (CDC13, 500 MHz): 6 7.36-7.30 (m, 3H), 7.25-7.21 (m, 2H), 6.53 (s, 1H), 3.85-3.83 (m,
1H), 2.79-2.74 (m, 1H), 2.61 (dd, J= 9.8, 13.7 Hz, 1H), 2.53-2.50 (m, 1H), 2.27-2.19 (m, 2H),
1.95 (d, J= 2.4 Hz, 1H), 1.58-1.42 (m, 4H), 1.17 (d, J= 7.0 Hz, 3H), 0.98 (t, J= 7.0 Hz, 3H),
0.12 (s, 9H).
13C NMR (CDC13, 125 MHz): 6 137.9, 137.6, 130.5, 129.1 (2C), 128.3 (2C), 126.6, 111.2, 85.7,
69.3, 45.5, 39.5, 37.4, 25.5, 21.4, 19.2, 14.4, 0.3 (3C).
HRMS (ESI) [M+Na]+: m/z calcd for C21H32 ONa 351.2115, obsd 351.2128.
[a]D =+ 116 (23 °C, c = 4.1, CH 2 C12)
211
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(-)-(5R)-Allyl-(2S)-(4-iodo-butyl)-(3S)-methyl-tetrahydro-furan (70). A solution of 93 in a
2:3 mixture of CH 3CN-Et 20 (220 mg, 1.11 mmnol, in 3.2 mL) was cooled to 0 °C. Imidazole (98
mg, 1.44 mmol), triphenylphosphine (350 mg, 1.33 mmol), and iodine (398 mg, 1.57 mmol)
were added sequentially, and the brown heterogeneous mixture was stirred at 0 °C for 4 h. Silica
gel was added, and the solvents were removed in vacuo. The dry silica gel was loaded onto a
slurry-packed column (95:5 hexane-EtOAc), the title compound was eluted and concentrated to
give a clear, pale yellow oil (295 mg, 86% yield). Rf (90:10 hexane-EtOAc) = 0.31.
IR (thin film/NaCl): 3074, 2960, 2935, 2873, 1641 cm-'.
'H NMR (C6D6 , 500 MHz): 6 5.91-5.83 (m, 1H), 5.10-5.04 (m, 2H), 4.04-3.98 (m, 1H), 3.65-
3.62 (m, 1H), 2.72 (t, J= 7.0 Hz, 2H), 2.34-2.28 (m, 1H), 2.15-2.10 (m, 1H), 1.91-1.86 (m, 1H),
1.54-1.48 (m, 3H), 1.42-1.36 (m, 2H), 1.35-1.28 (m, 1H), 1.27-1.15 (m, 1H), 1.10-1.03 (m, 1H),
0.70 (d, J= 7.0 Hz, 3H).
13C NMR (C6D6, 125 MHz): 6 136.1, 117.0, 81.2, 76.5, 41.9, 39.9, 36.6, 34.2, 30.0, 28.2, 14.5,
7.2.
HRMS (ESI) [M+Na]+: m/z calcd for C 12H21IONa 331.0529, obsd 331.0521.
[a]D = -1.1 (23 C, c = 4.5, C6H6)
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(-+)-6-[(5R)-Allyl-(3,S)-methyl-tetrahydro-furan-(2S)-yl]-(2S)-methyl-hexanoic acid 3-
benzylidene-(5R)-methyl-7-phenyl-(1R)-propyl-hept-6-ynyl ester (71). Acid 40 (48 mg, 0.19
nmmol) and alcohol 41 (31 mg, 0.093 mmol) were dissolved in 0.95 mL CH2Cl 2.
Dicyclohexylcarbodiimide (40 mg, 0.19 mmol) and 4-pyrrolidinopyridine (30 mg, 0.20 mmol)
were added and the heterogeneous mixture was stirred at ambient temperature 14h. Silica gel
was added, and the solvent was removed in vacuo. The dry silica gel was loaded onto a slurry-
packed column (93:7 hexane-EtOAc) and the title compound was eluted and concentrated to give
a clear, pale yellow oil (38 mg, 72% yield). Rf (90:10 hexane-EtOAc) = 0.23.
IR (thin film/NaCl): 2961, 2933, 2872, 2229, 1727, 1641, 1598 cm l.
'H NMR (CDC13, 500 MHz): 6 7.36-7.29 (m, 10H), 6.45 (s, 1H), 5.85-5.77 (m, 1H), 5.20-5.15
(rn, 1H), 5.10-5.04 (m, 2H), 4.13-4.08 (m, 1H), 3.84-3.80 (m, 1H), 2.99-2.94 (m, 1H), 2.70 (dd, J
= 9.5, 13.7 Hz, 1H), 2.59-2.52 (m, 1H), 2.48-2.39 (m, 2H), 2.37-2.32 (m, 1H), 2.23-2.17 (m, 2H),
1.79-1.72 (m, 1H), 1.71-1.66 (m, 2H), 1.63-1.58 (m, 2H), 1.47-1.26 (m, 10H), 1.24 (d, J= 6.7
Hz, 3H), 1.10 (d, J= 7.0 Hz, 3H), 0.92 (t, J= 7.3 Hz, 3H), 0.89 (d, J= 7.0 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 176.8, 138.1, 136.8, 135.3, 131.7 (2C), 130.4, 129.1 (2C),
128.32, 128.28 (3C), 127.7, 126.4, 124.0, 117.0, 94.1, 81.4, 76.1, 71.7, 42.6, 41.2, 39.9, 39.4,
37.1, 36.8, 36.0, 33.9, 30.5, 27.7, 26.7, 25.2, 21.3, 19.0, 17.4, 14.2 (2C).
HRMS (ESI)[M+Na]+: m/z calcd for C39H5203Na 591.3809, obsd 591.3814.
[O0]D = +11 (23 C, c = 6.3, CDC1 3)
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(+)-(15S)-(tert-Butyl-dimethyl-silanyloxy)-(6S,13R,19S)-trimethyl-(9R)-propyl-8,20-dioxa-
bicyclo[15.2.licosane-7,11,14-trione (72). A solution of 95 in CH 2Cl 2 (6.7 mg, 0.011 mmol in
35 mL) was cooled to -78 C. Ozone was bubbled through the solution until a blue color
persisted. Argon was immediately bubbled through until the solution was colorless.
Dimethylsulfide was added (0.80 ml) and the solution was allowed to slowly warm to ambient
temperature over 3 h. The solution was concentrated and purified by gradient column
chromatography (50:1 hexane-EtOAc, polarity increased to 93:7 hexane-EtOAc) to give the title
compound as a clear oil (4.5 mg, 78% yield). Rf (80:20 hexane-EtOAc) = 0.45.
IR (thin film/NaCl): 2932, 2858, 1732, 1717 (br) cm' .
IH NMR (C6D6, 500 MHz): 6 5.40-5.34 (m, 1H), 4.92 (t, J= 4.3 Hz, 1H), 4.43-4.38 (m, 1H),
4.02-4.00 (m, 1H), 3.60-3.56 (m, 1H), 3.09 (dd, J= 9.6, 18.8 Hz, 1H), 2.83-2.78 (m, 1H), 2.42-
2.38 (m, 1H), 2.27 (dd, J= 11.1, 14.8 Hz, 1H), 2.09 (dd, J= 3.0, 18.8 Hz, 1H), 1.82 (dd, J= 2.6,
14.8 Hz, 1H), 1.77-1.66 (m, 3H), 1.59-1.43 (m, 6H), 1.36-1.28 (m, 3H), 1.26-1.15 (m, 4H), 1.07-
1.04 (m, 15H), 0.77-0.74 (m, 6H), 0.26 (s, 3H), 0.14 (s, 3H).
13C NMR (C6 D6, 125 MHz): 6 211.8, 207.0, 174.3, 77.1, 76.5, 76.1, 71.4, 48.0, 45.9, 42.71,
42.67, 40.8, 37.5, 36.9, 36.7, 36.2, 30.5, 27.8, 27.2, 26.5 (3C), 19.0, 18.7, 18.6, 18.1, 14.8, 14.4, -
3.6, -4.2.
HRMS (ESI)[M+Na]+: m/z calcd for C3oH540 6NaSi 561.3582, obsd 561.3576.
[a]D = +3.3 (23 C, c = 0.9, C6 D6 )
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(--)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yl]-
hexanoic acid 3-benzylidene-(5S)-methyl-6-oxo-(1R)-propyl-hexyl ester (76). Dess-Martin
periodinane (56 mg, 0.13 mmol) was added to a solution of 85 in CH2C12 (21 mg, 0.037 mmol,
1.2 mL). The resulting solution was stirred at ambient temperature for 90 min, then partially
concentrated and purified via column chromatography (90:10 hexane-EtOAc) to give the title
compound as a clear, colorless oil (17 mg, 81% yield). Rf (90:10, hexane-EtOAc) = 0.11.
I:R (thin film/NaC1): 2960, 2932, 2871, 1724, 1597, 1490 cm' .
'H NMR (C6D6, 500 MHz): 9.22 (d, J= 1.8 Hz, 1H), 7.51-7.48 (m, 2H), 7.18-7.13 (m, 5H),
7.04-6.95 (m, 3H), 6.41 (s, 1H), 5.32-5.27 (m, 1H), 4.25-4.19 (m, 1H), 3.89-3.85 (m, 1H), 2.66
(dd, J= 6.4, 14.3 Hz, 1H), 2.60 (dd, J= 4.6, 16.5 Hz, 1H), 2.52 (dd, J= 7.3, 16.5 Hz, 1H), 2.46
(dd, J= 8.5, 14.3 Hz, 1H), 2.43-2.40 (m, 1H), 2.28-2.20 (m, 3H), 2.03-1.98 (m, 1H), 1.89 (ddd, J
= 7.0, 8.8, 10.7 Hz, 1H), 1.80-1.75 (m, 1H), 1.63-1.58 (m, 1H), 1.57-1.50 (m, 1H), 1.49-1.45 (m,
2H), 1.43-1.38 (m, 2H), 1.37-1.30 (m, 4H), 1.29-1.20 (m, 2H), 1.11 (d, J= 7.0 Hz, 3H), 0.89 (t, J
= 7.0 Hz, 3H), 0.75 (d, J= 7.0 Hz, 3H), 0.68 (d, J= 7.0 Hz, 3H).
13 C NMR (C6D6, 1.25 MHz): 6 203.1, 176.3, 138.4, 136.8, 132.3 (2C), 131.0, 129.9, 129.5 (2C),
128.92 (2C), 128.89 (2C), 128.7, 127.2, 125.0, 88.2, 82.7, 82.2, 75.6, 71.4, 45.3, 43.3, 40.4, 39.9,
37.4, 36.7, 34.6, 31.4, 31.2, 28.2, 27.8, 27.4, 19.5, 17.9, 14.5, 13.6.
HRMS (ESI) [M+Na]+: m/z calcd for C38H50NaO4 593.3601, obsd 593.3602.
[a]D = -7.8 (23 °C, c = 6.8, CH 2C1 2 )
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(+)-(2S)-Methyl-6-1(3S)-methyl-(5R)-(2-oxo-ethyl)-tetrahydro-furan-(2S)-yl]-hexanoic acid
(5S)-methyl-3-oxo-7-phenyl-(1R)-propyl-hept-6-ynyl ester (77). A solution of 94 in CH2C12
(35 mg, 0.062 mmol in 20 mL) was cooled to -78 °C. Ozone was bubbled through the solution
until a blue color persisted. Argon was immediately bubbled through until the solution was
colorless. Dimethylsulfide was added (0.4 ml) and the solution was allowed to slowly warm to
ambient temperature over 3 h. The solution was concentrated and immediately purified by
gradient column chromatography (85:15 hexane-EtOAc, polarity increased to 70:30 hexane-
EtOAc). Two products were isolated: a diastereomeric ketoalkynyl-ozonide (less polar) and the
desired ketoalkynal 77 (more polar). The ozonide was dissolved in 5 ml CH 2C12 and stirred with
triphenylphosphine (90 mg) for 40 min. Concentration and purification on a silica gel column
(elution with 80:20 hexane-EtOAc) afforded pure ketoynal which was combined with the
original portion (combined: 19 mg, 63% overall yield). Rf(80:20 hexane-EtOAc) = 0.26.
IR (thin film/NaCl): 2963, 2935, 2874, 2729, 2234, 1728 (br) cm l'.
'H NMR (C6D6, 500 MHz): 6 9.51 (dd, J= 1.7, 2.6 Hz, 1H), 7.48-7.46 (m, 2H), 7.02-6.95 (m,
3H), 5.48-5.43 (m, 1H), 4.23-4.18 (m, 1H), 3.66-3.63 (m, 1H), 3.23-3.19 (m, 1H), 2.53-2.44 (m,
2H), 2.40-2.36 (m, 1H), 2.27-2.18 (m, 3H), 1.96 (ddd, J= 1.8, 5.2, 15.9 Hz, 1H), 1.86-1.82 (m,
1H), 1.76-1.69 (m, 2H), 1.52-1.35 (m, 5H), 1.34-1.19 (m, 7H), 1.17 (d, J= 6.7 Hz, 3H), 1.12 (d,
J= 7.0 Hz, 3H), 0.81 (t, J= 7.3 Hz, 3H), 0.69 (d, J= 7.0 Hz, 3H).
13C NMR (C6D6, 125 MHz): 6 204.6, 200.4, 176.0, 132.3 (2C), 128.9 (2C), 128.6, 124.7, 94.1,
81.9, 81.7, 72.0, 70.0, 50.9, 50.0, 48.1, 40.42, 40.39, 37.1, 36.4, 34.5, 31.0, 28.2, 27.3, 22.8, 21.3,
19.2, 17.8, 14.4, 14.3.
HRMS (ESI)[M+Na]+: m/z calcd for C31H44 05Na 519.3081, obsd 519.3086.
[a]D = +4.8 (23 °C, c = 4.8, C6D6)
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(--)-2-[3-(tert-Butyldimethylsilanyloxy)-(2S)-methylpropyl]-1-phenyl-hept-1-en-(4R)-ol (78).
Prepared as described above (same scale) except ent-42 was used: (264 mg, 70% yield, >95:5 dr
by H NMR). Rf(90:10, hexane-EtOAc) = 0.22.
IR (thin film/NaCl): 3403, 2956, 2930, 2857, 1600, 1463 cm
'1-1 NMR (CDC13, 500 MHz): 6 7.34-7.31 (m, 2H), 7.27-7.20 (m, 3H), 6.49 (s, 1H), 3.82-3.80 (m,
1 H), 3.41 (dd, J= 5.8, 9.8 Hz, 1H), 3.37 (dd, J= 6.2, 9.9 Hz, 1H), 2.51-2.48 (m, 1H), 2.34-2.27
(rn, 2H), 2.12 (dd, J= 9.8, 13.6 Hz, 1H), 1.88-1.85 (m, 2H), 1.58-1.41 (m, 4H), 0.98 (t, J= 7.0
Hz, 3H), 0.90 (s, 9H), 0.77 (d, J= 6.7 Hz, 3H), 0.03 (s, 6H).
13C NMR (CDC13, 125 MHz): 6 139.0, 138.0, 130.1, 129.1 (2C), 128.3 (2C), 126.5, 68.8, 68.4,
45.8, 39.6, 34.7, 33.3, 26.1 (3C), 19.2, 18.5, 16.3, 14.4, -5.19, -5.21.
HRMS (ESI) [M+Na]+: m/z calcd for C23H4 0NaO2Si 399.2690, obsd 399.2693.
[o']D = -55 (23 C, c = 2.2, CH2C12).
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(-)-6-Benzylidene-(8S)-methyl-10-phenyl-dec-9-yn-(4R)-ol (79). Copper (I) iodide (4 mg,
0.02 mmol) and palladium tetrakis(triphenylphosphine) (12 mg, 0.01 mmol) were combined in a
round bottom flask. The flask was evacuated and back-filled with Ar three times. Pyrrolidine
(1.2 mL), alkyne 92 (52 mg, 0.20 mmol in 0.3 ml pyrrolidine), and iodobenzene (85 ptL, 0.76
mmol) were added sequentially and the mixture was stirred at ambient temperature 16 h. Et 2O
was added (10 mL) and the mixture was filtered through a plug of silica gel. Solvent was
evaporated, and the crude residue was purified via column chromatography (9:1 hexane-EtOAc)
to afford the title compound as a clear, yellow oil (51 mg, 77% yield). Rf (90:10, hexane-EtOAc)
= 0.14.
IR (thin film/NaCl): 3408, 2957, 2929, 2870, 1598, 1490 cm' .
'H NMR (CDC13, 500 MHz): 6 7.38-7.25 (m, 6H), 7.24-7.20 (m, 4H), 6.54 (s, 1H), 3.93-3.89 (m,
1H), 2.95-2.90 (m, 1H), 2.63-2.51 (m, 3H), 2.28 (dd, J= 9.5, 13.9 Hz, 1H), 1.88 (s, 1H), 1.59-
1.52 (m, 3H), 1.50-1.39 (m, 1H), 1.25 (d, J= 6.9 Hz, 3H), 0.96 (t, J= 7.0 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 137.9, 137.8, 131.7 (2C), 130.7, 129.0, 128.4 (2C), 128.4 (2C),
127.8, 126.7, 123.8, 94.2, 81.8, 69.4, 45.9, 39.6, 37.7, 25.7, 21.3, 19.2, 14.4.
HRMS (ESI) [M+Na]+: m/z calcd for C24H280ONa 355.2032, obsd 355.2035.
[a]D = -14 (23 °C, c = 7.3, CDC13).
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H11,15-Dibenzylidene-(14S)-hydroxy-(6S,13S,19R)-trimethyl-(9R)-propyl-8,20-dioxa-
bicyclo[15.2.1]icosan-7-one (80). A stock solution of catalyst was prepared in the following
manner: in a glovebox, Ni(cod) 2 (26 mg, 0.095 mmol) was placed in a flask containing a stirbar.
The flask was sealed with a rubber septum, removed from the glovebox, and immediately placed
under argon. Tributylphosphine (26 tL, 0.19 lmnol), toluene (4.74 ml, previously degassed by
bubbling argon through for 10 minutes), and triethylborane (0.26 ml, 1.80 mmol) were added
sequentially, producing a clear yellow catalyst solution. A 2 ml Woodward reaction tube
equipped with a stirbar, rubber septum, and septum screw cap on the side-arm was purged with
argon. Stock catalyst solution was added to the tube (500 L), and the tube was immediately
placed in an oil bath at 60 C for 3 min. A solution of 76 in degassed toluene (15 mg, 0.026
mmol in 500 tL) was added to the tube dropwise, causing the solution to turn red-brown. The
reaction was allowed to stir at 60 C for 14 h. After this time, the solution was cooled to ambient
temperature, diluted with 1.0 ml EtOAc, and stirred open to the air 1 h; then concentrated. The
crude residue was purified via Pasteur pipet column chromatography (93:7 hexane-EtOAc) to
give the title compound as a clear, colorless oil (6.0 mg, 35% yield, 8:1 dr 14S:14R). Rf (90:10,
hexane-EtOAc) = 0.21.
I' (thin film/NaC1): 3377, 2959, 2932, 2872, 1726, 1599, 1462, 1453 cm- .
HlI NMR (CDC13, 500 MHz, major diastereomer): 6 7.37-7.33 (m, 2H), 7.30-7.20 (3H), 7.14-7.11
(mn, 2H), 7.08-7.06 (m, 2H), 7.03-7.00 (m, 1H), 6.56 (s, 1H), 6.33 (s, 1H), 5.51-5.47 (m, 1H),
5.08 (d, J= 7.5 Hz, 1H), 4.18-4.14 (m, 1H), 3.75-3.71 (m, 1H), 3.65 (dd, J= 7.9, 9.5 Hz, 1H),
3.14 (dd, J= 2.4, 15.3 Hz, 1H), 2.81 (dd, J= 9.5, 13.1 Hz, 1H), 2.73-2.64 (m, 2H), 2.55-2.52 (m,
311), 1.97-1.88 (3H), 1.86-1.80 (m, 2H), 1.75-1.67 (m, 2H), 1.64-1.58 (m, 2H), 1.54-1.25 (m,
61H), 1.23 (d, J= 6.8 Hz, 3H), 0.90 (t, J= 7.3 Hz, 3H), 0.67 (d, J= 6.7 Hz, 3H), 0.56 (d, J= 7.0
Hz, 3H).
3C NMR (C6D6, 125 MHz, major diastereomer): 6 175.5, 142.3, 139.6, 139.5, 138.4, 131.6,
130.4, 129.9 (2C), 129.5 (2C), 128.9 (2C), 127.5 (2C), 127.2, 126.8, 84.3, 79.3, 78.0, 74.0, 42.8,
41.0, 40.6, 38.8, 36.9, 36.6, 35.6, 35.2, 34.7, 30.4, 30.3, 27.8, 26.2, 19.8, 18.8, 16.8, 14.5.
HRMS (ESI) [M+Na]+: m/z calcd for C3 8H52NaO4 595.3758, obsd 595.3762.
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(+)-(4S)-Isopropyl-3-[(2R)-methyl-5-phenyl-pent-4-ynoyl]-oxazolidin-2-one (81). 4 7 A
solution of diisopropylamine in THF (0.51 g, 5.0 mmol amine in 7.0 mL THF) was cooled to 0
°C. A solution of n-butyllithium in hexane was added (2.1 mL, 2.5 M, 5.2 mmol), and the
resulting solution was stirred 30 min at 0 C. After this time, the solution was cooled to -78 °C
and stirred 10 min. A separate solution of (S)-4-isopropyl-3-propionyl-oxazolidin-2-one4 7 in
THF (0.87 g, 4.7 mmol, in 1.5 mL THF) was slowly added via syringe down the side of the
reaction flask. The mixture was stirred 30 min at -78 °C. A solution of 3-bromo-1-
propynylbenzene4 8 in THF (2.50 g, 12.8 mmol, in 1.3 mL) was added via syringe down the side
of the reaction flask. The mixture was stirred 15 min at -78 C, then 2 h at 0 C. The reaction
was quenched at 0 C with saturated NH4C1 (5 mL), diluted with H2 0 (5 mL) and Et 20 (10ml).
The aqueous phase was extracted with Et20 (3 x 25 mL), washed with brine (3 x 25 mL), dried
over MgSO4, filtered and concentrated in vacuo. The crude residue was purified via column
chromatography (70:30 CH 2C12-hexane, a second column was necessary to separate
diastereomers) to afford the title compound as a yellow oil (1.30 g, 92% yield, >95:5 dr). Rf
(80:20, hexane-EtOAc) = 0.19.
IR (thin film/NaCl): 2966, 2877, 1779, 1703, 1387 cm
'H NMR (CDC13, 500 MHz): 6 7.38-7.34 (m, 2H), 7.28-7.25 (m, 3H), 4.51-4.47 (m, 1H), 4.29
(app t, J= 8.9 Hz, 1H), 4.20 (dd, J= 3.2, 9.2 Hz, 1H), 4.10-4.03 (m, 1H), 2.80 (dd, J= 6.9, 16.8
Hz, 1H), 2.70 (dd, J= 6.4, 16.8 Hz, 1H), 2.40-2.34 (m, 1H), 1.31 (d, J= 6.9 Hz, 3H), 0.89 (d, J=
7.2 Hz, 3H), 0.84 (d, J = 6.9 Hz, 3H).
'
3 C NMR (CDCI3, 125 MHz): 6 175.4, 153.9, 131.8 (2C), 128.3 (2C), 127.9, 123.7, 87.0, 82.4,
63.5, 58.7, 37.9, 28.6, 24.1, 18.1, 16.8, 14.8.
HRMS (ESI) [M+Na]+: m/z calcd for C18H21NaNO3 322.1414, obsd 322.1415.
[M]D = +37 (23 C, c = 4.8, CH2C12).
ent-81: []D = -43 (23 C, c = 6.3, CH 2Cl 2).
47 For the general asymmetric alkylation procedure, see reference 1 b. For asymmetric alkylation with a propargylic
bromide, see 1 Ic.
48 Prepared using the procedure reported in reference 1 a.
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(--)-8-(tert-Butyl-dimethyl-silanyloxy)-(3S)-methyl-octane-(1,4S)-diol (82).4 9 Gaseous cis-2-
butene was condensed (15 ml, 150 mmol) and transferred via cannula to a cooled suspension
(--78 C) of potassium t-butoxide in THF (4.21 g, 37.6 mmol in 15 ml THF). A solution of n-
butyllithium was added via syringe (15 mL, 2.5 M in hexane, 37.6 mmol), causing the mixture to
turn bright yellow. The mixture was stirred 5 min at -78 °C, warmed to -45 °C for 20 min, then
re-cooled to -78 °C. A solution of (+)-Ipc 2BOMe in Et20O was prepared (14.2 g, 45.0 mmol in 45
ml) and transferred to the reaction via cannula. After stirring 30 min at -78 C, BF3' OEt2 (7.6
rml, 60 mmol) was added via syringe and the mixture was stirred 5 min. Aldehyde 5519 was
added (9.75 g, 45.0 mmol), and the viscous mixture was allowed to stir 3 h at -78 °C. A mixture
of 3N NaOH and 30% H202 (27.0 mL NaOH, 11.0 mL H202) was added, and the reaction was
allowed to warm to ambient temperature with stirring for 3 h. H20 and Et 20 were added (50 mL
each) and the phases were separated. The organic phase was washed with H20 (2 x 50 mL) and
brine (3 x 50 mL), dried over MgSO 4, filtered and concentrated. The crude oil was then taken up
in 300 ml THF and cooled to 0 °C. BH 3 THF was added via syringe (150 mL, 1 M in THF, 150
mmol) and the solution was stirred 14 h, warming to ambient temperature. The solution was re-
cooled to 0 °C and methanol was added slowly (50 mL). After bubbling ceased, a mixture of 1.8
N NaOH and 30% H20 2 was added (30 mL NaOH, 12 mL H20 2) and the mixture was stirred at
ambient temperature 3 h. Brine and Et 2O were added (150 mL each), the layers were separated,
and the aqueous phase was extracted with 80:20 EtOAc:Et 2O (3 x 150 mL). The combined
organic phases were washed with brine (3 x 150 mL), dried over Na2SO4, filtered and
concentrated. The crude residue was purified via gradient column chromatography (70:30
hexane-EtOAc, polarity increased to 50:50) to afford the title compound as a viscous, clear oil
(4.75 g, 43% yield over two steps). Rf(80:20, EtOAc-hexane) = 0.25.
IR (thin film/NaCl): 3321, 2928, 2855 cm-'.
'H NMR (CDC13, 500 MHz): 7.9 (br s, 1H, OH), 3.81-3.76 (m, 1H), 3.70-3.60 (m, 4H), 2.3 (br
s, 1H, OH), 1.80-1.70 (m, 2H), 1.60-1.37 (m, 7H), 0.91 (d, J= 7.0 Hz, 3H), 0.90 (s, 9H), 0.06 (s,
611).
'
3C NMR (CDC13, 125 MHz): 6 74.9, 63.4, 60.6, 36.28, 36.26, 33.4, 32.9, 26.1 (3C), 22.9, 18.5,
14.1, -5.1 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C15H34NaO3Si 313.2169, obsd 313.2169.
[a]D = -8.9 (23 °C, c = 10.0, CH 2C12).
49 Prepared according to the general procedure reported in reference 18.
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(-)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yll-
hexanoic acid 3-benzylidene-6-(tert-butyl-dimethyl-silanyloxy)-(5S)-methyl-(lR)-propyl-
hexyl ester (83). A flask containing acid 38 (110 mg, 0.33 mmol) was charged with alcohol 78
(200 mg, 0.53 mmol), dicyclohexylcarbodiimide (120 mg, 0.58 mmol), 4-pyrrolidinopyridine (90
mg, 0.61 mmol), and CH2C12 (5.5 ml). The mixture was stirred 24 h at ambient temperature.
Silica gel was added, and the solvents were removed in vacuo. The dry silica gel was loaded
onto a slurry-packed column (90:10 hexane-EtOAc) and the title compound was eluted to give a
clear, colorless oil (120 mg, 53% yield) upon concentration. Rf(90:10, hexane-EtOAc) = 0.32.
IR (thin film/NaCl): 2957, 2933, 2857, 1729, 1599, 1462 cm'.
'H NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.30-7.24 (m, 5H), 7.19-7.16 (m, 3H), 6.36 (s,
1H), 5.16-5.12 (m, 1H), 4.31-4.26 (m, 1H), 3.96-3.92 (m, 1H), 3.41 (dd, J= 5.5, 9.8 Hz, 1H),
3.32 (dd, J= 6.4, 9.8 Hz, 1H), 2.68 (dd, J= 4.6, 16.5 Hz, 1H), 2.59 (dd, J= 7.3, 16.5 Hz, 1H),
2.41-2.28 (m, 4H), 2.23-2.19 (m, 1H), 2.08-2.02 (m, 1H), 1.88-1.81 (m, 2H), 1.69-1.62 (m, 1H),
1.60-1.55 (m, 2H), 1.48-1.25 (m, 10H), 1.08 (d, J= 7.0 Hz, 3H), 0.95-0.91 (m, 6H), 0.88 (s, 9H),
0.74 (d, J= 6.7 Hz, 3H), 0.02 (s, 3H), 0.01 (s, 3H).
13C NMR (CDC13, 125 MHz): 6 176.7, 138.4, 137.9, 131.8 (2C), 129.4, 129.1 (2C), 128.4 (2C),
128.2 (2C), 127.9, 126.2, 124.0, 87.1, 82.3, 81.9, 75.2, 71.6, 68.4, 42.8, 40.0, 39.4, 37.0, 36.0,
34.5, 33.9, 33.4, 30.5, 27.7, 27.2, 26.7, 26.1 (3C), 19.0, 18.5, 17.4, 16.5, 14.20, 14. 18, -5.2 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C44H66NaO4Si 709.4623, obsd 709.4643.
[]D = -23 (23 °C, c = 1.0, CH2C12)
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(+-)-(2S)-Methyl-6- [(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yll -
hexanoic acid 3-benzylidene-6-hydroxy-(5R)-methyl-(1R)-propyl-hexyl ester (84). A
solution of tetrabutylammonium fluoride (0.33 mL, 1.0 M in THF, 0.33 mmol) was added to a
stirred solution of 63 in THF (150 mg, 0.22 mmol in 1.8 mL). The mixture was allowed to stir 2
h, then EtOAc and saturated NaCl (aqueous) were added (5 ml each). The layers were separated,
the aqueous phase was extracted with EtOAc (3 x 5 ml), and the combined organic phases were
concentrated. The crude residue was purified via column chromatography (70:30 hexane-
EtOAc) to give the title compound as a clear, colorless oil (122 mg, 97% yield). Rf (70:30,
hexane-EtOAc) = 0.31.
IR (thin film/NaCI): 3447, 2959, 2934, 2872, 2360, 1727, 1458 cm'.
IH NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.32-7.28 (m, 5H), 7.22-7.17 (m, 3H), 6.40 (s,
11H), 5.14-5.09 (m, 1H), 4.32-4.26 (m, 1H), 3.97-3.93 (m, 1H), 3.36 (t, J= 5.8 Hz, 2H), 2.68 (dd,
J= 4.6, 16.5 Hz, 1H), 2.59 (dd, J= 7.0, 16.5 Hz, 1H), 2.49-2.40 (m, 3H), 2.39-2.34 (m, 1H),
2.32-2.28 (m, 1H), 2.15 (dd, J= 7.3, 14.0 Hz, 1H), 2.05 (ddd, J= 7.0, 9.0, 10.8 Hz, 1H), 1.91-
1.84 (m, 2H), 1.70-1.64 (m, 1H), 1.61-1.57 (m, 2H), 1.49-1.26 (m, 10H), 1.10 (d, J = 6.7 Hz,
3H), 0.94 (t, J= 7.3 Hz, 3H), 0.92 (d, J= 7.0 Hz, 3H), 0.85 (d, J= 6.7 Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 176.9, 138.0, 137.9, 131.8 (2C), 129.6, 129.0 (2C), 128.37 (2C),
128.35 (2C), 127.9, 126.5, 123.9, 87.0, 82.2, 81.9, 75.2, 71.8, 67.8, 42.7, 39.9, 39.3, 36.5, 36.1,
34.3, 33.9, 33.6, 30.4, 27.6, 27.2, 26.6, 18.9, 17.4, 17.1, 14.2 (2C).
HRMS (ESI) [M+Na]+: m/z calcd for C38H52NaO4 595.3758, obsd 595.3748.
[a]D = +0.16 (23 C, c = 12.6, CH 2C1 2)
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(-)-(2S)-Methyl-6-[(3S)-methyl-(5R)-(3-phenyl-prop-2-ynyl)-tetrahydro-furan-(2S)-yl]-
hexanoic acid 3-benzylidene-6-hydroxy-(5S)-methyl-(1R)-propyl-hexyl ester (85). A
solution of tetrabutylammonium fluoride (0.050 mL, 1.0 M in THF, 0.050 mmol) was added to a
stirred solution of 83 in THF (27 mg, 0.039 mmol in 0.6 mL). The mixture was allowed to stir 1
h, then EtOAc and saturated NaCl (aqueous) were added (1 ml each). The layers were separated,
the aqueous phase was extracted with EtOAc (3 x 1 ml), and the combined organic phases were
concentrated. The crude residue was purified via column chromatography (70:30 hexane-
EtOAc) to give the title compound as a clear, colorless oil (23 mg, 95% yield). Rf (70:30,
hexane-EtOAc) = 0.29.
IR (thin film/NaCl): 3439, 2932, 2869, 1725, 1490 cm ' l.
'H NMR (CDC13, 500 MHz): 6 7.41-7.39 (m, 2H), 7.31-7.27 (m, 5H), 7.21-7.16 (m, 3H), 6.40 (s,
1H), 5.15-5.13 (m, 1H), 4.30-4.27 (m, 1H), 3.96-3.93 (m, 1H), 3.44-3.41 (m, 1H), 3.37-3.34 (m,
1H), 2.67 (dd, J= 4.8, 16.6 Hz, 1H), 2.59 (dd, J= 7.2, 16.6 Hz, 1H), 2.43-2.35 (m, 4H), 2.30-
2.27 (m, 1H), 2.22-2.18 (m, 1H), 2.08-2.02 (m, 1H), 1.90-1.83 (m, 2H), 1.69-1.65 (m, 1H), 1.62-
1.56 (m 2H), 1.48-1.25 (m, 10H), 1.10 (d, J= 7.0 Hz, 3H), 0.95-0.91 (m, 6H), 0.79 (d, J= 6.7
Hz, 3H).
'
3C NMR (CDC13, 125 MHz): 6 176.8, 138.1, 137.6, 131.8 (2C), 129.8, 129.0 (2C), 128.4 (2C),
128.3 (2C), 127.9, 126.4, 123.9, 87.1, 82.2, 81.9, 75.2, 71.7, 68.2, 42.6, 39.9, 39.4, 36.8, 36.1,
34.3, 33.9, 33.5, 30.4, 27.7, 27.2, 26.6, 18.9, 17.4, 16.6, 14.19, 14.17.
HRMS (ESI) [M+Na]+: m/z calcd for C38H52NaO4 595.3758, obsd 595.3749.
[a]D = -0.16 (23 °C, c = 3.0, CDC13)
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(+)-1 1,15-Dibenzylidene-(14S)-(tert-butyl-dimethyl-silanyloxy)-(6S,13R,19R)-trimethyl-
(9R)-propyl-8,20-dioxa-bicyclo[15.2.1]icosan-7-one (86). A solution of 34 in CH 2Cl 2 was
prepared (9.0 mg, 0.016 mmol in 2.0 ml) and cooled to -78 °C. 2,6-Lutidine (30 IL, 0.24 mmol)
and t-butyldimethylsilyl trifluoromethanesulfonate (30 jiL, 0.13 mmol) were added via microliter
syringe, and the resulting solution was stirred 2 h at -78 C. A minimal amount of MeOH was
added to quench the reaction (5 drops); then the solution was warmed to ambient temperature
and concentrated. The crude residue was purified via Pasteur pipet column chromatography
(50:1 hexane-EtOAc) to give the title compound as a clear, yellow oil (9.1 mg, 84% yield). Rf
(90: 10, hexane-EtOAc) = 0.44.
IR (thin film/NaCl): 2958, 2931, 2856, 1728, 1599, 1461 cm-' .
t NMR (CDC13, 500 MHz): 6 7.39-7.35 (m, 3H), 7.24-7.19 (m, 5H), 7.09-7.06 (m, 2H), 6.81
(br s, H), 6.57 (s, 1H), 5.38-5.36 (m, 1H), 4.37-4.31 (m, 2H), 3.87-3.70 (m, 1H), 2.93 (app t, J=
12.4 Hz, H), 2.71 (dd, J= 8.0, 14.6 Hz, 1H), 2.64-2.59 (m, 2H), 2.53 (dd, J- 4.1, 14.6 Hz, 1H),
2.46-2.44 (m, 2H), 227 (dd, J= 5.8, 13.6 Hz, 1H), 1.96-1.91 (m, 1H), 1.83-1.72 (m, 2H), 1.71-
1.62 (m, 2H), 1.60-1.29 (br m, 10H), 1.17 (d, J= 6.7 Hz, 3H), 1.03 (d, J= 6.4 Hz, 3H), 1.01 (s,
9H), 0.91 (t, J= 7.3 Hz, 3H), 0.70 (d, J= 7.0 Hz, 3H), 0.15 (s, 3H), 0.13 (s, 3H).
'
3C NMR (CDC13, 125 MHz): 6 176.7, 140.6, 139.0, 138.7, 138.4, 129.4, 129.2 (2C), 129.0 (2C),
128.4, 128.3 (2C), 128.2 (2C), 126.3, 126.2, 80.0, 74.8, 74.5, 40.2, 39.7, 39.0, 36.8, 36.5, 36.2,
36.0, 34.8, 33.2, 29.9, 28.6, 26.4, 26.2 (3C), 24.7, 18.7, 18.4, 17.5, 14.6, 14.3, -3.9, -4.7 (missing
one C under CDC13 signal; when spectrum taken in C6D6 there are three signals in the 70-80 ppm
region: 6 80.8, 75.0 (2C), 74.8).
HRMS (ESI) [M+Na]+: m/z calcd for C44H66 NaO4 Si 709.4623, obsd 709.4615.
[a]D = +2.1 (23 C, c = 3.8, C6 D6 )
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(+)-(14S)-(tert-Butyl-dimethyl-silanyloxy)-(6S,13R,19R)-trimethyl- 1-methylene-(9R)-
propyl-8,20-dioxa-bicyclo[15.2.1]icosane-7,15-dione (87). A stock solution of methylenatin
reagent was prepared in the following manner: a 50 ml flask was charged with activated zinc 5
(0.51 g, 7.8 mmol), lead (II) chloride (0.093 g, 0.33 mmol), and THF (4.0 ml); then cooled to 0
°C. Diiodomethane (0.21 mL, 2.6 mmol) was added via syringe, and the mixture was stirred 30
min at 0 °C. During this time, a suspension of zirconium (IV) chloride in THF (0.25 g, 1.1 mmol
in 3.0 mL) was prepared by stirring together 20 min at ambient temperature. The suspension of
zirconium (IV) chloride transferred to the Zn/PbCl2/CH212 mixture via cannula. The resulting
heterogeneous mixture was stirred 30 minutes at 0 °C. (During this time, the mixture assumed a
green color, which indicated the generation of the active methylenation reagent.) A solution of
diketone 67 in THF (3.0 mg in 0.5 mL) was cooled to 0 C. Methylenating reagent was
transferred to the diketone solution via syringe (0.4 mL), and the reaction was stirred for 3.5 h at
0 °C. Water (0.5 mL) and Et2O (5 mL) were added; then the cold bath was removed. The layers
were separated, and the aqueous phase was extracted with Et 2O (5 x 5 mL). The combined
organic phase was dried over Na2 SO4, filtered and concentrated. The crude residue was purified
via Pasteur pipet gradient column chromatography (50:1 hexane-EtOAc, polarity gradually
increased to 13:1 hexane-EtOAc) to give the title compound as a clear, yellow oil (2.2 mg, 75%
yield). Rf(90:10, hexane-EtOAc)= 0.37.
IR (thin film/NaC1): 2928, 2856, 1728, 1458 cm' l.
'H NMR (C6D6, 500 MHz): 8 5.37-5.33 (m, 1H), 5.04 (s, 1H), 4.90 (s, 1H), 4.61-4.55 (m, 1H),
4.25 (d, J= 2.1 Hz, 1H), 3.77 (ddd, J= 3.5, 6.0, 8.2 Hz, 1H), 2.49-2.40 (m, 3H), 2.30 (app d, J=
5.5 Hz, 2H), 2.12 (dd, J= 3.4, 15.3 Hz, 1H), 1.86-1.80 (m, 1H), 1.61-1.43 (m, 7H), 1.39-1.29 (m,
5H), 1.26-1.16 (m 2H), 1.15-1.07 (m, 13H), 1.05 (d, J= 6.1 Hz, 3H), 0.89 (t, J= 7.3 Hz, 3H),
0.69 (d, J= 7.0 Hz, 3H), 0.30 (s, 3H), 0.11 (s, 3H).
13C NMR (C6D6, 125 MHz): 6 208.9, 175.5, 144.4, 116.2, 81.5, 78.8, 73.6, 72.3, 45.8, 42.1, 42.0,
40.5, 40.0, 36.9, 36.1, 35.3, 32.6, 30.6, 29.8, 27.1, 26.6 (3C), 26.2, 19.6, 18.5, 14.7, 14.6, 14.5, -
3.3, -4.3.
HRMS (ESI) [M+Na]+: m/z calcd for C 31Hs6NaOsSi 559.3789, obsd 559.3781.
[c]D = +5.7 (23 C, c = 0.7, CHC1 3)
50 Zinc was activated according to the procedure reported by Fieser and Fieser: Fieser, L. F.; Fieser, M. "Reagents
for Organic Synthesis"; Wiley: New York, 1967, Vol. 1, p. 1276.
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(-)-(2R)-Methyl-5-phenyl-pent-4-ynal (88). Dess-Martin periodinane (0.85 g, 2.0 mmol) was
added carefully to a solution of 68 in CH 2C12 (174 mg, 1.0 mmol in 25 mL) and the mixture was
stirred at ambient temperature 2.5 h. The volume of the solution was reduced to approximately 2
ml by concentration in vacuo and loaded onto a slurry-packed column (90:10 hexane-EtOAc) and
the title compound was eluted to give a clear, colorless oil (160 mg, 92% yield) upon
concentration. Rf (90:10, hexane-EtOAc) =0.22.
I1 (thin film/NaCl): 2972, 1728, 1490 cm l.
IH NMR (CDC13, 500 MHz): 6 9.78 (d, J= 0.9 Hz, IH), 7.41-7.39 (m, 2H), 7.31-7.29 (m, 3H),
2.77 (dd, J= 5.1, 15.9 Hz, 1H), 2.69-2.60 (m, 2H), 1.30 (d, J= 7.0 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 203.6, 131.82, 131.78 (2C), 128.4 (2C), 123.5, 86.6, 82.8, 45.6,
2:1.0, 13.4.
HRMS (ESI) [M+Na]+: m/z calcd for C12H12NaO 195.0780, obsd 195. 0785.
[a]D = +7.1 (23 C, c = 3.1, CH 2C1 2)
ent-88: [a]D = -6.9 (23 °C, c = 1.6, CH 2Cl 2)
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(+)-[6,6-Dibromo-(4R)-methyl-hex-5-en-1-ynyl]-benzene (89). A solution of carbon
tetrabromide in CH2C12 (1.26 g, 3.8 mmol in 5.0 ml) was cooled to 0 C. Triphenylphosphine
was added (1.99 g, 7.6 mmol) and the bright orange solution was stirred 40 min. Aldehyde 88
was added as a solution in CH 2C12 (0.32 g, 1.9 mmol in 2.0 ml) and the mixture was stirred 16 h,
warming slowing to ambient temperature. The heterogeneous mixture was diluted with hexane,
filtered through Celite and concentrated. The residue was taken up in hexane, filtered to remove
solid triphenylphosphine oxide, and re-concentrated. The crude residue was purified via column
chromatography (19:1 hexane-EtOAc) to give the title compound as a clear, light yellow oil (0.42
g, 69% yield). Rf(90:10, hexane-EtOAc) =0.47.
IR (thin film/NaCl): 2966, 2927, 1598 cm-'.
1H NMR (CDC13, 500 MHz): 6 7.46-7.43 (m, 2H), 7.35-7.30 (m, 3H), 6.42 (d, J= 9.2 Hz, 1H),
2.85-2.79 (m, 1H), 2.50 (dd, J= 1.2, 6.1 Hz, 2H), 1.21 (d, J= 6.7 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 142.3, 131.8 (2C), 128.4 (2C), 128.0, 123.7, 88.9, 87.1, 82.7,
37.8, 25.8, 18.6.
HRMS (EI) M+: m/z calcd for C1 3H12Br2 325.9300, obsd 325.9303.
[a]D = +5.1 (23 °C, c = 6.3, CH 2C12).
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(--)-6-Benzylidene-(8S)-methyl-10-trimethylsilanyl-dec-9-yn-(4R)-oI (90). Procedure and
scale exactly as described above except the opposite enantiomer of the diyne was used (ent-43).
The title compound was isolated as a colorless oil (120 mg, 33% yield). Rf (90:10, hexane-
EtOAc) = 0.16.
IR (thin film/NaCl): 3419 (br), 2959, 2932, 2873, 2163, 1599 cm 'l.
11 NMR (CDC13, 500 MHz): 6 7.35-7.29 (m, 4H), 7.25-7.22 (m, 1H), 6.51 (s, 1H), 3.88-3.84 (m,
1H), 2.76-2.71 (m, 1H), 2.56 (dd, J= 3.0, 13.7 Hz, 1H), 2.48 (dd, J= 9.2, 13.4 Hz, 1H), 2.39 (dd,
J= 6.4, 13.4 Hz, 1H), 2.22 (dd, J= 9.5, 13.7 Hz, 1H), 1.90 (d, J= 2.7 Hz, 1H), 1.58-1.49 (m,
3H1), 1.48-1.42 (m, 1H), 1.15 (d, J= 7.0 Hz, 3H), 0.98 (t, J= 7.3 Hz, 3H), 0.14 (s, 9H).
3C NMR (C6D6, 125 MHz): 6 138.6, 138.4, 131.2, 129.7 (2C), 128.8 (2C), 127.1, 112.2, 86.0,
69.8, 46.6, 40.5, 38.4, 26.5, 21.6, 19.8, 14.8, 0.6 (3C).
HRMS (ESI) [M+Na]+: m/z calcd for C2lH32 ONa 351.2115, obsd 351.2122.
[0]D =- 105 (23 °C, c = 2.4, CH2C12)
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(+)-6-Benzylidene-(8R)-methyl-dec-9-yn-(4R)-ol (91). A solution of alkyne 69 in THF (200
mg, 0.61 mmol in 6.0 mL) was cooled to 0 °C. A solution of tetrabutylammonium fluoride in
THF was added dropwise (0.75 ml, 1.0 M, 0.75 mmol). The solution was stirred 1 h at 0 °C,
then partitioned between EtOAc and brine (6 mL each). The aqueous phase was extracted with
EtOAc (3 x 6 mL), dried over MgSO 4, filtered and concentrated. The crude residue was purified
by column chromatography (85:15 hexane-EtOAc) to afford the title compound as a clear, light
yellow oil (132 mg, 80% yield). Rf (80:20, hexane-EtOAc) = 0.25.
IR (thin film/NaCl): 3420, 3307, 2960, 2931, 2872, 2170, 1599 cm' .
'H NMR (CDC13, 500 MHz): 6 7.35-7.26 (m, 3H), 7.25-7.22 (m, 2H), 6.54 (s, 1H), 3.85-3.83 (br
m, 1H), 2.75-2.71 (m, 1H), 2.63 (dd, J= 9.5, 13.7 Hz, 1H), 2.53-2.47 (m, 2H), 2.30 (dd, J= 6.1,
13.7 Hz, 1H), 2.26-2.21 (m, 1H), 2.08 (d, J= 2.4 Hz, 1H), 1.85 (br s, 1H), 1.56-1.42 (m, 4H),
1.18 (d, J= 6.7 Hz, 3H), 0.97 (t, J= 6.7 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 137.8, 137.4, 130.7, 129.0 (2C), 128.4 (2C), 126.7, 88.4, 69.4,
69.2, 45.6, 39.5, 37.2, 24.3, 21.2, 19.2, 14.4.
HRMS (ESI) [M+Na]+: m/z calcd for C18H24ONa 279.1719, obsd 279.1710.
[a]D = +7.8 (23 C, c = 3.6, CDC13)
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(--)-6-Benzylidene-(8S)-methyl-dec-9-yn-(4R)-ol (92). A solution of alkyne 90 in THF (120
mg, 0.37 mmol in 3.7 mL) was cooled to 0 C. A solution of tetrabutylammonium fluoride in
THF was added dropwise (0.46 ml, 1.0 M). The solution was stirred 1 h at 0 °C, then partitioned
between EtOAc and brine (4 mL each). The aqueous phase was extracted with EtOAc (3 x 4
mL), dried over MgSO 4, filtered and concentrated. The crude residue was purified by column
chromatography (85:15 hexane-EtOAc) to afford the title compound as a clear, light yellow oil
(53 mg, 52% yield). Rf (80:20, hexane-EtOAc) = 0.28.
IR (thin film/NaCl): 3411, 3306, 2959, 2932, 2872, 2111, 1598 cm -l.
'H NMR (CDC13, 500 MHz): 6 7.35-7.32 (m, 2H), 7.29-7.25 (m, 2H), 7.24-7.22 (m, 1H), 6.52 (s,
1H), 3.88-3.84 (m, 1H), 2.72-2.67 (m, 1H), 2.55 (dd, J= 3.5, 13.8 Hz, 1H), 2.48 (d, J= 7.9 Hz,
2H), 2.22 (dd, J= 9.5, 14.6 Hz, 1H), 2.09 (d, J= 2.4 Hz, 1H), 1.88 (br s, 1H), 1.58-1.50 (m, 3H),
1.48-1.41 (m, 1H), 1.15 (d, J= 7.0 Hz, 3H), 0.98 (t, J= 6.7 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 137.7, 137.6, 130.8, 129.0 (2C), 128.4 (2C), 88.7, 69.4, 69.3,
45.8, 39.6, 37.4, 24.7, 21.0, 19.2, 14.4.
HRMS (ESI) [M+Na]+: m/z calcd for Cls8H24ONa 279.1719, obsd 279.1718.
[ol]D = -7.8 (23 C, c = 1.8, CH 2C1 2)
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(-)-4-[(5R)-Allyl-(3S)-methyl-tetrahydro-furan-(2S)-yl-butan-l-ol (93). A solution of lactol
57a (0.29 g, 1.0 mmol) and allyltrimethylsilane (0.64 mL, 4.0 mmol) in 20 mL CH 2C12 was
cooled to -78 °C. Distilled boron trifluoride diethyl etherate was added dropwise (0.38 mL, 3.0
mmol), and the solution was allowed to stir, coming to ambient temperature, for 16 h. Saturated
NaHCO 3 and H20 were added (5 mL each), the layers were separated, and the organic phase was
extracted with CH 2C12 (3 x 15 mL). The combined organic layers were dried over Na2SO4,
filtered and concentrated. The crude residue was purified via gradient column chromatography
(70:30 hex-EtOAc, polarity gradually increased to 50:50) to afford the title compound as a clear,
colorless oil (0.18 g, 88% yield). Rf (50:50, hexane-EtOAc) = 0.25.
IR (thin film/NaCl): 3379, 3076, 2936, 2868, 1641 cm-'.
'H NMR (CDC13, 500 MHz): 8 5.85-5.76 (m, 1H), 5.10-5.04 (m, 2H), 4.15-4.09 (m, 1H), 3.89-
3.85 (m, 1H), 3.66 (t, J= 6.4 Hz, 2H), 2.36-2.31 (m, 1H), 2.26-2.17 (m, 2H), 1.80-1.65 (m, 2H),
1.64-1.46 (m, 4H), 1.43-1.37 (m, 2H), 0.89 (d, J= 7.0 Hz, 3H).
13C NMR (CDC13, 125 MHz): 6 135.2, 117.0, 81.5, 76.3, 63.0, 41.2, 39.5, 36.1, 33.0, 30.3, 23.0,
14.2.
HRMS (ESI) [M+Na]+: m/z calcd for C12H22 02Na 221.1521, obsd 221.1515.
[at]D = -1.3 (23 °C, c = 4.8, CH2C12)
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(-)-6-[(5R)-Allyl-(3S)-methyl-tetrahydro-furan-(2S)-yl]-(2S)-methyl-hexanoic acid 3-
be26nzylidene-(5S)-methyl-7-phenyl-(lR)-propyl-hept-6-ynyl ester (94). Acid 40 (83 mg, 0.3
mmol) and alcohol 79 (50 mg, 0.15 mmol) were dissolved in 2.0 mL CH2Cl 2.
Dicyclohexylcarbodiimide (61 mg, 0.30 mmol) and 4-pyrrolidinopyridine (44 mg, 0.30 mmol)
were added and the heterogeneous mixture was stirred at ambient temperature 14h. Silica gel
was added, and the solvent was removed in vacuo. The dry silica gel was loaded onto a slurry-
packed column (93:7 hexane-EtOAc) and the title compound was eluted and concentrated to give
a clear, pale yellow oil (71 mg, 84% yield). Rf(90:10 hexane-EtOAc) = 0.32.
IR (thin film/NaCl): 2962, 2934, 2873, 2231, 1728, 1598, 1491 cm-.
IH NMR (CDCl3, 500 MHz): 6 7.38-7.35 (m, 2H), 7.34-7.29 (m, 2H), 7.28-7.26
7.21 (m, 2H), 6.45 (s, 1H), 5.87-5.78 (m, 1H), 5.22-5.17 (m, 1H), 5.12-5.05 (m,
(mrn, 1H), 3.85-3.81 (m, 1H), 2.93-2.89 (m, 1H), 2.64-2.58 (m, 2H), 2.54-2.42 (m,
(m, 1H), 2.24-2.18 (m, 2H), 1.80-1.67 (m, 3H), 1.64-1.58 (m, 2H), 1.48-1.41 (m,
(m, 5H), 1.22 (d, J= 6.7 Hz, 3H), 1.12 (d, J= 7.0 Hz, 3H), 0.94-0.89 (m, 6H).
(m, 4H), 7.25-
2H), 4.14-4.09
3H), 2.40-2.33
4H), 1.40-1.24
13C NMR (CDC13, 125 MHz): 6 176.8, 138.0, 137.2, 135.3, 131.7 (2C), 130.0, 129.0 (2C), 128.3
(4C), 127.7, 126.5, 124.0, 116.9, 94.4, 81.4, 76.1, 71.7, 42.7, 41.2, 40.0, 39.4, 37.1, 36.7, 36.0,
33.9, 30.5, 27.7, 26.7, 25.5, 21.3, 19.0, 17.4, 14.2.
HRMS (ESI)[M+Na]+: m/z calcd for C39H520 3Na 591.3809, obsd 591.3800.
[O:]D =-7.8 (23 °C, c = 6.8, CH 2C1 2)
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(-)-14-Benzylidene-(15S)-(tert-butyl-dimethyl-silanyloxy)-(6S,13R,19S)-trimethyl-(9R)-
propyl-8,20-dioxa-bicyclo[l 15.2.1]icosane-7,11-dione (95). Macrocyclic alcohol 35b was
dissolved in anhydrous DMF (21 mg, 0.042 mmol in 1.0 mL) and t-butyldimethylchlorosilanle
(46 mg, 0.31 mmol), imidazole (36 mg, 0.53 mmol), and N,N-dimethylaminopyridine (1 mg,
0.008 mmol) were added sequentially. The mixture was stirred at ambient temperature 20 h, then
partitioned between 15 mL Et 2O and 10 ml H20. The organic phase was washed with H20 (3 x 5
mL) and brine (3 x 10 mL), dried over Na2SO4, filtered and concentrated. The crude residue was
purified via column chromatography (96:4 hexane-EtOAc) to afford the title compound as a
clear, colorless oil (17 mg, 68% yield). Rf(90:10 hexane-EtOAc) = 0.29.
IR (thin film/NaCl): 2959, 2932, 2857, 1733 (br), 1463 cm' l.
'H NMR (C6D6, 500 MHz): 6 7.35 (app d, J= 7.6 Hz, 2H), 7.19-7.16 (m, 2H), 7.07 (s, 1H), 7.05-
7.02 (m, 1H), 5.35-5.32 (m, 1H), 4.64 (d, J= 8.8 Hz, 1H), 4.46-4.41 (m, 1H), 3.78-3.75 (m, 1H),
3.67-3.62 (m, 1H), 2.58 (dd, J= 5.8, 17.4 Hz, 1H), 2.48-2.41 (m, 2H), 2.37-2.30 (m, 1H), 2.03-
1.96 (m, 2H), 1.86-1.79 (m, 1H), 1.67-1.53 (m, 5H), 1.52-1.44 (m, 3H), 1.42-1.31 (m, 3H), 1.30-
1.24 (m, 2H), 1.17 (d, J= 7.0 Hz, 3H), 1.14-1.08 (m, 2H), 1.07-1.04 (m, 12H), 0.78 (d, J= 7.0
Hz, 3H), 0.75 (t, J= 7.3 Hz, 3H), 0.29 (s, 3H), 0.24 (s, 3H).
13C NMR (C6D6 , 125 MHz): 6 206.3, 175.0, 149.8, 139.5, 129.4 (2C), 129.0 (2C), 127.0, 124.9,
78.3, 73.9, 71.6, 71.4, 50.0, 48.2, 47.9, 41.3, 41.0, 37.4, 37.0, 35.4, 30.7, 30.5, 27.7, 27.5, 26.6
(3C), 21.6, 18.90, 18.87, 17.5, 15.1, 14.4, -3.5, -4.1.
HRMS (ESI)[M+Na]+: m/z calcd for C31H44 05Na 635.4102, obsd 635.4094.
[a]D = -2.6 (23 C, c = 2.3, CH 2C12)
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(+)-(15S)-(tert-Butyl-dimethyl-silanyloxy)-(6S,13R,19S)-trimethyl-1 1-methylene-(9R)-
propyl-8,20-dioxa-bicyclo[15.2.1]icosane-7,14-dione (96). A stock solution of methylenating
reagent was prepared as described for 87. Methylenating reagent was transferred to the diketone
solution (4.2 mg, 0.0078 mmol, in 1.0 mL THF) via syringe (0.80 mL), and the reaction was
stirred for 1 h at 0 °C. Water (0.5 mL) and Et20O (5 mL) were added; then the cold bath was
removed. The layers were separated, and the aqueous phase was extracted with Et2O (5 x 5 mL).
The combined organic phase was washed with saturated NaS20 3 (1 x 10 ml), dried over Na2SO4,
filtered and concentrated. The crude residue was purified via Pasteur pipet gradient column
chromatography (50:1 hexane-EtOAc, polarity gradually increased to 13:1 hexane-EtOAc) to
give the title compound as a clear, colorless oil (3.6 mg, 85% yield). Rf (90:10 hexane-EtOAc) =
0.47.
IR' (thin film/NaC): 2933, 2857, 1725, 1461 cm' l.
'H NMR (C6D6, 500 MHz): 6 5.09-5.04 (m, 1H), 4.88 (s, 1H), 4.83 (s, 1H), 4.80 (dd, J= 2.1, 9.0
Hz, 1H), 4.46 (ddd, J= 2.4, 7.2, 15.8 Hz, 1H), 3.87 (ddd, J= 4.8, 4.8, 7.9 Hz, 1H), 3.27-3.23 (m,
1H), 2.57-2.50 (m, 2H), 2.41-2.36 (m, 1H), 2.21 (dd, J= 9.6, 14.3 Hz, 1H), 2.08 (app dd, J= 8.2,
13.4 Hz, 2H), 1.97-1.93 (m, 1H), 1.77-1.68 (m, 2H), 1.66-1.57 (m, 3H), 1.49-1.18 (br m, 10H),
1.10-1.05 (m, 15H), 0.83 (t, J= 7.3 Hz, 3H), 0.80 (d, J= 7.0 Hz, 3H), 0.27 (s, 3H), 0.14 (s, 3H).
13C NMR (C6D6 , 125 MHz): 6 212.8, 176.2, 143.4, 116.3, 78.4, 76.4, 73.7, 72.4, 41.4, 41.3, 41.2,
4:1.0, 40.4, 38.9, 36.3, 35.8, 33.8, 28.3, 26.54 (3C), 26.53, 26.0, 19.3, 19.1, 18.5, 17.5, 14.9, 14.3,
-:3.8, -4.5.
HRMS (ESI)[M+Na]+: m/z calcd for C31H5605NaSi 559.3789, obsd 559.3780.
[0']D = + 0.7 (23 °C, c = 1.4, CHC1 3)
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